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TERMINOLOGY 
Idtopatkia thrombocytopenia purpura. In this thesis the use of this term with­
out the adjective "acute" refers to the chronic form of this disease. 
ΤοταΙ megakaryocyte volume: the fractional volume of the bone marrow occupied 
by megakaryocytes. 
This can refer to the total bone marrow space of the body or to a marrow sample. 
Without other indications the term total megakaryocyte volume concerns a bone 
marrow sample. 
Serial section study: a study of all the consecutive histological sections 
(microtome slices of tissue). 
Random section study i a study of some randomly selected histological sections. 
(true) Diameter of a megakaryocyte: the maximum diameter of a megakaryocyte. 
If the diameter of a megakaryocyte is more than the thickness of the histologi­
cal section then the (true) diameter of the megakaryocyte is equal to the dia­
meter of the largest section of the megakaryocyte in a serial section study. 
(Megakaryocyte) section diameter: diameter of the profile of a (cross-) sec­
tion of a megakaryocyte in a histological section. 
Cellularity: the number of cells per tissue volume unit. 
Labelling index: the percentage of cells labelled with a radioactive marker. 
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GENERAL INTRODUCTION 
It is rather generally accepted that thrombocytopenia in patients with chronic 
idiopathic thrombocytopenic purpura (ITP) is mainly caused by a shortened pla-
telet survival. The influence of platelet production on the development of this 
kind of thrombocytopenia is not clear. Reports of platelet production, calcula-
ted from platelet survival in ITP patients are contradictory : increased, normal 
and decreased platelet productions are reported. This can points to the fact 
that quantitative or qualitative alterations in megakaryocytopoiesis is a patho-
genetic factor m ITP,at least in some of these patients. 
The aim of the present study was to iirprove our knowledge of ITP,especially con-
cerning megakaryocytopoiesis and the effectiveness of thrombocytopoiesis. There-
fore some quantitative and qualitative aspects of megakaryocytopoiesis and throm-
bocytopoiesis were examined with more recent methods of examination. 
Quantitative analysis of megakaryocytopoiesis was performed using histometncal 
determinations of the total megakaryocyte volume in bone marrow biopsies and 
using measurements of relative deoxyribonucleic acid (DNA) content of megakaryo-
cytic nuclei in bone marrow smears. Until now the morphometnc method employed, 
has not been used for quantitation of megakaryocytes. Therefore the sources of 
error will be discussed in full. Measurements of relative megakaryocytic DNA 
content were carried out by micro-fluorometry. Polyploidy levels of megakaryo-
cytes were calculated with the relative DNA content of other somatic (diploid) 
cells as a reference. The significance of ploidy levels for megakaryocytic size 
and for the degree of stimulation of thrombocytopoiesis will be discussed. The 
quantitative analysis of the total megakaryocyte volume of bone marrow tissue 
and the analysis of the ploidy of megakaryocytes were performed m order to gain 
some insight into the potential platelet generating capacity and into the de-
gree of stimulation of megakaryocytopoiesis in patients with chronic ITP. 
Qualitative insight into megakaryocytopoiesis was achieved by autoradiographic 
studies of megakaryocytes incubated with H -thymidine and by studying the ma-
turation stages of the megakaryocytes. Combined determinations of the labeling-
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index of megakaryocytes and the distribution of megakaryocytes in the various 
maturation classes gave information about the rate of maturation in chronic ITP 
in comparison with other forms of thrombocytopenia. Furthermore, some insight 
into qualitative aspects of megakaryocytopoiesis was obtained by analysis of 
autoradiographs of megakaryocytes incubated with H - undine and H - methionine, 
which gave information about ribonucleic acid and protein synthesis. These quali-
tative approaches to megakaryocyte- activity in patients with chronic ITP gave 
further information of the effectiveness of thrombocytopoiesis. 
Another indirect method of studying the megakaryocyte function in ITP was provi-
ded by the exact determination of the volume of circulating platelets. 
Finally the effective platelet production was examined using a retrospective 
study in chronic ITP patients who were splenectomized. The rise m platelet 
counts in ITP patients immediately after splenectomy was compared with platelet 
counts in other splenectomized patients. 
The results, obtained with the above mentioned methods, concerning quantitative 
and qualitative aspects of megakaryocytopoiesis in patients with chronic ITP 
suggest that ITP is a syndrome and not a clinical entity. An attempt has been 
made to distinguish different types of ITP m order to give improved indica-
tions regarding therapy and prognosis. 
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CHAPTER 1 
THROMBOCYTOPOIESIS AND MEGAKARYOCYTOPOIESIS 
1.1. THROMBOCYTOPOIESIS AND MEGAKARYOCYTOPOIESIS UNDER NORMAL CON­
DITIONS 
1.1.1 .Thrombocytopoiesis and thrombocytokmetics 
Platelets develop from megakaryocytes. This was suggested as early as 1906 by 
Wright and was later demonstrated by electronic microscopic examinations (Kautz 
1955;Yamada 1957) and by the cytochemical (Silber et al. I960) and antigenic im­
munological relationship between platelets and megakaryocytes (Vaquez et al. 
1960). 
Blood platelet counts are rather constant in man (Brecher et al. 1953;Morley 
1969a). Normal values vary between 150 and 450 χ 10 /yl. These differences are 
probüy the result of differences between the counting techniques used. 
After release from the bone marrow, about 70% of the platelets can be found cir-
culating in the blood and about 30% is enclosed within the spleen (Aster, 1966). 
With an increase in the size of the spleen there is an increase in the splenic 
platelet pool (Kutti et al. 1972). Platelets in the vascular pool and splenic 
pool are exchangeable (Aster 1966;Harker 1971a). 
Reports of platelet life span under normal conditions studied with various tech-
niques vary between 7 and 14 days (Bosch 1965,Harker et al. 1969;Na]ean et al. 
1969, 1972;Kotilainen 1969, 1971;Kuinmer 1972;Paulus 1974). In all methods for es-
timation of platelet life span,platelets are labelled with radioactive markers 
while afterwards the disappearance rate of those markers from the blood is mea-
sured. Leeksma and Cohen (1956) were the first to employ this method, using 
32 
Ρ -di-isopropylfluorophosphate for in vivo labelling of platelets. In later 
51 14 
years Cr -sodium Chromate (Aas and Gardner 1958;Aster 1969), С -serotonin 
(Heyssel 1968), S scdium sulphate (Odell et al. 1967a;Roozendaal 1973) and 
Se -mdihoonine (Nanean and Ardaillou 1969; Brodsky et al. 1972) have been em­
it 
ployed. The way in which platelets disappear, by ageing or consumption, is not 
clear. In recent publications it is postulated that the ageing of platelets in­
creases with the degree of their activity. This led to a mathematical analysis 
of platelet survival curves of labelled platelets based on the "multiple hits 
model"(Mustard et al. 1966;Murphy 1971;Paulus 1974). With this model exponential 
curves and linear curves as well as many intermediate forms can be explained by 
varying the number of hits needed for platelet death and the number of hits per 
time unit. Recent surveys of the methodology of platelet labelling, evaluation 
of recovery, survival and turnover are given by Kummer (1972) and Paulus (1971, 
1974) . 
Until recently it was generally accepted that young platelets were large plate­
lets and that platelet volume decreased with the ageing of the platelets (Det-
wiler et al. 1962;Mc. Donald et al. 1964;Karpatkin et al. 1969a,b;Garg et al. 
1971, 1972;Kraytman, 1973). Recent studies by Paulus (1974) proved that plate­
let volume is not age dependent but is determined by the manner of platelet for­
mation in megakaryocytes. 
At present there are no reliable methods for direct determination of platelet 
production. However there are various indirect approaches-
1. Estimation of platelet turnover 
U η der normal conditions there is an equilibrium between platelet turnover and 
platelet production. Platelet turnover can be calculated îvom the blood platelet 
count, corrected for splenic pooling, divided by the platelet life span. However, 
measurement of platelet life span is not reliable. Therefore the results of dif-
ferent techniques for labelling of platelets and the calculation of platelet 
turnover are rather divergent;varying from 30,000 - 70,000 platelets per micro-
litre of blood per day (barker et al. 1969;Kotilainen 1969; Kutti et al. 1971; 
Kummer 1972; Paulus 1974). 
2. Estimation of platelet radioactivity after m vivo incorporation by megakaryocytes 
35 75 
After incorporation of S -sodium sulphate or Se-methionine in megakaryocytes, 
labelled platelets are delivered into the circulation. From the course of the 
radioactivity of circulating platelets, platelet life span and platelet produc-
tion can be calculated (Nanean et al. 1969; Brodsky et al. 1970). 
3. Estimation of platelet volume 
Under normal conditions the mean platelet volume is 7 У with a range of 5 to 
]2U (Bull et al. 1965; Karpatkin 1969; Baadenhuysen 1971). If there is an in­
creased stimulation of thrombocytopoiesis the mean platelet volume is increased. 
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Therefore the mean platelet volume is a rough indication of platelet production. 
4. Estimation of total megakaryocyte volume 
The total megakaryocyte volume or megakaryocyte m ass is defined by the product 
of the number of megakaryocytes and their individual volumes.Marker et al. (]969) 
and Kutti et al. (1973) found a direct and positive relationship between platelet 
turnover rate and the total megakaryocyte volume. So, with some provisos, the to-
tal megakaryocyte volume reflects the platelet generating capacity of the marrow. 
1.1.2. Megakaryocytopoiesis 
Normally, the development of megakaryocytes from stem cells and their maturation 
occurs in the bone marrow. Megakaryocytes are also found m the circulating 
blood, more frequently in the central venous blood than m the venous blood of 
the pulmonary circulation. So pulmonary megakaryocytes (Breslow et al. 1968; 
Ikkala et al. 1972) probably do not arise in the lung (Kaufman et al. 1956b). 
Extramedullary megakaryocytes seem to be of inconsiderable importance m plate-
let production when there are no myeloproliferative diseases with myeloid metapla-
sia (Ebbe 1968c,· Marker 1970b) . 
Knowledge regarding the development and maturation of megakaryocytes has been 
mainly obtained by autoradiographic examinations of marrow cells after injection 
of labelled thymidine under various experimental conditions. These results are 
supported by studies on the haemopoietic colonies which develop in spleens after 
injection of marrow cell suspensions in animals with an aplastic marrow (Ebbe et 
al. 1971; Nakeff 1972). 
Current knowledge about megakaryocytopoiesis can be summarized as follows 
(fig. 1) : 
Pluripotential stem cells, which are not recognizable with standard morphological 
methods, develop into committed stem cells. These mononuclear committed stem 
cells, morphologically unrecognizable, can only develop up to megakaryocytes. 
Committed stem cells develop into polyploid precursor cells (Ebbe 1968c). Pluri-
potential stem cells, committed stem cells and precursor cells are proliferating 
cells. The subsequent stages of development of megakaryocytopoiesis are recog-
nizable with standard staining techniques and can be divided into three stages 
of maturation (Bessis 1956; Feinendegen et al. 1962; Odell et al. 1968). 
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Fig. 1. Model of megakaryocytopoiesis. 
In this study all recognizable cells of megakaryocytopoiesis will be denominated 
as megakaryocytes and differentiated in types I, II and III, using the classifi­
cation of Feinendegen et al. (1962). In some other studies the term megakaryocyte 
is restricted to the last maturation stage of the recognizable cells of megaka­
ryocytopoiesis while earlier maturation stages are indicated as megakaryoblasts 
and promegakaryocytes (Bessis 1956). 
Megakaryocytes, as indicated by their name, are characterized by a large amount 
of nuclear material. This varies from between 2 and 32 times the normal amount 
of DNA of somatic cells which is constant öiploid; 2N). Sklarew et al. (1971) 
postulate that polyploidal cells, at least the first stages, develop trom a fu-
sion of lymphoid cells. However most authors accept that the polyploidy of mega-
karyocytes is the result of synchronous nuclear replications without cell divi-
sion (Japa 1943; Garcia 1964,- de Levai 1964, 1968a,b; Odell et al. 1965a). This 
process is called endoduplication or polyploidization. These nuclear replica-
tions occur in precursor cells and m the megakaryocytes with the most immature 
cytoplasm (Ebbe 1965; Odell et al. 1965a). 
It is not known at which polyploidy level the most immature human megakaryocytes 
become morphologically recognizable. In animals this occurs at the 2N and 4N 
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levels (Odell et al. 1968) or at the most when the ΘΝ level is reached (Paulus 
1974). Until recently it was acocpted that the maturation of the cytoplasm occur­
red only when ploidization was finished because thymidine incorporation was only 
seen m megakaryocytes with the most immature cytoplasm (Feinendegen et al. 1962; 
Ebbe et al. 1965; de Levai 1966; Odell et al. 1968, 1971). Recently it became 
clear from studies with electron microscopic and autoradiographic techniques com­
bined with determinations of DNA that allready in DlsiA synthesizing and endomito-
tic megakaryocytes early signs of cytoplasmic specialization, such as the forma­
tion of granules and demarcation membranes, occurred (Paulus 1970, 1974; Mac Pher-
son 1971). 
Nuclei of DNA synthesizing megakaryocytes are practically round with cytoplasmic 
invaginations. These are only recognizable by electronic microscopy. After com­
pletion of the ploidization the nucleus develops to an irregular mass; a seg­
mented nucleus which finally, after platelet release becomes pycnotic (Paulus 
1974). 
It is generally accepted that maturation of megakaryocytic cytoplasm and plate­
let formation is possible in megakaryocytes at all ploidy levels of more than 
4N (Odell and Jackson 1968a; Paulus 1974) . Stadhouders (1974) has reported plate­
let formation in 4N megakaryocytes in Guinea-pigs. The amount of cytoplasm in­
creases during maturation. Granules and demarcation membranes develop in the 
cytoplasm (Yamada 1957; Odell and Jackson 1968a; Stadhouders 1974). Previously, 
it was accepted that the α granules are derived from Golgi vesicles (Jones 1960). 
But the recent observations of Stadhouders (1974): a synchronic appearance of α 
granules and demarcation membranes, the preference localisation of α granules 
in apposition to the demarcation membrane and the morphological continuity 
between demarcation membrane and the membranes of и granules, suggest a deve­
lopment of α granules from demarcation membranes. Finally, the cytoplasm is frag­
mented by the demarcation membranes and groups of granules are relaesed. The re­
sidual nuclear material is phagocytosed and destroyed by the reticuloendothelial 
cells. 
The maturation time of megakaryocytes from various animals proved to be 2 to 4 
days. This was studied by means of "flash-labelling" of megakaryocytic nuclei 
(Ebbe et al. 1965; Odell et al. 1969a). In man there are no such exact determi­
nations of maturation time available. Based on a) the results of labelling stu­
dies (Cronkite et al. 1961; Clarkson et al. 1971) b) the lag period between sti-
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mulation of thrombocytopoiesis and increased platelet production (Krevans et 51. 
1955) and c) calculations of megakaryocytic turnover from the total megakaryocyte 
volume and platelet production (Harker et al. 1969), the maturation time of human 
megakaryocytes is thought to be 4 to 6 days 
The number of human megakaryocytes is 6.1 χ 10 per kg. body weight according to 
Harker et al. (1969) using an isotope dilution method. Determinations of megaka­
ryocytic volume are only done on fixed material, so they do not have an absolute 
value. Quantitative aspects of megakaryocytopoiesis will be discussed in detail 
in the following chapter. 
1.1.3. Regulation of thrombocytopoiesis and megakaryocytopoiesis 
The rather constant blood platelet levels, the return to the original platelet 
level after an increase or decrease, e.g. m cases of blood loss and the simul­
taneous changes in megakaryocytopoiesis in those cases, indicates that there is 
a "feed back" mechanism (a regulatory mechanism) for platelet production. Many 
observations indicate that this regulatory mechanism is directed toward main­
taining a constant number of platelets per kg body weight (Aster 1967; de 
Gabriele et al. 1967c) while some observations indicate that the aim of the re­
gulatory mechanism is a constant level of circulating platelets (Harker et al. 
1969, 1970c, 1971a). One or more humoral factors are decisive in this regulato­
ry mechanism. A stimulating humoral thrombopoietic factor, thrombopoietin, has 
been demonstrated with certainty (OdeLl et al. 1961; Krizsa et al. 1969; Harker 
1970e; Roosendaal 1973; Mc Donald 1973) . 
The time interval between an induced thrombocytopenia and an increased platelet 
production is about equal to the maturation time of megakaryocytes. This implies 
a short generation time of thrombopoietin in cases of an induced thrombocytope­
nia. Roosendaal (1973) demonstrated that thrombopoietin can be formed within 24 
hours in rats. Many observations indicate that thrombopoietin influences mega­
karyocytopoiesis in different ways (Matter et al. 1960; Harker 1968b, 1969, 1970 ; 
Ebbe et al. 1968b, 1969, 1970a; Pennington et al. 1970; Rolovic et al. 1970; 
Nakeff 1972; Roosendaal 1973; Mac Pherson 1974). 
The action of the humoral factor at the committed stem cell level results in an 
increase in megakaryocytes, their ploidy and their amount of cytoplasm. It is 
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not known if the development from committed stem cell to platelet generating 
megakaryocytes or platelet release is increased by the action of thrombopoietin. 
Some investigators believe in the existence of stimulating and suppressing humo-
ral factors (Steinberg et al. 1965). While the existence of suppressing factors 
is very dubious (de Gabriele et al. 1967a,· Harker 1968b), inactivation of thrombo-
poietin by platelets seems possible (de Gabriele 1967b). 
Besides specific stimulation of thrombocytopoiesis there are also aspecific stimu-
li such as leucovorm and vincristine (Hayes et al. 1961; Räk 1972). 
Under normal conditions platelet life span is not influenced by the spleen. This 
is demonstrated by a normal platelet survival after splenectomy (Leeksma et al. 
1956). In man platelet count per kg body weight after splenectomy was normal ac-
cording to Aster (1966, 1967). On the contrary Harker (1971a) found lower pla-
telet counts per body weight in asplemc rats. 
The transient thrombocytosis immediately following splenectomy is often explained 
£у the decreased distribution volume for the circulating platelets and an aspe­
cific effect of the surgical procedure. The distribution of platelets over the 
blood volume and splenic pool is changed in splenomegaly. The number of platelets 
in the splenic platelet pool then increases (Kutti et al. 1972). Moreover some 
investigators reported a slight decrease in platelet life span associated with 
splenomegaly (Aster 1966; Kotilainen 1969; Kutti et al. 1973), while Harker et 
al. (1969) reported a normal platelet life span. Shulman et al. (1965) observed 
a fall in platelet count within a few hours following administration of a spleen 
preparation and suggested that platelets were being removed more rapidly by the 
reticuloendothelial system. 
Recent surveys of the regulation of megakaryocytopoiesis and thrombocytopoiesis 
are given by Ebbe (1970) and Harker (1970e). 
In summary it can be concluded that platelet production seems to be regulated 
by humoral factors. The existence of a stimulating humoral factor, called throm­
bopoietin, is proven. In man it is uncertain if thrombopoietin generation depends 
on the circulating platelet concentration alone or on the platelet number per kg 
body weight which is inclusive of splenic platelets. The points of attack of 
thrombopoietin in megakaryocytopoiesis are known to some extent. The spleen may 
have an inhibitory effect on thrombocytopoiesis besides the well known platelet 
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pool function. 
1.2. THROMBOCYTOPOIESIS AND MEGAKARYOCYTOPOIESIS IN CONDITIONS WITH 
ABNORMAL PLATELET COUNTS 
1.2.1. Classification of abnormal platelet counts 
Abnormal circulating platelet counts can be the effect of abnormal production, 
distribution or destruction. Sometimes there are also simultaneous qualitative 
platelet disorders, such as functional disorders (thrombopathy) which are outside 
the field of this study. 
Thrombocytopenia 
A decreased platelet count, a thrombocytopenia, can be caused by a decreased 
platelet production, a decreased platelet life span, or an increased pooling of 
platelets in the spleen. Sometimes more than one mechanism is simultaneously 
active. 
A decreased platelet production can be caused by decreased megakaryocytic con­
centration. This rarely occurs in itself but mainly as part of an insufficiency 
of all hae mato poietic cell lines (a bone marrow aplasia). 
Sometimes the total megakaryocyte volume is relatively large in comparison to 
the platelet production. These conditions are defined as ineffective thrombocyto-
poiesis. In fact one can only prove the existence of an ineffective thrombocyto-
poiesis if one can prove that the maturation time of the megakaryocytes is not 
longer in these cases, or more generally if it is possible to compare the total 
megakaryocyte volume turnover rate and the turnover rate of the total circula­
ting platelet mass with the product of the number of platelets and their indivi­
dual volumes. This has never been reported. In cases of an ineffective thrombo-
cytopoiesis the defect may be related to platelet formation, platelet release or 
intramedullary platelet destruction. These abnormalities may be congenital, as 
in some cases of familial thrombocytopenia, or acquired, as in patients with ВІ2 
or folate deficiency and Di Guglielmo's syndrome (Harker and Finch 1969). 
An abnormal platelet distribution occurs in all cases of splenomegaly due to 
an increased pooling of platelets in the spleen. This may lead to a decreased 
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platelet count in the general circulation (Aster 1966). Sometimes 90% of all pla-
telets are pooled in the spleen. 
An increased platelet turnover can be the result of inferior platelet quality. 
More frequently an increased turnover is observed in cases with an increased 
platelet destruction caused by immunological mechamsmsor by an increased plate-
let consumption by coagulation processes or direct platelet damage. Specific 
platelet destruction by immunological processes has been examined in detail. A 
well known form is the so called idiopathic thrombocytopenic purpura (ITP) which 
will be discussed separately in section 1.2.2. Moreover, immunological thrombo-
cytopenia may be drug induced. The drug may acts as hapteen or by causing an im-
munological reaction by changing the platelet membrane. Auto-immune thrombocyto-
penias are kwown as e.g. in lupus erythematosus, mononucleosis and haemolytic 
anaemias. An increased platelet consumption, sometimes leading to a thrombocyto-
penia, is seen in cases of disseminated intravascular coagulation (DIO, in ca-
ses with abnotmal vascular surfaces, e.g. caused by viral infections or athero-
sclerosis, in cases of acute promyelocytic leukaemia, hypersplenism or through 
phagocytotic activity of platelets in viral infections. 
Good surveys of conditions with increased platelet consumption are given by 
Harker (1971c) and Paulus (1971, 1974). 
Thrombocytosis 
Thrombocytosis can be the result of a reactive or autonomous process. 
Reactive thrombocytosis is seen in patients with haemorrhagia, infectious disea-
ses, malignant diseases (Hodgkin), chronic bowel diseases, rheumatoid arthritis, 
iron deficiency or temporarily after injections of vincnstin (Selroos 1973) . The 
platelets m cases of reactive or secondary thrombocytosis are functionally nor-
mal. Therefore those cases of thrombocytosis lead to an increased frequency of 
thrombosis . 
Autonomous (essential or primary) thrombocytosis rarely occurs in itself. General-
ly these thrombocytosis is a stage before, or a part of polycythaemia vera, chro-
nic myeloid leukaemia or osteomyelofibrosis. In spite of the increased platelet 
count a haemorrhagic diathesis may occur because the platelets are inferior. 
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1.2.2. Idiopathic thrombocytopenic purpura (ITP) 
Definition 
In this study ITP is defined by means of the following criteria: 
1. a decreased platelet count in the blood 
2. the absence of a primary disease which can lead to thrombocytopenia 
3. the absence of an enlarged spleen 
4. the absence of preceding drug use which could lead to thrombocytopenia 
Pathological conditions with the above mentioned criteria are often characte-
rized by the following laboratory findings which are however not obligatory for 
the diagnosis ITP: 
1. a shortened platelet life span 
2. an increase in the number of megakaryocytes 
3. the existence of antiplatelet antibodies which cannot be explained by 
exogenous causes or primary diseases 
If this clinical syndrome exists for more than 3 months we define it as chronic 
ITP. Acute ITP is characterized by data suggesting a different pathogenesis than 
in chronic ITP (Dameshek 1960; Baldini 1972). In acute ITP previous infectious 
diseases are often important in the pathogenesis (Lusher and Zuelzer 1966). 
Some authors restrict the term ITP to conditions with a shortened platelet life 
span and/or the presence of antiplatelet antibodies. Others enlarge the defini-
tion of ITP by reckoning all immunological thrombocytopenias among ITP as long 
as the specificity of the various immunological processes is not demonstrated 
(Karpatkin 1971; Baldini 1972; Stijnen 1973). 
Pathogenesis 
It is generally well accepted that shortened platelet survival due to an in-
creased destruction by the reticuloendothelial system, especially by the spleen, 
is an important factor in the pathogenesis of ITP while the role of platelet pro-
duction is controversial (Karpatkin et al. 1971; Nanean et al. 1973). 
Platelet life span 
Nanean et al. (1973) in the largest described series of 135 ITP patients always 
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encountered a decreased platelet life span. Others occasionally observed a nor-
mal platelet life span (Cohen et al. 1961; Aster et al. 1964; Donaldson et al. 
1971). These latter observations suggest decreased platelet production as a con-
tributory cause in ITP. 
Various arguments indicate an immunological, especially humoral cause of the 
decreased platelet life span: 
1. Plasma of ITP patients is mostly capable of immediately inducing a transient 
thrombocytopenia in normal recipients (Harrington et al.1951) 
2. In neonates of mothers with ITP a transient thrombocytopenia is often found 
(Epstein et al. 1950; Lusher and Zuelzer 1966) 
3. Platelets tranfused into ITP patients disappear quickly from the circulation 
(Nanean et al. 1973) 
4. Antiplatelet antibodies, in the IgG globulin fraction of the blood, can be 
demonstrated with various kinds of techniques in about 70% of the ITP patients 
(Karpatkin et al. 1969, 1972a,b) 
5. Treatment with immunosuppressive agents and corticosteroids is often success-
ful in ITP patients (Harrington et al. 1951; Shulman et al. 1964; Karpatkin 
1971a). 
Recently, cellular immunity to autologous platelets has also been suggested 
(Clancy 1972; Wybran et al. 1972). 
ITP is often assumed to be an autoimmune disease since there are similarities 
with other autoimmune diseases and the cause of the development of the antipla-
telet antibodies is idiopathic. However recently the autoimmune character was 
questioned by Nieweg et al. (1969) and Stirnen (1973) because in many cases 
they could not distinguish, by m vitro methods, between the antibodies in ITP 
and the antibodies in drug induced or post infectious thrombocytopenia. They 
suggested that multiple exogenous factors in those diseases can cause non-
specific platelet damage ("spoiled membrane") which activates a common pathway 
of immunological platelet destruction. A change m the platelet membrane should 
be necessary for the activity of these antibodies. However with this "spoiled 
membrane allergy" hypothesis (Stijnen 1973) the transient thrombocytopenia in 
normal recipients following transfusion of ITP plasma (Harrington et al. 1951) 
and the frequency of ITP in young woman, as in other autoimmune diseases, is 
difficult to explain. 
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Site ©f platelet destruction 
Studies with labelled platelets showed that in about 70% of the ITP patients 
the major site of platelet destruction is the spleen. In a minority of patients 
the liver or other sites in the reticuloendothelial system are more important 
sites of platelet destruction; possibly even intravascular destruction occurs 
(Najean et al. 1967; Fontein 1971; Aster 1971, 1972). Phagocytosis of platelets 
by splenic cells has been demonstrated by electronic microscopy {Mac Millan et 
al. 1974). 
The role of the spleen 
The spleen plays an important role in pathogenesis of ITP as it is often the 
major site of platelet destruction (Najean et al. 1971). Platelet survival time 
may return to normal after spelenctomy. 
The antiplatelet antibody production in the spleen of ITP patients seems to 
be less important although this acitivity of the spleen is suggested by the 
much increased IgG synthesis activity of lymphoid cells from suspensions of 
spleen tissue (Mac Millan et al 1974). Moreover a significant decline in 
the serum anti-platelet antibody titre following splenectomy is seen in many 
patients with ITP (Karpatkin 1972a). 
The platelet pooling in the spleen of patients with ITP is normal. 
It is an old question if m ITP the spleen has an inhibitory effect on platelet 
production. This possibility has not been ruled out with certainty. 
Platelet production 
Studies concerning calculations of platelet productiore from survival rates of 
labelled platelets in ITP are conflicting. Most observations indicate an increa-
sed platelet production, however in some studies a normal or even a decreased 
platelet production was calculated in some patients (Cohen et al. 1961; Ebbe 
et al. 1963; Äster et al. 1964a, 1966b; Davey 1966; Baldini 1966; Najean et al. 
1963, 1969; Harker 1970c; Brodsky et al. 1972; Paulus 1974). The great diffe-
rences in reported platelet production is illustrated by comparing the studies 
of Najean et al. (1963) concerning 85 untreated patients and Harker (1970c) who 
studied 16 patients. They calculated respectively that the mean platelet pro-
duction was 1.3 and 4 times the normal value, with a range of 0.5 to 8. These 
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conflicting results of platelet production calculated with platelet survival 
studies are probauy the result of the differences between these methods and the 
inaccuracy of all methods (Brodsky et al. 1972). 
Another approach to the problem of the eventually decreased platelet production 
in ITP is a qualitative and quantitative study of megakaryocytes. 
Assuming an immune basis in ITP it is conceivable that since the platelets and 
the megakaryocytes have antigens in common, they are therefore both attacked 
(HumphiEy 1955; Vaquez et al. I960; van Boxtel 1Э72) . 
Antibodies have been demonstrated on megakaryocytes from some ITP patients and 
on normal megakaryocytes incubated with sera from patients with chronic ITP 
(Pisciotta et al. 1953; Mac Kenna 1962). The functional significance of these 
observations is not clear. In only very few of the many experimentally induced 
thrombocytopenias has an impairment of megakaryocyte function and platelet pro­
duction been suggested (Witte 1955; Rolovic 1970a). A single patient with, pro­
bably, an immunologic pathogenesis of a reduced number of megakaryocytes has been 
described (Quattrm et al. 1963). 
One would expect that in cases of drug induced immune thrombocytopenia megakaryo­
cytes are also attacked. However a recent survey by M с Vie (1973) gives no evi­
dence of a disturbance of megakaryo cyte function and platelet production in these 
cases. Based on a normal platelet life span or an inconsiderable decrease in pla­
telet life span m some patients with a drug induced thrombocytopenia, Stijnen 
(1973) suggests the existence of an allergially impaired bone marrow function. 
However, to our opinion it is unlikely that in cases of a drug allergy platelets 
would be completely, or nearly completely, spared while megakaryocytes are exten­
sively damaged. 
1.2.3. Thrombocytopoiesis and megakaryocytopoiesis in conditions 
with abnormal platelet counts 
The platelet generating capacity and platelet production rate can be studied in 
megakaryocytes. Not only the number of megakaryocytes, and the volume but also 
the ploidy, the nucleus-cytoplasm ratio, the amount of platelet generating cyto­
plasm and the maturation of the cytoplasm are decisive. Moreover it is necessary 
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to know the maturation rates of megakaryocytes and the velocity of platelet re­
lease. Information about the platelet volume gives insight into the amount of 
platelets which can be formed from the total megakaryocyte volume and into the 
degree of stimulation of thrombocytopoiesis. In man only some of the factors men­
tioned regarding megakaryocytopoiesis and thrombocytopoiesis are known. 
The numbers of megakaryocytes in various conditions have been most extensively 
studied. An increased number of megakaryocytes has been reported in various con­
ditions for instance during an increased platelet turnover or an increased poo­
ling of platelets in the spleen, in conditions which may lead to thrombocytopenia, 
and in primary or secondary thrombocytosis. In table 1 the results of some stu­
dies in marrow biopsies are summarized. Maximal increases in the number of mega­
karyocytes, up to 10 times the normal values, were observed in cases of throm­
bocytosis and Di Guglielmo's syndrome. A decreased number of megakaryocytes 
has occasionally been reported in congenital disorders; amegakaryocytic throm­
bocytopenia (Shaw et al. 19 59) and frequently secondary to bone mariow damage 
by drugs or radiation. 
The diameter of megakaryocytes in various pathological conditions has been amply 
studied by Harker and Finch (1969) . They found that megakaryocyte size was in­
versely related to the circulating pbtelet count. There are two exceptions: auto­
nomous thrombocytosis and ineffective thrombocytopoiesis. In cases of autonomous 
thrombocytosis, as observed in myeloproliferative diseases (see section 1.2.1.), 
the mean volume of megakaryocytes is not decreased but on the contrary is some­
times even Й times more than normal (Harker et al. 1969; Kutti et al. 1973). 
In cases of ineffective thrombocytopenia the mean volume of megakaryocytes was 
decreased or normal, with mean values of about 50% of normal values, although 
there exists a thrombocytopenia. 
An increased mean megakaryocytic size was demonstrated in hypoproliferative throm­
bocytopenias e.g. in patients treated with cytostatic drugs. The mean megakaryo­
cytic diameter was also nearly always increased in thrombocytopenia caused by 
an increased platelet turnover. This resulted in an increase in the megakaryocy­
tic volume of between 10 and 50% in idiopathic thrombocytopenic purpura, lupus 
erythematosus, chronic lymphatic leukaemia, lymphosarcoma, Hodgkin's disease 
and consumptive coagulopathy (Harker et al. 1969, 1 α70). In thrombocytopenia 
caused by an enlarged splenic pooling of platelets,e.g. in patients with conges­
tive splenomegaly or osteomyelofibrosis, the mean megakaryocytic diameter was 
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Table 1 
Quantitation of megakaryocytes in histological sections of bone marrow in va-
rious diseases 
Studies 
Barta (1932) 
Williams (1942 
Franzén 
et al. (1961 
Harker and 
Finch (1969) 
Megakaryocytes 
no. of sections 
(x normal) 
0.8-
1.Τ­
Ι.4-
0Л-
1.4-
) 0.3-
0.8-
» 0.4-
0.02 
1.2 
1.9 
1.5 
0.9 
1.6 
4.9 
5.8 
4.6 
-1.6* 
Number 
of 
patients 
3 
2 
2 
3 
2 
39 
20 
20 
15 
Platelet 
count 
(χ103/μ1) 
103- 138 
158- 186 
118- 137 
104- 139 
242- 267 
? 
60-1100 
120- 960 
2- 84 
Diagnosis 
typhoid fever 
sepsis 
acute leukaemia 
pernicious anaemia 
gastric cancer 
pneumonia 
chron. myelogenous leukaemi 
polycythaemia vera 
hypoplasia о r marrow 
infiltration 
1.5-11.4* 
Rutti et al. 
(1973) 
1.0-
1.1-
2.0-
2.4-
1.3-
1.9-
3.6-
2.2-
3.1* 
4.7* 
2.6* 
8.5* 
8.9* 
8.0* 
9.4* 
8.1 
9 
7 
4 
9 
7 
5 
3 
20 
42- 86 
4- 70 
9- 100 
434-1484 
265-2670 
430-1440 
507- 981 
148-1045 
14- 99 ineffective production 
(Di Guglielmo, В defic, 
familial thrombocytopenia) 
splenomegaly (Hodgkin, myelo­
fibrosis, congestive) 
sec. immune thrombocytopenia 
platelet consumption (coagu­
lopathy) 
reactive thrombocytosis 
thrombocythaemia 
polycythaemia vera 
chron. myelogenous leukaemia 
polycythaemia vera 
•number of whole megakaryocytes, not the number of sections 
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normal or increased. 
A decrease in the mean diameter of megakaryocytes was observed in patients with 
a reactive thrombocytosis e.g. caused by infectious diseases, iron deficiency 
or malignant diseases (Marker et al. 1969). In patients with chronic myeloid 
leukaemia with thrombocytosis a decreased megakaryocytic diameter was observed 
not only by Franzen et al. (1961) but also by Harker et al. (1969), suggesting not 
an autonomous but a reactive proliferation of megakaryocytes. 
The total megakaryocyte volume, the product of the number of megakaryocytes and 
their volumes, was calculated by Harker and Finch (1969) and Rutti et al. (1973). 
In pathological conditions this sometimes proved to be 12 times the normal value. 
These maximal values were seen in patients with polycythaemia vera and idiopathic 
thrombocytosis. 
The few investigations of maturation time of megakaryocytes in man showed no 
clear difference between normal and stimulated thrombocytopoiesis e.g. after 
massive blood loss (Krevans et al. 1955» Harker et al. 1969). However the num-
ber of observations is still scanty. The influence of a suppression of thrombo-
cytopoiesis on the maturation time of megakaryocytes in man has not been exa-
mined. 
No other observations have been reported concerning the influence of stimula-
tion or suppression of thrombocytopoiesis on the nuclear-cytoplasm ratio and 
the platelet release in man. 
Conclusion 
Of the methods now available to characterize megakaryocytopoiesis quantitative-
ly, the estimation of the total megakaryocyte volume per bone marrow volume 
or per kg body weight seems to be the most useful because of the good positive 
relationship between this value and the calculated platelet production. 
This study will attempt to give a better insight into the megakaryocytopoiesis 
and thrombocytopoiesis of ITP, especially bone marrow function, by studying 
qualitative and quantitative aspects of megakaryocytes with methods which 
are relatively new in this field. 
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CHAPTER 2 
OBSERVATIONS ON MEGAKARYOCYTES BY MORPHOMETRY AND BY PLOIDY QUAN-
TITATION 
2.1. INTRODUCTION 
2.1.1. The number of megakaryocytes 
The value of megakaryocyte counts will depend on the representativity of the mar-
row sample for the marrow as a whole. Therefore it is necessary to know: 
1. if the marrow cellularity in different bones and in different localisations 
within a bone is constant and if there is a homogeneous distribution of vari-
ous cell types. 
2. if the marrow sample is representative of that marrow localisation of the bo-
dy. This seems especially questionable in aspirated marrow samples. 
There are only a very few accurate data concerning bone marrow cell constancy. 
Williams(1942) found a considerable variation in the cellularity of the marrow 
from different bones. So if megakaryocyte counts are expressed per unit marrow 
volume the marrow sample should always be taken from the same localisation. 
However, in different parts of a particular bone marrow localisation a constant 
cellularity has been reported by Barta (1932), Chan et al.(1966) and Krizsa et 
al. (1966). It is generally accepted that there is a uniform distribution of 
different cell types in different marrow localisations (Barta 1932; Custer and 
Krumbhaar 1936; Nickerson and Sunderland 1937; Williambl942; Chan et al. 1966; 
Krizsa et al. 1966; Harker 1968a). The last mentioned author found a standard 
error of the mean of only 5% for the number of meqakaryocvtes in human marrow 
obtained from multiple biopsies of the right and left iliac crest. 
Sometimes it is suggested that marrow aspirates are less representative for the 
marrow than marrow biopsies (Diggs 1948; Presley 1952). However this has never been 
proven by comparison of megakaryocyte counts in aspirates and biopsies from the 
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same marrow localization. 
Counting megakaryocytes in bone mcœrow aspirates 
Techniques for counting the number of megakaryocytes 
Megakaryocyte counts m marrow aspirates can be carried out by a variety of 
techniques e.g. techniques using bone marrow smears, coverslip preparations 
(Diggs and Hewlett 1949), thick drop preparations (Osgood 194Θ) and haemocyto-
metric methods (Pizzolato 1948). All methods using aspirated marrow have theo­
retical and practical disadvantages, namely: 
1. The mentioned representativity of the aspirated marrow. 
2. The dilution of marrow with aspirated blood is unknown and varies with every 
puncture. This variable dilution causes an important error in determining me-
cplaryocytes per μΐ. This error can be overcome to some extent by determining me­
gakaryocytes in proportion to nucleated red cells or young myeloid cells. 
3. There is a variable loss of megakaryocytes during preparation. This can be con­
cluded from the wide range of normal values found m different studies and 
from a comparison of megakaryocytic counts in aspirated marrow and marrow 
biopsies. 
4. A number of unknown variables and errors are introduced: by taking a relati­
vely small sample from a non homogeneous aspirate; by the settling out of 
cells; by the dilution error; and by the counting technique using a haemo-
cytometer (Ebaugh, 1951). 
In smears and coverslip preparations there is an irregular distribution of mega­
karyocytes. In smears the megakaryocytes tend to concentrate at the far end 
and at the lateral margins of the preparation. In the best coverslip preparations 
the distribution is still uneqial (Diggs 1948). Counting of megakaryocytes in 
marrow aspirate suspensions with the aid of a haemocytometer (the chamber method) 
gives better results than megakaryocyte counts in smears, mainly due to the more 
even distribution of the megakaryocytes. 
The results of megakaryocyte counts from smears, coverslip and thick drop techni­
ques reported by Pizzolato (1946), Ebaugh (1951), Garg (1971) and Harker (1971) 
are very unsatisfactory. Normal megakaryocyte counts vary greatly in these stu­
dies and there is a wide range in each study; much more than the range found 
with methods using a haemocytometer or histological sections. For this reason 
Presley (1952) stopped the time consuming counting method in marrow smears and 
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used a screening method. 
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Fig. 2. Comparison of the evaluations of the number of megakaryocytes by screening 
in the same 18 bone marrow smears by 3 experienced workers (S,D and B) . N:nor-
mal number of megakaryocytes; > , ^  N: increased number; <N: decreased number 
Pizzolato (1948) compared various chamber method studies and found that the 
results were m agreement with each other. The range for normal values in indi­
vidual studies was often much smaller than with the other above mentioned methods 
which also employed aspirated material. Good results were obtained by Pizzolato 
(1948): the highest value for normal subjects was only about 2.5 times greater 
than the lowest value. The admixture of current blood cells m aspirated marrow 
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can be prevented by isolation of particles of bone marrow from aspirated material. 
One would expect that estimations of the number of megakaryocytes in dispersions 
of the disintegrated tissue would give better results. Japa (1943) used such a 
method but found too few megakaryocytes in normal subjects; 0.25% ± 0.08 (1SD) 
of the nucleated cells. 
In conclusion, the results of methods for counting the number of megakaryocytes 
using aspirated fluid marrow samples are unsatisfactory, especially regarding 
the questionable representativity of the sample. Of these methods counting tech­
niques employing a haemocytometer give the best results. 
Counting of megakaryocytes in histological maxvow sections 
The use of bone marrow biopsies or particles of aspirated marrow (Lundin et al. 
1972; Rutti et al. 1973), for the counting of megakaryocytes has the following 
advantages over the use of the previously discussed aspirated fluid marrow 
samples: 
1. There is no loss of megakaryocytes during preparation. 
2. The sample is more representative of the marrow as a whole. 
3. There is no dilution with peripheral blood. 
4. There areno faults introduced by preparation of the smears or dilutions. 
Some disadvantages are the time consuming preparation, and the overestimation 
of the number of megakaryocytes. In a histological preparation only a portion of 
each megakaryocyte appears in a single section aid a single megakaryocyte is 
therefore counted several times in serial sections. This "multiple counting" 
makes a correction of the number of cross-sections of megakaryocytes counted ne­
cessary. The theoretical number (N) of cross-sections of a megakaryocyte in 
histological sections is given by the formula (Harker ]968 a): 
N = ^  + 1 (1) 
Τ 
2 R is the true (maximal)diameter of the megakaryocyte 
Τ is the thickness of the section 
N is the number of cross-sections (cuts) per megakaryocyte 
The diameter of the megakaryocyte in the prepared histological material is in­
fluenced by the nature of the fixation and embedding. The recognizability of 
cross-sections of megakaryocytes depends on the staining, the maturation stage 
of the cytoplasm and the presence or absence of a part of the typical nucleus. 
In practice these factors lead to a mean multiple megakaryocyte counting fac­
tor of about 7 in histological sections with a thickness of 3 ym, while the 
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multiple counting of smaller cells e.g. nucleated erythroid cells may be dis-
regarded in the counting of these cells (Barker 1968a). Comparing the results of 
counting of megakaryocytes in different studies, the following points areto be 
taken into account: 
l.The number of cross-sections of megakaryocytes depends not only from the nuirber 
of megakaryocytes but also from the diameter of megakaryocytes. 
2. The thickness of the histological section influences the number of cross-sec-
tions per megakaryocyte. 
3. Shrinkage of the marrow during the histological preparation influences the 
number of cross-sections per unit marrow volume. 
4. The recognizability of the cross-sections of megakaryocytes depends from stai-
ning techniques and thickness of the section. 
5. The significance of the number of .cross-sections of megakaryocytes per unit 
marrow volume depends on the cellularity of the examined marrow. There is a dif-
ference in cellularity between different bones. 
All these factors can markedly influence the number of megakaryocyte cross-sec-
tions per unit marrow volume or per area of the histological section. If mega-
karyocyte numbers are given as a proportion of other marrow cells point 5 can be 
disregarded. So it has to be realized that the megakaryocyte numbers, especially 
when given per test volume, are only relative data. 
Results of studies of the number of megakaryocytes in histological sections are 
summarized in table 2. Barta (1932) found in sections of 4-5 \im thickness, 50 
to 60 megakaryocytes per 100 test fieHs in normal subjects. As he did not des-
cribe the dimensions of the examined test fields, his numbers are only of impor-
tance in showing the narrow range of his normal values. Dameshek (1935) reported 
differential counts in marrow sections. 0.7 -3.3% of the nucleated cells were me-
gakaryocytes. The number of analyzed cells studied (300), was too limited since 
Custer and Krumbhaar (1936) have remarked the inaccuracy in a differential count 
of 500 cells for determining the incidence of cells as sparsely distributed as 
megakaryocytes. Based on empirical data they decided to count a total of about 30 
megakaryocytes and found that 0.15-0.37% of the nucleated cells were megakaryo-
cytes (table 2). Nickerson and Sunderland (1937) recommended examining still more 
nucleated cells and reported that 0.25 to 0.42% of the nucleated cells were me-
gakaryocytes. In the studies of Custer and Krumbhaar (1936) and Nickerson and 
Sunderland (1937) material for normal controls was obtained by post mortem exa-
minations, sometimes of patients diagnosed as purpura, polycythaemia vera, chro-
nic haemorrhage, neutropenia, pulmonary embolism and some other abnormalities 
with known alterations in the number of megakaryocytes. One of the first reports 
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of numbers of megakaryocytes in presumable normal subjects is given by Williams 
Table 2 
The number of megakaryocytes in bone marrow sections in "normal*" subjects 
Studies 
Megakaryocyte count 
no. of sections 
% of nucleated 
cells 
mean S.D.** 
per mm marrow 
S.D.** 
Thickness 
of section 
ym 
Custer and Krumb- 0.25 24 
haar (1936) 
Nickerson and Sun- 0.33 17 
derland (1937) 
Williams(1942) 
Franzén et al.(1961) 
Harker et al. (1969) 0.33 13 
Lundin et al.(1972) 
This study 
No. of 
subjects 
studied 
2747 
5087 
6300 
5495 
31 
33 
42 
28 
5 
6 
3 
3 
5 
16 
20 
15 
25 
14 
* In some of these studies the examined subjects were suffering from diseases 
which may influence megakaryocytopoiesis 
**SD: as % of mean value 
(1942). He studied the vertebral marrow of 16 patients who died some hours af-
ter traumatic injuries»and reported 1791-4837 megakaryocytes per mm of marrow 
(table 2). In a study of megakaryocyte counts in polycythaemia vera and chronic 
myelocytic leukaemia Franzén et al. (1961) used patients with Hodgkin's disease 
as control subjects. They counted 5087 megakaryocytes per mm in the control 
subjects. Although in Hodgkin's disease the blood platelet count is frequently 
moderately increased (Abrahamsen 1970), this figure is in accordance with the 
finding of 6300 megakaryocytes per mm in healthy control subjects by Lundin 
et al. (1972). Harker et al. (1969) reported in biopsies of normal subjects a 
nucleated red cell-megakaryocyte number ratio of 465(t)60:1. They were the 
first to correct the number of observed megakaryocytes for the multiple 
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counting of megakaryocytes brought about by the large diameter of megakaryocytes 
in comparison with the thickness of the histological section . Assuming 22% of 
the nucleated cells are nucleated red cells, one can calculate that Marker's 
findings correspond to a number of sections of megakaryocytes totalling 0.33% 
of all the nucleated cells. 
Conclusion 
Although the described studies often show differences in examined bone marrow 
localizations, histological techniques, thickness of sections and selection of 
test areas, the similarity of the megakaryocyte counts in control subjects and 
the small range in most studies supports the validity of the method. The range 
for normal values in histological sections of biopsies is smaller than the 
range in most studies concerning megakaryocyte numbers in aspirated marrow, 
which indicates that estimating the number of megakaryocytes In histological 
sections in the more accurate method. 
Total number of megakaryocytes in the human body 
Τ he number of megakaryocytes in the body has not been studied by examina­
tion of post mortem material but only employing isotope dilution methods. A mar­
row biopsy is taken some time after the injection of radioactive iron. In the 
marrow sample the ratio" number of megakaryocytes/ number of nucleated red 
cells is estimated. Using plasma radioactive iron turnover figures, the total 
number of nucleated red cells in the body is estimated. With this knowledge and 
the ratio megakaryocytes / nucleated red cells in the marrow sample, the total 
number of megakaryocytes in the body can be calculated (Marker 1968a). A va­
riant of this principle was used by Fillet (1971), measuring the ratio: number 
of megaleiyocytes /radioiron activity m the marrow sample. A disadvantage of 
the present isotope dilution methods is the radiation exposure of the patient. 
59 Moreover methods using Fe can only be applied in subjects with normal erythro-
poiesis and iron kinetics. Marker's (1968a) results with this method showed a 
small range for normal subjects, 6.1+0.7 χ 10 megakaryocytes/kg body weight. 
However when theie is a normal erythropoiesis one can expect that the erythroid 
mass/kg body weight will be constant. In this case the use of the isotope dilu­
tion method has no advantages over the estimation of the number of megakaryocytes 
in the marrow saiple as a proportion of the nucleated red cells. On the other hand 
in cases of anaemia, the isotope dilution method has the advantage of correc­
ting the megakaryocyte count m histological sections for the eventually abnor-
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mal marrow erythroid mass/kg body weight. But especially in cases of anaemia 
the risk of abnormal iron kinetics often makes this method impracticable. So 
in clinical practice isotope dilution methods, using iron kinetics to estimate 
the total number of megakaryocytes in the body, has often no advantage over the 
estimation of the number of megakaryocytes as a percentage of nucleated red 
cells in a biopsy. 
Conclusions 
The best results in estimation of the number of megakaryocytes have been obtained 
in marrow samples from marrow biopsies. As the diameters of megakaryocytes are 
more than the thickness of histological sections one has to take into account 
a multiple counting of megakaryocytes because one megakaryocyte is visible in 
more than one histological section. When there is a normal turnover of ery-
throid or myeloid cells, comparison of the number of megakaryocytes with the 
number of these haemopoietic cells in marrow biopsies gives good information 
regarding the number of megakaryocytes, not only in the histological section, 
but also in the whole body. 
2.1.2. Megakaryocyte volume and cytoplasm-nucleus ratio 
The importance of the volume of megakaryocytes for the platelet production 
capacity is often underestimated. Many studies concerning alterations in throm-
bocytopoiesis have only been concerned with the number of megakaryocytes. One 
has to realise that a relatively small increase in the diameter of a sphere 
results in a rather large increase in the volume. 
The size of megakaryocytes increases both with increases in ploidy level and 
with degree of cytoplasmic differentiation (Japa ]943;Harker 1968a;Ebbe et al. 
1968a,· Odell et al. 1970; Stadhouders 1974). Therefore the mean megakaryocytic 
volume will depend on the frequency distribution of ploidy levels and maturation 
stages. These depend on the degree of stimulation or suppression of megakaryocyto-
poiesis. In animals Stadhouders (1974) found a fixed cytoplasm-nucleus volu­
me ratio for a particular maturation stage which was defined by the number of 
α granules. In Guinea pigs this ratio was about 2 for very immature and about 
8 for mature megakaryocytes. This implies that the volume of a megakaryocyte of 
a particular ploidy level at the end of maturation is 3 times more than at the 
start of maturation. This constancy of the cytoplasm-nucleus volume ratio implies 
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that the megakaryocytic volume of a 64 N megakaryocyte will be twice the volume 
of a 32 N megakaryocyte of the same maturation stage. So there is an overlap of 
volumes of mature megakaryocytes at a particular ploidy level and immature mega­
karyocytes from a subsequent ploidy level. 
Harker and Finch (1969) found a constant mean cytoplasm-nucleus volume ratio 
of megakaryocytes in normal human subjects, in patients with idiopathic throm­
bocytopenic purpura, in hypoplastic thrombocytopenia and also in В., deficiency-
thrombocytopenia, although in the last case there was a decreased platelet pro­
duction per nuclear unit. In the first stages of acute changes in megakaryocyto-
poiesis in rats Harker (1968a) found a small decrease in the mean cytoplasm-
nucleus ratio. This decrease can be explained by an increase in the number of 
immature megakaryocytes. 
Influenae of the teahmque employed for measurement of тедакагуосуіга size 
Megakaryocytic size is measured by estimation of the diameter or the surface 
area of the image of intact megakaryocytes in smears or squash preparations or 
the diameter of sections of megakaryocytes in histological sections. Comparing 
the results of measurements of megakaryocytic size one has to take into account: 
a. the mode of preparation of the marrow sample 
b. whether the measurements were done m marrow smears or in sections 
c. m random sections or serial sections. 
a. Marrow sample preparation 
Estimation of megakaryocytic diameter is usually done on fixed and stained mar­
row samples. Fixation, dehydration, embedding and staining often cause shrinkage 
or swelling of the various bone marrow cells (Harker 1968a). Diameter measure­
ments therefore are only relative and does not represent the diameter in vivo. 
Therefore measurements of megakaryocytic diameter are valid for comparative stu­
dies using the same method, but large differences can be expected between stu­
dies using different methods of marrow preparation. 
b. Measurements in smears or m sections 
In smears and squash preparations of marrow particles the megakaryocytes are 
more or less flattened. The degree of flattening is different for the various 
megakaryocytic sizes (Odell et al. 1970). As a consequence of these differences 
in thickness of megakaryocytes of different volumes in smears and squash prepa-
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rations, measurements of the megakaryocytic diameter (which vary from 30 to 
60 μιη) , or the surface area of the image of megakaryocytes cannot be used for 
calculations of the megakaryocytic volume. 
c. Histological studies of serial or random sections 
In serial section studies megakaryocytes appear as approximately spheroidal cells 
(Нагкег 1968ώ). As the diameters of megakaryocytes are larger than the thickness 
of the histological section one has to measure the diameter of a section passing 
through the centre of the megakaryocyte. If serial sections of each megakaryo­
cyte are not available one can use the known relationship between the mean maxi­
mal diameter of spheres of different sizes and the diameter of sections through 
the spheres; given by the formula (Vnderwood, ]970): 
r = -
π
- (2) 
4 m 
r is the mean maximal radius of the spheres 
m is the mean of the reciprocal values of diameters 
of sections of the spheres 
This formula assumes infinitely thin sections and the recognition of all small 
sections of a sphere. However in practice this formula 's use is restricted 
because 
a. histological sections through megakaryocytes have a certain thickness and 
b. not all sections of megakaryocytes are recognized. 
Regarding a., therefore, the relationship between the maximal diameter of a 
single megakaryocyte and the mean diameter of all the sections through that 
msgakaryocyte depencs on the relationship between the maximal diameter and the 
thickness of the sections. When the thickness of the section is very large with 
respect to the maximal diameter of the megakaryocyte the diameter of a section 
of a megakaryocyte will be the true diameter of that megakaryocyte. With decrea­
sing thickness of the section the difference between the maximal diameter and 
the mean diameters of sections of megakaryocytes will increase. If the size 
of the megakaiyocyte decreases and the thickness of the section is constant then 
the difference between the maximal diameter and the mean diameter of the sec­
tions will decrease. 
Regarding b it is easier to recognize small sections of megakaryocytes in 
serial section studies than in random studies, e.g. with the aid of photomicro­
graphs of adjacent sections. Recognizing more small sections results in a smal­
ler mean diameter of the sections of the megakaryocytes. So the difference be­
tween the maximal diameter and the mean diameter of the sections will be greater 
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in serial sections than in random sections. 
From the foregoing it must be concluded that the results of megakaryocytic size 
measurements in histological sections are only relative. 
Results of measurements of megakaryoaytio size 
With a photomicrogravimetnc technique Ebbe et al. (1968a) measured the surface 
area of the image of megakaryocytes of rats in smears. The mean surface areas of 
successive maturation stages, of megakaryocytes types I, II and III, were res-
2 
pectively 771, 1401 and 1799 pm. Using the same technique Odell et al. (1970) 
found about the same ratio for these different maturation stages m squash pre-
parations. The ratio between the surface area of 8N, 16N and 32N type I mega-
karyocytes was 10:17:26. With a microplanimetnc procedure Albrecht et al. (1974) 
found that the surface area of the image of normal human megakaryocytes in smears 
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was often between 500 and 3000 pm . Franzen et al. (1961) illustrated the above 
mentioned influence of the flattening of human megakaryocytes in smears. They 
found a larger surface area of the image of megakaryocytes in smears than in 
histological sections. In patients with Hodgkin's disease Franzén et al. (1961) 
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reported a cross section area of megakaryocytes between 140 and 800 um , with 
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a peak value at 350 Urn . Despite the differences in the methods used there is 
rather good agreement with the results of studies concerning the size of sections 
of megakaryocytes in histological sections. Lundin et al. (1972) found a mean 
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cross section area in megakaryocytes of 296 \im ± 60 in normal man. Exact com-
parison of the mean diameter of megakaryocytes with the mean surface area of the 
images of megakaryocytes is not possible without some knowledge of the frequency 
distribution of both. The calculated surface area of the images of megakaryo-
cytes, using the mean diameter of spheres of different size, is much less than 
the true mean surface area of images of megakaryocytes. Still the results of 
measurements of cross section areaj of megakaryocytes of Franzén et al. (1961) 
and Kutti et al. (1973) agree with the measurements of diameters of sections 
of megakaryocytes made by Pennington (1970) and Harker et al. (1968a, 1969). 
Pennington (1970) found section diameters of 10 to 26 μπι in random sections of 
megakaryocytes from rats. Harker et al (1968a, 1969) found no differences be­
tween the size of megakaryocytes in man and rats and calculated the mean true 
diameter of human megakaryocytes as 20.8 цт + 3.3 from measurement of diameters 
m random section studies corrected with the quotient of the true diameter and 
mean diameter of the sections of megakaryocytes found in serial section studies. 
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Calculations of mean megakaryoaytia volume 
In principle calculation of mean megakaryocytic volume can be done using diffe-
rent data: 
1. Frequency distribution of individual volumes of megakaryocytes. 
2. Frequency distribution of individual true diameters of megakaryocytes 
3. Total megakaryocytic volume or total megakaryocytic surface and the number 
of megakaryocytes. 
Up to the present such data are almost lacking and no exact data on mean mega-
karyocytic volumes are available. Harker (1968a) calculated a mean megakaryocytic 
volume of 4700 ym ± 100, from the mean megakaryocytic diameter, with the formu-
la: 
volume of a sphere= 0.5236(2R) (3) 
R is the radius of a sphere 
However the volume calculated from the mean diameter of spheres of different 
sizes is less than the mean volume of the spheres. 
Conolusions 
There are no exact measurements of megakaryocytic volume available. Upto now the 
best available approaches are measurements of the true diameters of megakaryo-
cytes in histological serial section studies. This has yielded diameters varying 
from about 14 to 28 pm (Harker 1968a, 1969). These data are probably relative 
as a consequence of the influence of the histological preparation of megakaryocy-
tes on their size. 
2.1.3. Total megakaryocyte volume 
As mentioned in chapter I the total megakaryocyte volume of the marrow (the pro-
duct of the number and volume of megakaryocytes) indicates the potential plate-
let production capacity of the marrow if there is a steady state with normal 
maturation time of the megakaryocytes, a normal cytoplasm-nucleus ratio, a nor-
mal volume of delivered platelets and when there are no extramedullary platelet 
producing megakaryocytes. In studies of megakaryocytopoiesis attention has often 
only been paid to the number of megakaryocytes. Often the large effect of a small 
increase in the diameter of the megakaryocytes on the platelet production capa-
city is neglected. For instance, one can calculate that Pennington's (1971b)re-
ported small difference in polyploidy distribution of megakaryocytes, which 
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means a small difference in the diameter of megakaryocytes between normal and 
ITP patients, implies a two fold increase in the total megakaryocyte volume in 
ITP patients (table 3). In the studies by Lundinet al. (1972) and Kutti et al. 
(1973) the mean megakaryocyte area of sections of megakaryocytes was measured 
by planimetry and the total volume of sections of megakaryocytes m marrow sec-
tions was determined by calculating the product of the mean megakaryocyte area 
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times the number of sectiore of megakaryocytes per mm bone marrow. This resulted 
in a total megakaryocyte volume of 0.57% of the marrow volume in normal subjects. 
Until now only Marker et al. (1968a, 1969 ) has tried to calculate the total mega-
karyocyte volume of the marrow in the body. As already stated they estimated the 
total number of megakaryocytes in the body (6xl0"/kg body weight) with a sensi-
tive isotope dilution method and calculated the mean volume of megakaryocytes 
(4700 y3) from the mean diameter of megakaryocytes in marrow biopsies. Regard-
less of some imperfections in the methods used, Harker found a positive corre-
lation between the total megakaryocyte volume and the effective platelet produc-
tion. As, in theory, the platelet generating capacity of the bone marrow will 
depend on the number of megakaryocytes and their individual volumes, and a close 
relationship was found (Harker et al. 1969) between the total megakaryocyte vo-
lume of the marrow and platelet production, we tried to obtain information 
about the number of megakaryocytes, together with their volumes, in normal sub-
jects and ITP patients. For this reason we studied the total megakaryocyte volume 
of tissue sections of marrow biopsies with a morphometncal method which is des-
cribed in 2.2.1. 
2.1.4. Megakaryocyte ploidy 
Teahmques for determnatbon of megakaryocyte-ploidy 
Ploidy determinations are approached in three ways: 
a. the number of "nuclei" or lobes of nuclei, (Japa 1943, Harker 1968b) may be 
counted 
b. DNA may be quantitated 
c,· the nuclear volume may be measured 
a. The number of "nuclei" or lobes of the nuclei. As discussed in chapter I the 
nuclear segmentation will be visible by light microscopy if the polyploidization 
of the individual megakaryocyte is completed. Therefore there will be no good 
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relationship between the number of nuclear lobes and the DNA content in imma-
ture megakaryocytes. Moreover the technique of lobe counting is not free from 
criticism (de Levai et al. 1971). 
b. The DNA content 
DNA measurements of individual Feulgen stained nuclei of megakaryocytes has 
been conducted by absorption-cytophotometry and microfluorometry (Paulus et 
al. 1971). Microfluorometry with incident light proved to be superior (Böhm 
et al. 1968). The measured stain content is related to the amount of DNA pre-
sent. In recent studies some influence of the structure of the chromatin net-
work on the Feulgen-DNA values was observed. Nuclei with a condensed chromatin 
showed lower Feulgen-DNA values than nuclei with the same karyotype in a simi-
lar phase of the generation cycle but which had a looser chromatin meshwork 
(James 1973) . The chromatin structure of megakaryocytes is not constant. This; 
in part, explains the large number of megakaryocytes with ploidy values (N) 
other than θ Ν, 16 Ν, 32 N and 64 Ν, suggesting DNA synthesis, in comparison 
with the number of megakaryocytes synthesising DNA according to thymidine label­
ling in autoradiographic studies. 
c. The nuclear volume 
A positive relationship between the nuclear volume and the DNA content of mega­
karyocytes has been observed by Queisser et al. (1971). If there was a good 
relationship between nuclear volume and ploidy level then we might expect the 
nuclear volume would increase in discrete twofold steps. However results of 
more exact measurements of nuclear volumes carried out by Stadhouders (1974) 
showed a large number of megakaryocytes which fell in between the expected size 
classes. This suggests that the relationship between nuclear volume and the DNA 
content of megakaryocytes is not very constant and therefore determination of 
nuclear volume is not a reliable index for ploidy level. 
In all studies concerning ploidy distribution of megakaryocytes one has to 
realise that there is an unavoidable error resulting from the sampling of a 
small number of megakaryocytes from a large population (Paulus et al. 1971). 
This sampling error is important in all types of studies as the number of exa­
mined megakaryocytes is rarely more than 100. 
In summary it has to be concluded that the methods employed up to now for de­
termination of the ploidy distribution of megakaryocytes have been rather rough 
ones. 
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Results of déterminations of megakaryocyte ploidy 
In normal human subjects the ploidy values of megakaryocytes varied between 4N 
and 64N, with a frequency peak of about 50 percent at the 16N level. There are 
more 32N megakaryocytes than ΘΝ megakaryocytes (see table 3). There are only a 
few studies of ploidy values under pathological conditions available (Undritz 
et al. 1969; Lagerlof 1971; Queisser et al. 1971, 1973; Kinet-Denoel et al. 1973) 
In some patients with polycythaemia vera, chronic myeloid leukaemia, acute leu­
kaemia and preleukaemia a decrease in ploidy values has been observed. In 
chronic myeloid leukaemia even mature diploid megakaryocytes have been reported. 
Ploidy values of 128N have occasionally been seen. 
Table 3 
Polyploidy of megakaryocytes in normal subjects and patients with ITP 
Study 
No. 
studied 
Norm. ITP 
Megakaryocytes (%) 
8N 16N 32N 64N 
Conclusion 
concerning 
ploidy in ITP 
Japa (1943) 10 26 54 19 
Harker et al. (1969,1970c) 15 
de Levai (1968) 
16 
10 
10 
65 
54 
25 
29 
'tnegakaryocyte volume 
and nuclear lobe num­
ber increased" 
Queisser et al. (1971) 3 
Pennington et al.(1971b) 1 
Kinet-Denoel et al. (1971) 4 
and 
Paulus et al. (1973) 
3 Lagerlof (1972) 
This study 14 
3 
3 
5 
0 
14 
16 
9 
13 
17 
47 
6¿ 
57 
55 
40 
46 
26 
23 
27 
34 
35 
29 
20 
-
-
2 
11 
7 
6 
'tnegakaryopoiesis 
unaltered" 
'Very similar" 
8 out of 10 patients 
"marked shift to-
ward lower ploidy" 
14 
5 
8 
41 
37 
37 
48 
7 
7 
Shift toward 
higher ploidy 
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Results of ploidy measurements m patients with ITP are very contradictory (ta­
ble 3). Harker et al. (1969, 1970c) employing cell and nuclear size measjrements 
together with lobe counting, found an increase in megakaryocyte size and ploidy 
in 16 patients with ITP. In the studies of Queisser et al. (1971) and Pennington 
et al. (1971b), each concerning 3 patients with ITP a normal ploidy distribution 
was reported. However, if one calculates from the data of Pennington the mean 
ploidy value in his patients with ITP, this seems to be 19% more than normal.In 
studies from the group of Kinet-Denoel and Paulus θ out of 10 patients with ITP 
showed a decrease in ploidy values, with a frequency peak at the ΘΝ level in 
several patients (Kmet-Denoel et al. 1971, 1973; Paulus et al. 1973). 
In induced immune thrombocytopenia in animals an increase in polyploidy of 
megakaryocytes has been described ( Pemngton et al. 1970). 
2.2. INVESTIGATIONS ON MEGAKARYOCYTES BY MORPHOMETRY AND BY PLOIDY 
QUANTITATION 
2.2.1. Materials and methods 
Platelet counts 
Four ml blood samples were collected in disposable collecting tubes containing 
4 mg di-K EDTA. Platelets were counted electronically after separation by means 
of differential centnfugation, essentially according to the method of Nakeff 
and Ingrain (1970) . Exactly 10 yl blood plus approximately 5 μΐ silicone oil 
(S.G. 1.040) was sucked up in a capillary micropipette. The pipettes were 
closed with Seal Ease (Clay Adams) and centnfuged in a microhaematocrite cen­
trifuge (Hawksley) for 12 sec. at 18000 rpm. The platelet layer containing 
part of the micropipette was broken off at the oil level which, after centnr 
fugation, remains above the red cell mass. Platelets were resuspended in 10 ml 
isotonic saline and counted with a Coulter Counter В equipped with a 50 μ tube. 
The counting procedure was carried out with settings: Amplification \, aper­
ture current i, lower threshold 10, upper threshold 96, Matching switch Η 64, 
gain control 90, "separate locked" switch on "separate" and volume on 0.05ml. 
The mean platelet count for ages from 18 to 48 years was 207,7 00 ± 49,600 
( 1 SD) per μΐ blood. 
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Ptatelet survival 
Platelet survival studies were done using tritiated diisopropylfluorphosphate 
(3H-DFP) according to the method of Bithell et al. (1967). 
In some patients with a severe thrombocytopenia, platelet survival studies 
were carried out with homologous Cr labelled platelets, according to the 
method described by de Maat (1969). Circulating platelet-bound radioactivity 
was determined using daily blood samples. 
Platelet half-life time was employed as the measure of platelet survival. 
Bone marrow biopsy and histological preparation 
Biopsy technique 
Marrow biopsies were obtained from the posterior iliac crest under local anaes­
thesia with a needle as described by Jamshidi (1971). The specimens ware appro­
ximately 2 mm in diameter and ranged from about 5 to 30mm in length upwards. 
Histological preparation of biopsies 
Fixation 
Biopsy specimens were fixed for six hours in the dark in a freshly prepared 
mixture of Zenker's solution (Romeis 1968), formaldehyde and glacial-acetic-
acid, (20:1:1). After fixation the specimens were rinsed for 24 hours with 
running tap-water. 
Dehydration 
Dehydration was performed sequentially with ethanol 70%, ethanol 96% and etha­
nol 100%, each for 1 hour . When the embedding procedure could not take place 
at once the specimens were stored in ethanol 70%. 
Embedding 
After 1 hour in benzoic acid methyl ester the specimens were placed in an em­
bedding solution, a mixture of 99 parts methyl-methacrylate (BDH chemicals) and 
1 part benzoic peroxide, for 24 hours at room temperature. After that the em­
bedding solution was replaced by 9 parts of the mentioned embedding solution 
mixed with 1 part Plastoid-N (Rohm and Haas).Heat polymerization was performed 
in enclosed tubes at 50 С for about 24 hours. 
Tissue sectioning 
* 
Sections of 5)jm thickness were cut. Of each 5 successive sections only the first 
was stained and examined. Besides these random sections»one serial section stu­
dy of an ITP patient was made. 
*Miсrotóme Leitz 
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Staining 
A variant of Goldner's staining technique (Romeis 1968) was used according to 
the following procedure· 
distilled water, 5 m m . 
haematoxylm Weigert solution*, 20 min. 
rinse with tap water, 20 m m . 
rinse with distilled water, 1 m m . 
Ponceau-f uchsin-azophloxLne so lu t ion* , 5 mm. 
acetic acid 1%, 15 sec. 
phosphotungstic acid-orange II solution *, 5 m m . 
acetic acid 1%, 15 sec. 
light green solution*, 5 min. 
acetic acid 1%, 1 min.,repeated 3 times 
ethanol 30%, 1 m m . 
ethanol 70%, 1 m m . 
ethanol 99%, 1 m m . 
*The solutions were prepared according to Romeis (1968). The dyes were obtained 
from Merck. 
Morphometncal methods 
Quantitation of megakaryocytes in histological sections of bone marrow biopsies 
was performed with a)stereologic methods using an ocular grid, b)methods 
using an ocular micrometer and c) photomicrography. 
a) Stereologic methods, using an ocular grid 
Morphometry, a term orgmally used by geographers to indicate quantitative 
descriptions of geographical features, has been recently introduced into the 
field of microscopic anatomy. In biological morphology, morphometric data can 
be obtained by various means. When stereological methods are employed the 
procedures are often efficient and accurate (Weibel and Elias 1967). Stereo-
logy is a body of procedures, mainly geometrical-statistical, which may be 
used to obtain information about three-dimensional ob]ects from two-dimensio-
nal images. This method was applied for the first time m the field of astrono-
my. 
In 1847 the French geologist Delesse described the fundamental relationship 
of stereology, which states that in random sections of a testvolume the mean 
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fractional area of a testarea occupied by cross-sections of a component i, 
A , corresponds with the fractional volume of a component i, V,,, of the 
Αι \α. 
test volume 
V A 
VI = Ai (4) 
In 1933 Glagoleff developed the point counting method to estimate the relation­
ship between two surface areas. So planimetry could be done by superimposing 
a regular point lattice on the section and counting the points which lay on 
cross-sections of structures (fig. 3 ) . So the fraction of points, Ρ , laying 
on cross-sections of objects i, led to an estimate of volume fraction V , if 
the sections are 2 dimensional, (v,<= Pp )· By the point counting procedure 
the measurement of the collective volume of objects included in the unit test 
volume is reduced to counting. 
The number of objects 
In counting objects in pictures of transparent sections the section thickness 
is not negligible. It is impossible to count the number of objects;one can 
only count the number of cross-sections of objects. The relationship between 
the number of objects, included in the unit test volume, and the number of 
cross-sections of objects depends on the relation between thickness of the 
section and the size of the objects. If the objects are spheres this relation 
will be (see:formula 1 and Harker ]968a): 
N = Ν': {Щ + 1 ) (5) 
Where N is the actual number of objects per unit test volume· 
N' is the number of cross-sections (cuts) of objects per unit test volume. 
R is the mean radius of the spheres (not the mean radius of cross-sec­
tions of objects). 
Τ is the thickness of the section. 
It will be clear that without knowledge of the mean diameter of the spheres 
it is impossible to get information about the number of spheres included in 
the unit test volume. 
A regular pattern of points and test lines, superimposed on the histological 
section image, was obtained by placing a test system, aMerz-(1967) grid, in 
one ocular of the microscope (fig.3). This grid contains a square with 36 test 
points (points of intersection of the curved test lines and the short horizon­
tal lines). The length of the sides of the square (the test area) projected 
on the field of observation was calibrated as ]Θ9 pm. M easurements were per -
formed at a maginification of 560 x. 
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Fig.3.Histological section of a bone marrow biopsy with a superimposed ocular 
(Merz) Grid. The square with 36 test points was employed for determination of 
total megakaryocyte volume in histological sections. 
This system fulfilled the conditions:a) rare components, as megakaryocytes,re-
mained seldom undetected, b) as a rule no more than one test-point fell on the 
same cross-section of a megakaryocyte (Weibel, 1973). 
Measurement procedure 
Whole adjacent fiels free of bone trabeculae were examined regardless of 
their cellularity. The number of test points on megakaryocytes and the number 
of transsections of megakaryocytes per test area were counted. Megakaryocytes 
lying on the edge of the left and upper margin of the field were not counted. 
In most cases the number of test points on fat vacuoles, on sinusoids, on 
vessels, on nuclei of non-megakaryocytic haemopoietic cells, on ruptures in 
histological sections and the number of test line intersections with megakaryo-
cytes were also determined. For statistical reasons a minimum of 100 fields 
was examined and, where necessary, more fields were examined until at least 
50 points on megakaryocytes had been counted. One field corresponds to an area 
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of 189 χ 189 μιη and with a volume of 179000 μπι fixed solid marrow since the 
sections were of 5 ym thickness. 
b) Ocular micrometry 
M easurements of diameters were carried out on a minimum of 100 cross-sections 
of megakaryocytes m histological sections employing an ocular micrometer, 
a 100 χ objective and an ocular of 10 x. On the ocular micrometer each calibra­
tion line represented 0.8 |jm and measurements were made to the nearest 0.8 μιη. 
sections of megakaryocytes were measured in adjacent fieHs. Sections of 
megakaryocytes less than 10 ym in diameter could rarely be recognized with 
certainty. Megakaryocyte diameters were measured in one direction since the 
jembedding procedure, using methyl-methacrylate, prevented distortion of cells 
by sectioning on the microtome. The measurements were done on projected images 
from sections of finite thickness. So the problems described above such as 
the Holmes effect, non-identiflable small transsections of megakaryocytes and 
overlap of opaque structures, also arise in ocular micrometry and in measure­
ments on photomicrographs. 
c) Photomicrography 
The diameter of all cross-sections of each megakaryocyte was obtained by linear 
measurements on serial section photomicrographs of 101 megakaryocytes. Measure­
ments were made with a simple ruler to the nearest 1 mm. The total magnifica­
tion was 282 x. Moreover the number of transsections of each megakaryocyte 
were counted. 
Kspression of results of morphometvLaal déterminations 
Total megakaryocyte volume unccorrected for cellularity 
This term is used for the volume density of megakaryocytes, the fractional volume 
of the bone marrow volume occupied by the collective volume of megakaryocytes. 
This is estimated by determining the relative area of a test area occupied by 
the collective area of cross-sections of megakaryocytes by use of the equation: 
^ χ 100 % (6) 
P T 
Ρ is the mean number of test points on megakaryocytes per test area 
Ρ is the total number of test points (36) per test area. 
In subjects with a normal erythropoiesis and myelopoiesis rather small ranges 
for the peripheral blood cell concentration, life span and production rate have 
been found. This is in accordance with the observed narrow range for the number 
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of myeloid- and erythroid cells per kg body weight. It implies that if there 
is a difference in the concentration of haematopoietic cells per bone marrow 
volume unit between individual subjects one.can also expect a difference in 
the total marrow volume per kg body weight between individual subjects. For 
this reason the cellularity of the histological sections of bone marrow tis­
sue has also been determined. 
Cellularity of histological sections 
The cellularity is expressed as the fractional volume of the bone marrow volume 
occupied by the collective volume of nuclei of haem opoietic cells (excluding 
megakaryocytes). This is estimated by use of the following equation: 
^ χ 100% ( 7 ) 
Ρ 
τ 
P
n
 is the mean number of test points on nuclei of haemopoietic cells 
(excluding megakaryocytes) per test area.(Because nuclei were better visible 
they were prefered to whole cells as a parameter for cellularity). 
Total megakaryocyte volume corrected for cellularity. 
This term is used for the collective volume of megakaryocytes expressed as a 
percentage of the collective volume of nuclei of haemopoietic cells (exclu­
ding megakaryocytes). This is estimated by: 
mkc _ ,
ΧΛΛ /Λ, 
χ 100% (θ) 
Ρ 
η 
Three parameters for megakaryocytic size are used: 
a. True diameter 
In histological sections the true diameter of megakaryocytes can only be esti­
mated in serial section studies by measuring the diameter of the largest cross-sec­
tion of all the sections through an individual megakaryocyte. 
b. Mean diameter of sections of megakaryocytes 
Henceforth this term will be employed for the diameter of random sections of 
megakaryocytes unless serial sections are expressly mentioned. 
с Mean area of sections of megakaryocytes 
This is estimated by: 
"
P
mkc x ( 1 8 9 ^ (9> 
Ñ , x Ρ 
_ mkc τ 
Ν , is the mean number of sections of megakaryocytes per test area. 
mkc 
2 (1Θ9 vim) is the surface of the test area. 
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•The number of sections of megakaryocytes 
a. Number of sections uncorrected for cellulanty 
This term is used for the mean number of sections of megaxaryocytes per test 
2 
area of (189 μπι) . 
b. Number of sections corrected for cellulanty 
This term is used for the number of sections of megakaryocytes expressed per 
collective volume of nuclei of haemopoietic cells (excluding megakaryocytes). 
This is given by: 
N
mkc (10) 
Ρ 
η 
Method for determination of megakaryocyte ploidy 
Preparation and staining of cells 
The aspirated marrow was collected in plastic tubes with an equal volume of an-
ticoagulans*.M arrow smears were made, dried for 1 or 2 hours and fixed for 
1 hour. The fixative contained 85% methanol (100%), 10% formalin, and 5% glacial 
acetic acid. Fixation was followed by a 10 min. rinse in distilled water. 
Fixed smears, enclosed in plastic, were kept in the refrigerator at -20 С 
until they were stained. 
ïfeulgen reaction: 
Hydrolysis was performed in 4N HCL at 28 С in a thermostatically controlled 
water bath (± 0.2 C) for 100 min. Smears were then kept in the staining bath 
with Schiff reagent for 1 hour at room temperature. The Schiff reagent was 
prepared according to the method of Graumann (1953) with the modification that 
0.1 g pararosaniline instead of 0.5 g m 15 ml IN HCL was used. The stained 
smears were twice placed in a freshly prepared sulphite solution for 15 min. 
The sulphurous acid solution was a mixture containing 5ml IN HCL, 5 ml 10% 
К S o
 a
nd 90 ml distilled water. After rinsing with this sulphite solution the 
smears were washed with distilled water f or 10 m m , dehydrated for 30 min. in 
•Composition of anticoagulans: 
1 volume acid citrate solution (tri-Na-citrate 22 g, acidum citncum 8 g, dex­
trose anhydncum 25 g, distilled water 1000 ml) 
4 volumes NaCl 0.85% 
1 volume buffer (O.lSMNa HPO , 0.15 M NaH PO ) adjusted to pH 7.0 with 2.5N 
NaOH diluted with distilled water to an end concentration of 300m.osmol/l. 
This buffered acid citrate solution was filtered through a millipore filter 
of 0.45 μη pore size and wet sterilized at 100oC for 30 m m . 
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ethanol 70%, 30 min. in ethanol 96%, 30 min. in absolute ethanol and 5 min in 
xylol, mounted in iluormount purr) and left in the dark until measured. 
Instrumentation 
A microscope photometer (Carl Zeiss) with adjustable measuring diaphragm (MPV) 
and an optical arrangement that allowed successive illumination with transmitted 
and incident light,was used. The characteristic feature of the instrument is 
the optimum separation of the excitation beam from the fluorescence light emit­
ted by the Feulgen stained nucleus. Light was provided by a stabilized tungsten 
lamp, 60 Watt, 12 V. The selection of the activating wavelength was obtained 
by an FL 546 and KP 630 (Schott) filter in the excitation beam and the dichroic 
mirror, FL 580, in the vertical illuminator. A barrier filter 630 was inserted 
in the emitted light path. Premature excitation during optical focusing of the 
cells was prevented by restricting the amount of transmitted light, especially 
light of the wavelength used for excitation of the Feulgen stained nuclei. The 
smears were screened using a 10 χ objective. The cells were measured with a 
neofluar, Ph 100 χ 1.30, oil immersion objective.The detector was a photometer 
with a variable measuring diaphragm in conjunction with a photomultiplier (Ha-
mamatsu, HTV 446) with a red sensitive S-20 photocathode, type 955ΘΑ, which 
takes its extraction voltage from a stabilized high voltage supply (Knott, type 
ΝΞΗΜ-ΒΝ-600). Readings were performed with an amperometer (Kipp, Flatbed Re­
corder B.D.8). 
Measurement procedure 
Smears were screened for megakaryocytes with a low power magnification and trans­
mitted illumination. A single cell was brought into the measuring field and the 
variable diaphragm was adjusted to the size of the cell. After focusing with an 
oil immersion 100 χ objective the cells were excited by the incident light beam 
to a red fluorescence. The emitted fluorescent light was measured in arbitrary 
light units. MBtamyelocytes in the environment of megakaryocytes were measured 
as reference diploid cells. To prevent selection of megakaryocytes all mega­
karyocytes in each smear were measured . At least 100 megakaryocytes were measu­
red. 
Expressbon of results of ploidy determination 
Ploidy value is obtained by dividing the measured emission units of megakaryo­
cytes by ore half of the emission units of 2N, diploid cells such as metamyelo-
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cytes. Magakaryocytes were compared with metamyelocytes from the same slide 
because there was a variation in the emitted light from metamyelocytes m dif­
ferent slides even when the slides were stained together. The ploidy histogram 
was plotted on semilogarithmic coordinates assuming a log normal ploidy distri­
bution m each ploidy class. The limit between two successive ploidy classes 
is 1.416 (second root of 2) χ ploidy of the lowest class. Recognition of 4N 
megakaryocytes is difficult and other marrow cells can also be tetraploid in the 
premitotic phase. Fbr these reasons cells having a ptoliy value less than 
5.6 N (midpoint between 4N and ΘΝ classes) were excluded. Beside the ploidy 
histogram was made, the mean ploidy value of all megakaryocytes m each sub­
ject was calculated. 
Subjects studied by marrow biopsy for morphometry 
Normal controls (14) 
Control subjects were persons without known blood disorders and a normal 
blood platelet count , haemoglobin concentration and leucocyte count. They 
were not suffering from diseases with known altered megakaryocyto-or thrombocy-
tokinetics. In most cases the bone marrow biopsy was done to exclude metabolic 
bone diseases (table 4). 
Thrombocytopenia was defined as a platelet count less than 110,000/μ1, (the 
mean platelet count of normal subjects 208,000/μ1, minus twice the standard 
deviation, 100,000/μ1). 
Patients with (a history of) chronic ITP (18). Chronic idiopathic thrombocyto­
penic purpura (ITP) was diagnosed if the following three criteria were met: 
1. there was a thrombocytopenia for more than 3 months for patients needed 
therapy to prevent a thrombocytopenia ) . 
2. other primary diseases causing thrombocytopenia and drug induced thrombo­
cytopenia were excluded; if there were no abnormalities found in bone mar­
row smears, except a suspicion of an increased number of megakaryocytes. 
Drug induced thrombocytopenia was excluded by withholding drugs during 
clinical observation and careful anamnestic examination. Patients who were 
treated with heavy metal depot injections, which require treatment with 
chelating agents to see if this heavy metal is the cause of the thrombo­
cytopenia, were excluded. 
3. there was no splenomegaly. 
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•This ITP group contained patients before and after splenectomy and with or 
without treatment with corticosteroids, (table 5). In some patients the marrow 
biopsy was carried out during a period of normal platelet counts following 
splenectomy. 
Patients with hypoplastic thrombocytopenia (4) 
îtour patients with a diagnosis of hypoplœtic thrombocytopenia had a history of a 
severe pancytopenia during which they needed blood transfusions. Marrow biopsy-
and iron kinetic studies confirmed the diagnosis of bone marrow hypoplasia. 
Three of them improved markedly during treatment with androgens (oxymethalone). 
The other patient improved spontaneously. The marrow biopsy for this study 
was done at least one year after the start of the partial remission, in a 
period with normal or slightly decreased red cell production and leucocyte 
count but still with markedly reduced platelet count (table 6). 
Patients with various kinds of thrombocytopenia (5) 
Five patients with various kinds of thrombocytopenia have been studied. Their 
data are summarized in table 7. The platelet count in 3 patients was often 
less than at the date of biopsy. 
Patients with thrombocytosis (4) 
Thrombocytosis was defined as a platelet count of more than ЗІО.ООО/уІ (the 
mean platelet count of normal subjects/ 208,000/yl, plus twice the standard 
deviation, 100,000/μ1). The five patients with a thrombocytosis do not form a 
homogeneous group. There were cases with reactive or secondary thrombocytosis 
but also with primary or autonomous thrombocytosis (table 8). 
Subjects studied for determination of megakaryocyte ploidy 
Control subjects (12) 
4 Ncrmal volunteers and 8 patients with complaints or diseases in which 
no alterations of thrombocytopoiesis or megakaryocytopoiesis could be ex­
pected were examined (table 17). 
Patients with chronic ITP (12) 
12 Patients with (a history of ) chronic ITP were examined. In six of them 
splenectomy had been performed. In 3 patients the platelet count was normal 
at the time of bone marrow sampling for ploidy determinations. In 2 of these 
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3 patients this was the result of therapy with corticosteroids (table 18). 2 Pa­
tients were examined before and after splenectomy; patient no. 19 some months 
after splenectomy; patient no.14 3 days after splenectomy. 
Patients with chronic myeloid leukaemia (2) 
The leukocyte counts of the patients with chronic myeloid leukaemia were 23,000 
and 230,000/μ1 (table 19). One of them was treated with busulphan. 
Patients with thrombocytopenia following cardiac surgery (3) 
In three patients who developed a thrombocytopenia following cardiac surgery 
for prostheses of valves a marrow sample was taken the second or third post­
operative day (table 19). 
Patient with idiopathic thrombocytosis (1) 
One patient with thrombocytosis and urticaria pigmentosa, who developed poly-
cythaemia vera 2 years later, was examined (table 19). 
2.2.2. Results 
Cellulartty of hzstologtcal seations 
In fig. 4 the cellularity of histological sections from the subjects is 
shown. The cellularity between subjects differed by a factor of 4 maxi­
mally. The differences in cellularity of bone marrow tissue can also be 
expected from the results in fig. 5 in which the part of a test field with 
fat vacuoles, sinusoids, vessels or ruptures of histological sections, in­
dicated as "non-haemopoietic (cell) volume", is shown. This varied from 11.8% 
to 56.5%, mean 36.7% - 10.2 (SD) of the test volume in 36 biopsies. 
Total megakaryocyte volume uncorrected for cellularity 
In 14 control subjects, the mean fiactLonal vdume of the test volume occu­
pied by the collective volume of megakaryocytes was 0.71% ± 0.21 (table 4). 
Lower values were obtained in patients with hypoplastic thrombocytopenia 
(fig.6). These values did not overlap the values obtained in patients with 
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Fig. 4.Cellularity of marrow biopsies from normal controls and patients with (a 
history of) thrombocytopenia or thrombocytosis. The cellularity is expressed 
as the fractional volume of the bone marrow volume occupied by the collective 
Volume of nuclei of haemotopoietic cells (excluding megakaryocytes). 
(a history of) chronic ITP. In 24 marrow biopsies from 18 patients with (a 
history of) chronic ITP the mean total megakaryocyte volume uncorrected for 
cellularity was 1.34% ± 0.60 (SD) of the test volume (table 5). This is sig-
nificantly increased in comparison with normal controls; p= 0.0002, using 
Wilcoxon's two-sample test. 
The total megakaryocyte volume uncorrected for cellularity in the group of 
patients with various forms of thrombocytopenia was within the normal range 
(table 7, fig. 6). 
In three of four patients with thrombocytosis the total megakaryocyte volume 
uncorrected for cellularity was three times greater than the mean normal value 
(table Θ). 
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Fig.6.Total megakaryocyte volume in marrow biopsies uncorrected for celiuiarity 
in normal controls and patients with (a history of) thrombocytopenia or thrombo­
cytosis. The total megakaryocyte volume is expressed as the fractional volume 
of the test volume occupied by the collective volume of megakaryocytes. In chro­
nic ITP patients the total megakaryocyte volume is significantly increased in 
comparison with normal controls; p= 0.0002. 
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Table 4 
Total mec 
Case 
n o . 
Sex Age Biopsy Diagnosis P l a t e l e t 
count* 
(χ103/μ1) 
M e g a k a r y o c y t e s 
t o t a l v o l u m e 
uncor­
r e c t e d 
for c e l l u -
l a r i t y 
c o r r e c ­
t e d 
for c e l l u -
l a r i t y 
number of s e c t i o n s 
uncor­
rected 
for c e l l u -
l a r i t y 
c o r r e c ­
t e d 
for c e l l u -
l a r i t y 
mean 
diameter 
of s e c t i o n s 
pm 
48 m 33 24-05-72 Hypercalciemia 199 
49 f 20 06-11-72 None 208 
50 f 38 27-02-73 Osteoporosis? 173 
51 m 52 06-06-72 Sprue 334 
52 f 45 14-03-73 Hypercalciemia 189 
53 m 25 03-04-73 Nephrolithiasis 216 
54 f 40 19-03-73 Nephrolithiasis 287 
55 f 41 26-01-73 Osteoporosis? 227 
56 m 52 15-03-73 Osteoporosis 238 
57 f 47 29-05-72 Nephrolithiasis 216 
58 f 40 28-05-73 Nephrolithiasis 172 
59 m 37 13-04-73 Hypercalciuria 125 
60 m 47 09-04-73 Osteoporosis 316 
61 m 29 21-09-73 Osteoporosis 132 
0.77 
0.69 
0.47 
0.58 
0.87 
0.93 
1.16 
0.67 
0.48 
0.56 
0.78 
0.93 
0.54 
0.52 
4.1 
7.7 
5.2 
6.7 
6.1 
5.9 
5.6 
5.7 
4.3 
3.6 
4.0 
6.0 
3.0 
4.6 
1.6 
0.8 
0.9 
0.7 
1.1 
1.2 
1.3 
1.1 
0.7 
0.9 
1.1 
1.0 
0.7 
0.6 
Mean (n=14) ± SD 217 0.71±0.21 5.2±1.3 
0.23 
0.25 
0.27 
0.22 
0.21 
0.22 
0.17 
0.26 
0.18 
0.16 
0.16 
0.19 
0.10 
0.14 
14.4 
17.9 
16.1 
16.1 
17.0 
18.2 
17.3 
17.1 
17.0 
15.9 
16.1 
18.1 
18.1 
16.3 
1.0 ±0.3 0.2010.05 16.8+1.0 
* Platelet count at the time of biopsy 
ibr 1,2,3 and 4; see: expression of results of morphometrical determinations (2.2.1.) 
Total megakaryocyte volume and number of sections in marrow biopsies from 18 patients with ITP. 
Case 
n o . 
S e x Age Biopsy S p l e n e c ­
tomy 
P r e d ­
n i s o n 
(mg/day) 
P l a t e l e t 
c o u n t * 
( x l 0 3 / U l ) 
M e g а к 
t o t a l v o l u m e 
u n c o r ­
r e c t e d 
f o r c e l l u -
l a r i t y 
c o r r e c ­
t e d 
f o r c e l l u -
l a r i t y 2 
a r y o c y t e s 
n u m b e r o f s e c t i o n s 
u n c o r ­
r e c t e d 
f o r c e l l u -
l a r i t y 3 
c o r r e c ­
t e d 
f o r c e l l u -
4 
l a r i t y 
mean 
d i a m e t e r 
of s e c t i o n s 
μπι 
1 
2 
3 
4 
5 
6 
7 
8 
9 
1 0 
1 1 
1 2 
1 3 
14 
1 5 
1 6 
17 
1 8 
Mean ± 
Normal 
m 
m 
f 
f 
f 
m 
f 
m 
f 
f 
f 
f 
f 
m 
f 
f 
f 
f 
SD 
4 1 
1 9 
3 4 
2 7 
5 5 
5 9 
6 5 
2 6 
5 9 
24 
2 6 
4 5 
6 5 
3 0 
3 3 
4 9 
57 
2 2 
06-07-72 
08-01-73 
29-11-72 
11-10-72 
12-01-73 
18-10-72 
25-01-73 
07-09-72 
01-02-73 
20-09-73 
04-05-72 
18-01-73 
19-06-72 
13-06-72 
18-12-72 
12-06-73 
20-02-73 
28-08-72 
22-06-72 
11-01-73 
04-07-73 
21-05-73 
15-10-73 
04-10-73 
(n=24) 
r a n g e (mean± SD;n= 
-
-
+ 
+ 
-
-
+ 
-
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
-
-
1 4 ) 
-
-
-
-
-
3 0 
-
6 0 
-
-
2 5 
-
2 0 
-
-
-
-
1 0 
5 
-
3 0 
1 0 
-
-
ч 
1 6 
2 6 8 
1 1 0 
1 7 0 
92 
9 2 
1 5 6 
5 8 
5 5 
6 6 
5 6 
3 2 2 
2 
4 8 
2 0 5 
2 0 0 
1 6 6 
2 3 
8 
1 0 
1 0 
1 0 
7 
3 5 
91±90 
2 1 7 
1.67 
0 . 9 0 
1.20 
1.09 
1.30 
0 .63 
1.28 
0 .92 
1.53 
1.23 
0 . 6 1 
0 .52 
0 .65 
1.92 
1.42 
1.75 
1.81 
2 . 7 5 
1.25 
3 .03 
0.98 
1.23 
1.55 
1.09 
1 . 3 4 ± 0 . 6 0 
0 . 7 1 І 0 . 2 1 
1 0 . 2 
5 . 5 
7 . 3 
8 . 6 
9 . 4 
9 . 8 
9 . 6 
9 . 0 
1 1 . 9 
9 . 7 
5 . 6 
8 . 2 
5 . 5 
9 . 7 
7 . 5 
6 . 8 
1 1 . 1 
1 6 . 8 
8 . 5 
2 1 . 5 
1 1 . 1 
9 . 1 
1 1 . 6 
8 . 9 
9 . 7 ± 3 . 5 
5 .2 ± 1 . 3 
1 . 8 
0 . 9 
1 . 3 
1 . 2 
1 . 5 
0 . 8 
1 . 3 
1 . 2 
1 . 4 
1 . 6 
0 . 9 
0 . 5 
0 . 9 
3 . 5 
1 . 6 
1 . 8 
2 . 4 
3 . 0 
1 . 2 
3 . 5 
1 . 1 
1 . 5 
2 . 3 
1 . 7 
1 . 6 + 0 . 8 
1 . 0 + 0 . 3 
0 . 3 1 
0 . 1 6 
0 . 2 3 
0 .26 
0 .29 
0 . 3 5 
0 .26 
0 .34 
0 . 3 1 
0 . 3 5 
0 . 2 2 
0 .22 
0 .22 
0 .49 
0 . 2 3 
0 . 2 2 
0 . 4 1 
0 . 5 1 
0 . 2 3 
0 . 6 8 
0 .29 
0 . 3 3 
0 . 4 3 
0 .44 
0 . 3 2 + 0 . 1 2 
0 . 2 0 + 0 . 0 5 
1 6 . 8 
1 7 . 6 
2 0 . 5 
1 7 . 9 
2 1 . 5 
1 7 . 8 
2 2 . 6 
1 8 . 3 
1 7 . 4 
2 2 . 9 
1 9 . 7 
2 1 . 1 
1 7 . 9 
1 8 . 2 
2 2 . 0 
2 0 . 8 
2 0 . 3 
2 0 . 9 
2 0 . 4 
2 1 . 4 
1 8 . 6 
2 0 . 5 
1 9 . 8 
2 0 . 3 
1 9 . 8 ± 1 . 8 
1 6 . 8 ± 1 . 1 
UI 
platelet count at the time of biopsy 
îbr 1,2,3 and 4; see: expression of results of morphometrical determinations (2.2.1.) 
Table 6 
Total megakaryocyte volume and number of sections in marrow biopsies from 4 patients with hypoplastic thrombocyto­
penia 
Case 
no. 
Sex Age Biopsy Hb 
g/100 ml 
Leucocyte 
count 
(X103//J1) 
23 
24 
25 
25 
f 
f 
f 
f 
48 
53 
18 
19 
19 
17-12-72 
28-08-72 
12-09-72 
19-09-73 
18-09-72 
8.4 
13.0 
9 .6 
8 .2 
13.0 
1.8 
5.0 
2.5 
2.9 
4.5 
Normal range (mean ± SD 14) 
Platelet 
count * 
(х103/л1) 
M g a к a 
total volume 
uncor­
rected 
for cellu-
larityl 
30 
50 
27 
34 
19 
0.21 
0.21 
0.38 
0.39 
0.15 
correc­
ted 
for cellu-
larity 2 
2 
7 
1 
2 
4 
У ° У t 
number of s e c t i o n s 
uncor­
rected 
for ce l lu-
l a r i t y 3 
0 . 3 
0 . 2 
0 . 5 
0 . 5 
0 . 2 
217 0.17t 0.21 5.2±1.3 1.0±0.3 
*Platelet count at the time of biopsy 
E>r 1,2,3 and 4; see: expression of results of morphometrical determinations (2.2.1.) 
correc­
ted 
for cellu-
4 
lanty 
0.05 
0.10 
0.07 
0.07 
0.06 
0.20±0.0F 
Table 7 
Total megakaryocyte volume and number of sections in marrow biopsies from 5 patients with various thrombocytopenia 
Case 
n o . 
Sex Age Biopsy Diagnosis P l a t e l e t 
count* 
(х103Ді1) 
M e g а к a 
t o t a l v o l u m e 
uncor­
rected 
for c e l l u -
l a r i t y 1 
c o r r e c ­
t e d 
for c e l l u -
l a r i t y 2 
r y o c y t e s 
number of s e c t i o n s 
uncor­
r e c t e d 
for c e l l u -
l a r i t y 
c o r r e c ­
t e d 
for c e l l u -
l a r i t y 4 
27 
28 
29 
30 
31 
f 
f 
f 
f 
f 
23 
62 
32 
26 
13 
19-06-72 
23-10-72 
18-01-73 
08-03-73 
15-09-73 
27-09-73 
Lupus erythematosus 
Drug induced? (gold) 
Thrombocytopathy 
Familial tiiromboc}topenia 
Familial thrombocitopenia 
15 
84 
120 * 
113** 
50 
110** 
1.02 
0.58 
0.82 
0.79 
0.81 
0.96 
1.3 
0.9 
0.9 
1.0 
1.3 
1.3 
30 
23 
0.22 
0.25 
0.31 
0.20 
Normal range (mean±SD 14) 
•Platelet count at the time of biopsy 
.** Platelet counts were often ücwer in other periods 
Ibr 1,2,3 and 4 ; see: expression of results of morphometrical determinations (2.2.1.) 
Table θ 
Total megakaryocyte volume and number of sections in marrow biopsies from 4 patients with thrombocytosis 
Case 
no 
32 
33 
34 
35 
Norm 
Sex Age 
f 46 
m 64 
f 58 
f 34 
al range ( 
Biopsy 
10-05-73 
24-05-72 
29-06-72 
29-03-72 
Tiean+ SD; η 
Diagnosis 
Primary thrombccytesis 
Urticaria pigmentosa 
Rieumatoid arthritis 
Osteomyelofibrosis 
= 14) 
Platelet 
count* 
(xlO3/ 1) 
1,031 
850 
686 
980 
217 
M 
total 
uncor­
rected 
for cellu-
larity1 
5.61 
2.39 
1.08 
8.73 
0.71±0.21 
г g а к a 
volume 
correc­
ted 
for cellu-
larity 2 
35.4 
17.0 
8.6 
35.8 
5.2+1.3 
г у о с у 
number of 
uncor­
rected 
for cellu­
lari ty3 
4.6 
2.8 
1.0 
7.4 
1.0±0.3 
t e s 
sections 
correc­
ted 
for cellu-
larity 4 
0.75 
0.55 
0.23 
0.84 
0.20+0.05 
•platelet count at the time of biopsy 
for 1,2,3 and 4; see: expression of results of morphometrical determinations (2.2.1.) 
Table 9 
total megakaryocyte volume in mothers (with a history of)chronic ITP newborn with a thrombocytopenia 
Case 
no. 
3 
10 
11 
Age 
34 
25 
26 
M o t h 
Course after 
splenectomy 
Platelet counts 
normal 
No result of splenec­
tomy; normalized 
after azathioprine 
Mild thrombocyto­
penia 
e r 
Total 
megakar 
volume* 
8.6 
6.8 
11.1 
yocyte 
Platelet 
counts 
(χ103/μΐ) 
170 
200 
166 
N 
Platelet 
counts 
(χ103/μ1) 
6 
60 
5 
e w b о r η 
Haemcrrhagic 
symptoms 
Cephalhae-
matoma 
None 
Petechiae 
some ecchy­
moses 
Duration of 
thrombocyto­
penia 
2 months 
4 months 
4 months 
•corrected for cellularity; normal range: 2.6-7.8 
Total megakaryocyte оіьапе corrected for eellularity 
In 14 control subjects this value was 5.2% ± 1.3 (table 4). In 18 patients with 
chronic ITP (fig. 7) significantly greater values were obtained than in control 
subjects; ρ = 0.0001 (Wilcoxon's two sample test). The mean value in ITP patients 
total mejakiiryocyte volume (%) 
coi 'ected ft» cellulanty ^j « .35 8 
.35 4 
10.0 
16.0 
14.0 
120-
10.0-
ao-
6.0-
4.0-
-
2.0 -
• 
• 
m 
• 
• 
• 
normal 
controle 
j _ 
hypopUetic 
thrombo-
Cytoptfm^ 
chconic дпоие 
I T P thrombo-j cytopeni^ 
thrombo-
cytoeie 
Fig. 7.Total megakaryoycte volume in marrow biopsies corrected for eellularity 
from normal controls and patients with (a history of) thrombocytopenia or throm­
bocytosis. The total megakaryocyte volume is expressed as the collective mega­
karyocyte volume/ collective volume of nuclei of hemopoietic cells (excluding 
megakaryocjtes) . In chronic ITP patients the total megakaryocyte volume is signi­
ficantly increased in comparison with normal controls; ρ = 0.0001. 
was 1.9 times greater than the mean value in normal controls. The results in 
patients with hypoplastic thrombocytopenia, thrombocytosis or various forms 
of thrombocytopenia were in accordance with the findings for total megakaryo­
cyte volume uncorrected for eellularity (fig. 7, tables4,5,6,7 and 8). 
Total megakaryocyte volume during pregnancy in patients with a history of 
chronic ITP 
Three patients with a history of chronic ITP were examined during pregnancy 
while there was a normal platelet count. The total megakaryocyte volume in 2 
of the 3 patients was markedly increased, in the other patient a high normal 
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Table 10 
Reproducibility of determinations of total megakaryocyte volume and number of 
sections of megakaryocytes in marrow biopsies. Two marrow biopsies were taken at 
different times from each of 4 subjects 
Case 
no. 
Biopsy Total megakaryocyte volume 
uncorrected 
for 
cellularity1 
corrected 
for 
cellularity 
No- of sections of megakaryocytes 
uncorrected 
for 
cellularity 
0.9 
1.0 
1.6 
1.8 
1.4 
1.6 
0.5 
0.5 
corrected 
for 
cellularity 
0.22 
0.25 
0.23 
0.22 
0.31 
0.35 
0.07 
0.07 
29 
10 
25 
18-01-73 
08-03-73 
18-12-72 
12-06-73 
01-02-73 
20-09-73 
12-09-72 
19-09-73 
0.82 
0.79 
1.42 
1.75 
1.53 
1.23 
0.38 
0.39 
7.0 
7.1 
7.5 
6.8 
11.9 
9.7 
2.1 
2.2 
1,2,3 and 4: see expression of results of morphometrical determinations 
^•normal value 0.71 ±0.21 
normal value 5.2 ±1.3 
normal value 1. 0 ±0.3 
4 
normal value 0.20 ± 0. 0 5 
Table 11 
Infüuerce of megakaryocyte size on the relationship true diameter: diameter 
of cross-sections of megakaryocytes in a serial section study of 101 megakaryo-
cytes of an ITP patient (no.9) 
Size classes 
range of true 
diameter (ym) 
number of 
megakaryo-
cytes 
mean 
true 
diameter 
mean 
section 
diameter 
12 - 17 
17 - 20 
20 - 23 
23 - 26 
26 - 30 
30 - 39 
5 
25 
26 
30 
12 
3 
14.5 
18.3 
21.3 
24.0 
27.5 
34.9 
12.9 
15.2 
17.0 
18.9 
21.3 
25.0 
true diameter 
section diameter 
1.13 
1.20 
1.25 
1.27 
1.29 
1.39 
mean (n=101) 22.2 18.3 1.21 
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value was found. The offsprings of all these 3 patients suffered from a neona­
tal thrombocytopenia (table 9). 
Total megakaryocyte volume in relation to age, splenectomy and platelet count 
The age of the subjects examined varied between 13 and 65 years. There was no 
relationship between the total megakaryocyte volume and the age m normal 
controls and chronic ITP patients (table 4 and 5). 
In chronic ITP patients there was no relationship between the total megakaryo­
cyte volume and platelet count (table 5). 
In chronic ITP patients the estimation of the total megakaryocyte volume was 
performed 8 times before splenectomy and 16 times after splenectomy. There 
was no difference found in the total megakaryocyte volume before and after 
splenectomy (table 5). 
Reproducibility of total megakaryocyte volume estimations 
Two biopsies from each of 4 patients obtained with a minimal time interval of 
two months, were available. One of them (no. 10) was pregnant when the second 
biopsy was carried out. One of them (no. 6) was not in remission after sple­
nectomy. The platelet counts of these patients were rather constant. The two 
other patients also seemed to be in a steady state. The total megakaryocyte 
volume was very constant in 3 of 4 patients (table 10). 
Fbr practical reasons there was some difference m duration of dehydration 
time in 70% ethanol. The influence on the estimation of the total megakaryo­
cyte volume was studied by dividing a biopsy m two parts, one part was dehy­
drated for the normal time of 1 hour in 70% ethanol and the other for 2 
days. The difference between the total megakaryocyte volume estimations in the 
two parts of the biopsy was 6%. 
Megakaryocyte size 
a. True diameter 
In a serial section study of 101 megakaryocytes from an ITP patient,460 sections 
were recognized as parts of megakaryocytes on photomicrographic enlargements. 
The true diameters of these 101 megakaryocytes varied from 12.4 to ЗЭ.ІІіт. 
The mean true diameter was 22.2 ym ± 4.1 ym (SD) (table 11). 
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b. Мэап section diameter 
b.l Measurenents on photomicrographs 
In the above mentioned serial section studies (photomicrographs) the diameter 
of the smallest sections was 7.2 pm. The mean diameter of all sections from 101 
serially sectioned meqakaryocytes Was 18.3 pm (table 11). 
Some at random chosen photomicrographs of the same serial section study were 
examined. The mean section diameter of 97 sections of megakaryocytes from 
these microphotographs was 20.6 μιη (table 12). 
Table 12 
Comparison of diameters (pm) in serial and random section studies measured on 
photomicrographs and measured with an ocular micrometer in 101 megakaryocytes 
and their sections from ITP patient (no.9) 
Type of study 
Serial sections 
Random sections 
Photomicrographs 
mean 
true 
diameter 
mean 
section 
diameter 
22.2 18.3 
20.6 
Ocular 
micrometer 
mean 
section 
diameter 
18.2 
True 
diameter 
section 
diameter 
1.21 
1 08 
1.22 
Table 13 
Comparison of diameters of random sections of megakaryocytes measured on photomi-
cmgraphs and measured with an ocular micrometer in 2 control subjects and a 
patient with chronic ITP 
Case 
no. 
M e a n diameter of sections 
photomicro­
graphs 
\im 
ocular 
micrometer 
Um 
photo 
oc. meter 
9 20.6 18.2 1.13 
55 20.1 17.1 1.17 
56 20.8 17.0 1.22 
Results of measurements of diameters of more than 100 sections of megakaryo­
cytes on microphotographs from two other subjects are given in table 13. 
Ratio true diameter mean section diameter 
The factual influence of the true diameter of a megakaryocyte on the quotient 
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true diameter 
—. τ-. r — is given in table 11 
mean section diameter ^ 
The qudient varied from 1.13 for the smallest megakaryocytes to 1.3 9 for the 
largest megakaryocytes in serial sections. Decrease in the size of megakaryo­
cytes resulted in a decrease in the difference between true diameter and mean 
diameter of sections in serial section studies (fig. 8). The quotient 
section dtameteriμιη 
"4 
10 30 35 
true di¿>iTietffr(¿im) 
Fig.8.Relationship between the true diameter of megakaryocytes and the mean dia-
meter of sections of megakaryocytes in a serial section study of 101 megakaryo-
cytes from a patient with chronic ITP (no.9), categorized in 6 size classes 
of true diameters 
true Jiameter 22 2 
_ was 1.08 (__!__) if the sections of megakaryocytes were 
m§an section diameter 20.6 
measured on at random duplicated photographs of the serial section study (ta-
ble 12) . 
As described above (2.1.2.) the theoretical relationship between true diameters 
of spheres and diameters of sections is: 
4m (2) 
Application of this formula to the data obtained from measurements on 460 
serial sections resulted in a mean true diameter of 28.2 pm. The calculated 
mean true diameter from the 97 random sections of the serial section study 
resulted in a mean true diameter of 35.4 Um. 
b.2.Measurements of diameters of sections of megakaryocytes by ocular micro-
metry. 
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sections of megakaryocytes (%) 
100 
Θ0 
6 0 
40 
20 
τ — ' ' Ι Τ Ì τ ι 1 τ — 
4 β 12 16 20 24 26 32 36 40 
diameter of sections of me^akaryocytee ( ^m) 
Fig.9.Cumulative diameter distribution curve of a total of 3594 sections of 
megakaryocytes in marrow biopsies, measured with an ocular micrometer, in 14 
normal controls and in 18 patients with (a history of) chronic ITP 
The mean section diameter of approximately 100 - 125 random sections of mega­
karyocytes measured in each subject varied in 14 normal controls between 14.4 
and 18.2 μιη, and in 18 chronic ITP patients from 16.8 to 22.9 \im (fig.10) .This 
difference was significant, p= 0.0001, using Wilcoxon's two sample test (fig. 
10). The mean diameter of the individual values in the group of normal con­
trols was 16.8 um ± 1.1 (SD),and in ITP patients 19.8 ym ± 1.8 (SD) (table 4 
and 5). The section diameters varied between 6 and 40 ym, with a top level 
between diameters of 16 and 21 ym. Sections with diameters less than 10 ym 
were rarely recognized as parts of megakaryocytes. 
The reproducibility of the estimation of the mean diameter of sections of 
megakaryocytes from a single biopsy, measured with an ocular micrometer, is 
given in table 14. 
The influence of a different dehydration time, which occured in practice, 
was studied by dividing a biopsy in two parts, one part was dehydrated for 
the normal time of 1 hour, the other part was kept for 2 days in 70% ethanol. 
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Fig.10 Mean diameters of sections of megakaryocytes measured with an ocular 
micrometer in 14 normal controls and in 18 patients with (a history of) chronic 
ITP 
Table 14 
Reproducibility of measurements of mean diameter (Um) using an ocular micrometer 
on the same histological sections from a single biopsy in 4 subjects by one 
investigator 
Case 
no · 
9 
10 
58 
59 
Result о 
17.3 
21.6 
15.5 
17.3 
f various measurements 
17.9 
22.4 
16.0 
18.9 
19.4 
16.8 
Mean 
18.2 
22.0 
16.1 
18.1 
In the two parts of the biopsy the mean diameter of 125 sections of megakaryo­
cytes was respectively 17.0 pm and 16.9 ym. 
Comparison of mean section diameter obtained from measurements on photomicro­
graphs and measuements by ocular micrometry was carried out in 3 biopsies.As 
is shown in table 13 the mean diameter of about 100 sections of megakaryocytes 
measured on photographs was 1.13 to 1.27 times greater than the diameter mea­
sured by studying histological sections more directly by ocular micrometry. 
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с. Mean area of sections of megakaryocytes 
This parameter for megakaryocyte size was significantly greater in patients 
with (a history of) chronic ITP in comparison with normal controls (p=0.04) 
(fig.11). 
mean area of megakaryocyte sections (¿лгп2) , 
•чзи -
JtOO 
3 7 0 -
3-Ч0-
-
3 1 0 -
2 6 0 -
2 5 0 -
-
2 2 0 -
1 9 0 -
м 
• 
• 
• 
• 
• 
• 
• 
• 
I 
• 
normal 
ι 
hypoplastic 
controls ! thrombo-[cytopenia 
chronic various 
ITP thrombo-
ι cytopenia 
thrombo-
cytosi* 
Pig.11 Mean area of sections of megakaryocytes in marrow biopsies from normal 
controls and patients with (a history of) thrombocytopenia or thrombocytosis. 
In chronic ITP patients the mean area of sections of megakaryocytes is signi­
ficantly increased in comparison with normal controls; p= 0.04 
Megakaryocyte size in relation to platelet count, splenectomy, total megakaryo­
cyte volume and megakaryocyte count 
Withan increasing mean diameter of the megakaryocyte sections there was some 
increase in the total megakaryocyte volume. However there was no significant 
correlation between the different functions of megakaryocytic size and the 
blood platelet count or the total megakaryocyte volume in ITP patients. No 
difference was found in the functions of megakaryocytic size in ITP patients 
before and after splenectomy (table 5). 
Number of sections of megakaryocytes in histological sections 
The number of sections of megakaryocytes uncorrected for cellularity in 
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14 rcrmal controls varied between 0.6 and 1.6 per test area with a mean value 
of 1.0 ± 0.3 (SD) (table 4). 
In patients with a history of aplastic anaemia lower figures were obtained 
(table 6). 
The number of sections of megakaryocytes uncorrected for cellulanty in pa­
tients with chronic ITP showed a mean value of 1.6 ± 0.8 (SD). This differed 
significantly from normal controls, p= 0.001, using Wilcoxon's two sample test 
(table 5). 
In patients with various other forms of thrombocytopenia the number of sections 
of megakaryocytes was in the normal range (table 7). The greatest number of 
sections of megakaryocytes was found m patients with a thrombocytosis (table 
8). 
N umber of sections corrected for cellulanty 
Number of sections corrected for cellulanty from the examined groups of sub­
jects is given in fig. 12. There was a significant difference between normal 
no of sections of megakaryocytes 
corrected For cellulanty 
0 6 -
06 
0 4 -
0 2 -
normal 
controle 
hypoplastic 
thrombo 
cv topen id 
chrome чапоие 
ITP thrombo 
Cytopeniei 
thrombo-
Cvt0£45 
Fig.12.Number of sections of megakaryocytes, corrected for cellulanty, in mar­
row biopsies from normal controls and patients with (a history of) thrombocytope­
nia or thrombocytosis. In chronic ITP patients the number of sections of megaka­
ryocytes is significantly greater than in normal controls; p= 0.0003 
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controls and ITP patients (p=0.0003). In normal controls the mean value of the 
number of sections of megakaryocytes corrected for cellularity ъаз 0.20 ± 0.05 
(SD), in chronic ITP patients 0.32 ± 0.12 (SD). 
Reproducibility of megakaryocyte count 
In each of 4 patients there were 2 biopsies available which were taken with some 
time interval, while they seemed to be in a clinically steady state. The coun­
ting results are rather constant as is shown in table 10. 
no oFsections of megakaryocytes 
corrected for c e l l u l a r i t y 
0 4 -
0 3 
0 2 
0.1 
O B " Π 
»' l i-« 
•—16 
д normal controls 
о chronic ITP 
m hypopleiatic thrombocytopenic! 
α various thrombocytopeniei 
• thrombocytosis 
20 4 0 6 0 a o 10 12 П 
total megakaryocyte volume 
corrected for c e l l u l a r i t y 1%) 
Fig.13.Relationship between megakaryocyte count and total megakaryocyte volume 
in marrow biopsies from normal controls and patients with (a history of) thronbo-
cytopenia or thrombocytosis. The regression line is defined by y=0.0225 x+0.0859. 
The correlation coefficient is 0.928 
Megakaryocyte count in relation to other morphometrical parameters and clini­
cal data 
There was a good positive relationship between the number of megakaryocytes 
corrected for cellularity and the total megakaryocyte volume in marrow biopsies 
of normal controls and various patients (fig. 13). 
With an increase in diameter of the sections of megakaryocytes there was some 
increase in the number of sections of megakaryocytes (fig. 14). However this 
correlation was not significant. The number of sections of megakaryocytes be­
fore and after splenectomy was the same. There was no relationship found between 
the number of sections and the platelet count or subject's age.
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Fig.14.Relationship between mean diameter of sections of megakaryocytes and the 
megakaryocyte count in normal controls and in patients with (a history of) chro­
nic ITP. The regression line is defined by 0.0235 χ - 0.1630. The correlation 
coefficient is 0.425 
Megakaryocyte ploidy 
The reproducibility of the determination of the distribution of megakaryocytes in 
ploidy classes and mean ploidy values from six marrow aspirates is given in 
table 15. In table 16 the reproducibility of ploidy determinations from two con­
trol subjects is shown; in each subject two marrow aspirations were taken at dif­
ferent times. 
Control subjects 
In 9 out of 12 control subjects a frequency peak was visible in the 16 N class. 
The mean ploidy values varied between 19.6 N aid 29.6 N. The percentages of 
megakaryocytes in various ploidy classes and the mean ploidy values of mega­
karyocytes from each subject is given in table 17. A histogram of ploidy values 
of megakaryocytes in a normal subject is given in fig. 15. 
Patients with chronic ITP 
In comparison with control subjects the percentages of megakaryocytes in various 
ploidy classes in 12 patients with (a history of) ITP showed a shift from the 16N 
class toward the 32N class (table 18, fig.16).The mean ploidy values of each sub­
ject varied between 19.3N and 31.2N. These ploidy values were increased in com­
parison with control subjects (fig. 17). Using Wilcoxon's two sample test 
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megakaryocytee (% ) 
30 η chronic myeloid leukemta 
. п.-143 
20 
10 
20 
10 
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п. 93 
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64 Ν 
ploidy values 
Pig.15.Histograms of ploidy values, determined by microfluorometry of îfeulgen 
stained megakaryocytes, in a normal subject, a patient with chronic ITP, a 
patient with primary thrombocytosis and a patient with chronic myeloid leukae-
mia. The ploidy value was calculated using metamyelocytes as 2N reference. Ploi-
dy values are plotted on a logarithmic scale. N: The number of measured megaka-
ryocytes 
ρ was 0.057. The average of the mean ploidy values in the ITP group was 26.5N, 
in the control subjects 23.9N (table 18). A histogram of ploidy values in an 
ITP patient is given in fig. 15. 
Patients with chronic myeloid leukaemia 
The 2 patients suffering from chronic myeloid leukaemia showed a shift toward 
lower ploidy values (table 19). The mean ploidy of each subject did not over­
lap the values obtained in control subjects (fig. 17). In one of these two 
patients a mean ploidy value of 13N was measured. This was the lowest value 
observed in this study. 
Patients with thrombocytopenia following cardiac surgery 
In 3 patients with acute thrombocytopenia some days after cardiac surgery, 
normal ploidy values of the megakaryocytes were obtained (table 19). 
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Table 15 
Reproducibility of microfluorometnc determinations of ploidy values of Eteulgen-
stained megakaryocytes from a single marrow aspirate in 6 subjects 
Case 
n o . 
M e g a k a r y o c y t e s (%) 
8N 16N 32N 64N 
M ean 
p l o i d y 
(N) 
1 
5 
20 
37 
6 2 
72 
3 . 1 
5 . 1 
9 . 6 
1 7 . 6 
2 . 8 
-
1 8 . 2 
2 7 . 0 
2 0 . 0 
2 0 . 2 
2 1 . 8 
2 6 . 0 
36 .7 
4 5 . 8 
2 6 . 1 
26 .4 
3 3 . 3 
2 8 . 6 
5 8 . 6 
4 9 . 5 
2 7 . 3 
3 4 . 6 
3 8 . 6 
4 2 . 7 
T a b l e 
5 4 . 7 
3 5 . 6 
4 8 . 7 
4 9 . 5 
4 7 . 2 
6 1 . 6 
2 2 . 2 
2 0 . 7 
4 4 . 5 
3 8 . 5 
3 0 . 7 
2 4 . 0 
16 
5 . 5 
1 3 . 6 
1 5 . 7 
6 . 6 
16 .7 
9 . 8 
1 . 0 
2 . 7 
8 . 2 
6 . 7 
8 . 9 
7 . 3 
2 7 . 1 
2 7 . 8 
3 0 . 6 
2 5 . 7 
3 1 . 3 
3 0 . 6 
1 8 . 6 
1 8 . 4 
2 5 . 5 
2 3 . 8 
2 3 . 4 
2 1 . 3 
Reproducibility of microf luorometnc determinations of ploidy values of Psul-
gen-stained megakaryocytes in 2 subjects. Marrow aspirates were not taken si-
multaneously 
Case 
n o . 
Marrow 
a s p i r a t e 
M e g a k a r y o c y t e s 
8N 16N 32N 64N 
Mean 
p l o i d y 
(N) 
62 
6 5 
10-03-72 
0 4 - 0 7 - 7 3 
10 -03 -72 
10 -05 -72 
1 4 . 0 
2 0 . 1 
1 4 . 8 
8 . 6 
3 9 . 5 
3 2 . 2 
3 0 . 4 
4 4 . 8 
41 .1 
4 0 . 7 
3 9 . 1 
3 3 . 3 
5 . 4 
7 . 0 
1 5 . 7 
1 3 . 3 
2 4 . 0 
2 4 . 3 
2 8 . 6 
2 7 . 0 
72 
Table 17 
Percentage of megakaryocytes in various ploidy classes and mean ploidy of megakaryocytes from each subject in 
12 control subjects 
Case 
no. 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
Mean 
SD 
Sex 
m 
f 
f 
m 
f 
m 
m 
m 
f 
m 
m 
f 
n=14) 
Age 
36 
40 
25 
28 
34 
29 
37 
36 
16 
46 
34 
58 
M arrow 
aspirate 
10-03-72 
04-07-73 
28-05-73 
10-07-73 
10-03-72 
10-05-72 
26-05-73 
16-10-72 
09-10-73 
16-05-72 
13-06-72 
12-07-73 
10-03-72 
24-04-72 
Diagnosis 
-
-
Nephrolithiasis 
Hypertension 
-
-
Diarrhea 
-
Nephrolithiasis 
Gastritis' 
Anorexia nervosa 
Hepatitis 
-
-
M e g 
8N 
14.0 
20.1 
8.8 
19.3 
14.8 
8.6 
5.8 
14.9 
17.9 
22.5 
19.4 
23.4 
12.4 
10.3 
15.1 
5.5 
a k a r y o c y t e s % 
16N 
39.5 
32.2 
61.9 
42.2 
30.4 
44.8 
23.3 
40.6 
53.6 
39.2 
51.6 
39.6 
40.2 
33.3 
40.8 
9.9 
32N 
41.1 
40.7 
27.4 
33.9 
39.1 
33.3 
62.1 
37.6 
28.6 
39.2 
28.3 
27.9 
37.1 
44.4 
37.2 
9.0 
64N 
5.4 
7.0 
1.8 
4.6 
15.7 
13.3 
8.7 
6.9 
-
1.0 
0.8 
9.0 
10.3 
12.0 
6.9 
4.7 
M ean 
ploidy 
(N) 
24.0 
24.3 
20.5 
22.1 
28.6 
27.0 
29.6 
22.1 
19.2 
21.3 
19.3 
22.9 
25.9 
28.0 
23.9 
3.4 
Table 18 
Percentage of megakaryocytes in various ploidy classes and mean ploidy of megakaryocytes from each subject in 
12 patients with (a history of) chronic ITP 
Case 
No. 
1 
5 
6 
7 
β 
11 
12 
13 
14 
18 
19 
20 
Mean 
SD 
Norma 
Sex 
m 
f 
m 
f 
m 
f 
f 
f 
m 
f 
m 
f 
(n= 14) 
1 range 
Age 
41 
55 
59 
65 
26 
26 
45 
65 
30 
22 
13 
20 
: mean 
Marrow 
aspirate 
06-07-72 
04-06-73 
28-07-72 
04-09-72 
04-05-72 
19-06-72 
20-02-73 
17-04-72 
13-03-72 
11-01-73 
03-03-73 
04-10-73 
28-09-72 
05-06-72 
(n=14) 
Splenec­
tomy 
-
+ 
-
-
-
+ 
+ 
+ 
+ 
-
+ 
-
-
-
Predni­
son 
mg/day 
-
-
-
60 
25 
20 
-
5 
5 
-
80 
-
-
15 
Platelet 
count 
(χ103/μ1) 
16 
213 
38 
29 
56 
2 
166 
16 
14 
10 
188 
35 
20 
80 
(208) 
M e g 
8N 
4.5 
9.7 
13.2 
9.4 
7.7 
3.6 
4.5 
7.3 
4.2 
6.9 
4.8 
29.0 
7.1 
1.4 
8.1 
6.7 
15.1 
a k a r y o c y t 
16N 
40.4 
49.6 
27.3 
47.8 
36.5 
33.9 
24.2 
41.7 
42.7 
33.7 
33.7 
38.0 
34.8 
30.9 
36.7 
7.2 
40.8 
32N 
46.5 
35.4 
47.3 
39.1 
51.0 
47.2 
58.4 
48.9 
50.1 
55.4 
56.7 
32.0 
50.0 
54.5 
48.3 
7.9 
37.2 
e s % 
64N 
8.5 
5.3 
12.3 
3.6 
4.8 
15.2 
12.9 
2.1 
3.1 
4.0 
4.8 
1.0 
8.0 
13.2 
7.1 
4.6 
6.9 
Mean 
ploidy 
(N) 
27.5 
23.4 
28.4 
23.2 
25.8 
30.5 
31.2 
24.6 
25.8 
26.2 
27.0 
19.3 
27.3 
30.9 
26.5 
3.3 
23.9 
SD ( 50) 5.5 9.9 9.0 4.7 3.4 
Table 19 
Percentage of megakaryocytes in various ploidy classes and mean ploidy of megakaryocytes from each subject in 
patients with chronic myeloid leukaemia (CML), thrombocytopenia following cardiac surgery or thrombocytosis 
Case 
no. 
Sex Age Marrow 
aspirate 
Diagnosis Platelet 
count 
(xlOVlil) 
M e g a k a r y o c y t e s 
8N 16N 32N 64N 
Mean 
ploidy 
(N) 
33 
36 
37 
38 
39 
40 
m 
m 
f 
m 
m 
m 
64 
53 
61 
43 
49 
30 
24-05-72 
23-11-72 
12-07-73 
02-03-73 
29-03-73 
29-03-73 
thrombo-
cytosis 
CML* 
CML* 
ASD** 
AI *** 
AI 
850 
673 
295 
83 
80 
64 
10.5 
50.5 
23.3 
17.3 
13.8 
20.0 
16.8 
46.2 
52.9 
57.2 
27.0 
42.1 
44.1 
1.0 
21.4 
24.9 
50.0 
27.4 
28.7 
2.0 
2.4 
1.0 
9.2 
10.5 
36.0 
13.0 
18.5 
19.1 
27.3 
23.8 
Normal range: mean (n=14) 208 15.1 40.8 37.2 6.9 23.9 
SD 50 5.5 9.9 9.0 4.7 3.4 
OÏL: chrome myeloid leukaemia, **ASD: atrial septal defect, *** aortic insufficiency 
Patient with thrombocytosis 
In a patient with primary thrombocytosis and urticaria pigmentosa an increased 
number of 64 N megakaryocytes was observed with an increased mean ploidy value 
of 36.0 N (table 19, fig. 17). 
me^äLaryocytes (0/o ) 
100 
64 Ν 
ploidy values 
îlg.16.Cumulative ploidy distribution of megakaryocytes in normal controls and 
in patients with (a history of) chronic ITP. Ploidy is determined by micro-
fluorometry of Ffeulgen stained nuclei. 
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mean ploidy (Ν ) 
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3 4 -
3 2 -
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« 
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cytoeie 
Fig.17Mean ploidy values of megakaryocytes from each subject, determined by mi-
crofluorometry of Peulgen stained nuclei, in normal controls and in patients 
with (a history of) chronic ITP, chronic myeloid leukemia, thrombocytopenia fol-
lowing cardiac surgery or thrombocytosis 
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2.2.3. Discussion 
Morphometr-Loal aspects 
In patients with chronic ITP an increase in total megakaryocyte volume (1.9x), 
megakaryocyte size fr.ean section diameter 1.17 x) and number of sections of me-
gakaryocyte (1.6x) has been observed. However some errors occur in morphometry: 
true (mean) diameter ofa traneeechcn 
\ "Tbhickneeeof 
J - L h i á t o •tologtcM section 
measured diameter o f a section 
opaque megakaryocyte opaque e n v i r o n m e n t 
(¡eg nucleus of other cel l ) 
•
yL J--. •ФІ_ 
o v e r e s t i m a t i o n 
of the diameter 
Holmea effect 
section of \arge 
m e g a k a r y o c y t e 
u n d e r e s t i m a t i o n 
of the d i a m e t e r 
section o f »mall 
m e f akaryoc y t e 
-Holmes e f f e c t 1 
Big.18.Illustration of the effect of environmental opacity on the determina­
tion of megakaryocytic section diameters in histological preparations 
l.Not recognizing small sections of megakaryocytes 
When the diameter of transsections of megakaryocytes is less than about 10 μιπ 
these pieces of the megakaryocytes are not recognized ( Penìngton et al. 1970; 
Harker 1968a). Also in our study only a few sections of megakaryocytes with 
a diameter less than 10 μπι were found (fig. 9) . 
2.Holmes effect 
Tissue slices are investigated by transmitted light and measurements are done 
on projected images. The projection area of opaque objects will occupy a 
larger fraction of the field of observation than corresponds to their volume­
tric contribution (fig. 18). This overestimation was first described by Holmes 
(1927). The degree of this overestimation depends on the diameter of the mega­
karyocytes (fig. 18) and the thickness of the section (Weibel 1967). 
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3. Overlap of opaque structures 
When there is an overlap of a part of a megakaryocyte by an opaque structure in 
the histological section, for instance nucleated cells, this section of the me­
gakaryocyte will not be recognized or such an overlap can result in a decrease 
in the recognized area of the megakaryocyte (fig. 1Θ). 
Therefore the influence of these errors on the results of the determinations of 
megakaryocyte size (a), the total megakaryocyte volume (b) and the number of 
sections of megakaryocytes (c) in marrow sections will be discussed. 
a) Significance of the observed differences in megakaryocyte size between ITP 
patients and control subjects 
In ITP patients the mean section diameter and mean area of sections of megaka­
ryocytes were greater than in control subjects. However, in theory determina­
tions of these parameters for megakaryocyte size may be influenced by the 3 
above mentioned errors. The Holmes effect (2) and not recognizing small sec­
tions of megakaryocytes (1) cause an overestimation of the megakaryocyte size, 
whereas the overlap of opaque structures (3) causes an underestimation. 
The existence of errors 1 and 2: could be demonstrated in the following manner ι 
Error 1) In serial section studies i*ith the aid of the photographs of adjacent 
sections of the same megakaryocytes) more sections were recognized than in 
random section studies of the same photographs. 
Error 2) The total volume of megakaryocytes from the serial section study cal­
culated with the largest section diameter of each individual megakaryocyte, 
assuming a spherical form of the megakaryocyte, was about equal to the total 
volume of the recognized sections of these megakaryocytes calculated with the 
diameter of each section, assuming a cylindrical form of the section of the 
megakaryocyte. However the total volume calculated from all recognized sec­
tions should be much less than the total volume calculated from the sections 
with the largest diameter of each megakaryocyte, because not all sections are 
recognized. Therefore, the measured diameters of sections of megakaryocytes 
are overestimated in comparison with the measured maximal diameter of megaka­
ryocytes, which is explained by the Holmes effect. 
The mean true diameter calculated from the diameters of sections employing 
the formula (2) r = - 7 Τ·
=
- (section 2.1.2.) was greater than the measured mean 
4m 
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trœdiameter.This is also in accordance with an overestimation of the measured 
section diameter due to the Holmes effect and to not recognizing small sections. 
The influence of error 3 is difficult to determine. It will be more important 
in small megakaryocytes than in large megakaryocytes. 
So in small megakaryocytes error 1 and 2 are more important while error 3 is 
less important (fig. 18). Therefore, comparing sections of large and small 
megakaryocytes,the effect of the 3 errors will be cumulative and will diminish 
the difference in the mean section diameter. 
Erom the foregoing discussion it may be concluded that the differences m size 
between megakaryocytes of ITP patients and of normal subjects are greater than 
the observed differences in mean section diameters of megakaryocyte suggest. 
The observed increase in megakaryocyte size in ITP patients agrees with the 
results of Harker et al. (1969) and Albrecht et al. (1974). 
The differences in diameter a) between those measured and calculated (formula 
2), b) from serial and random sections, c) from microphotography and ocular 
micrometry, can be explained in terms of the 3 mentioned errors. 
The importance of these errors will be influenced by the recognizibility of the 
sections which depends on factors such as the focusing of the microscopical 
image and the colour of the microscopical image in contrast to the photographic 
image. 
b) Influence of diameter of megakaryocytes on morphometrical determination of 
total megakaryocyte volume 
An increase in diameter of megakaryocytes results in an increase in the per-
centage of sections of megakaryocytes which are recognized. Therefore it is 
questdcnable whether the increase in total megakaryocyte volume of ITP patients, 
found in this study, is reliable. To resolve this question we calculated the 
influence of the diameter of megakaryocytes on the results of the determina-
tion of the total volume of megakaryocytes for some arbitrarily chosen size 
classes of megakaryocytes (table 20). 
The megakaryocyte diameters 15,20, 25 and 30 pm were chosen because in our 
material the measured diameter in serial and random section studies were in 
this range and were in accordance with the range found by Harker et al. (1969). 
The theoretical number (N) of sections of a megakaryocyte with a radius R 
in histological sections of 5 μπι thickness (Τ) , can be calculated with the 
formula developed in section 2.1.1. 
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τ 
(1) 
Пгот this theoretical number of sections only sections with a certain minimal 
size will be recognized. The radius of the smallest recognized section is in­
dicated by r . The percentage of the theoretical number of sections which will 
be recognized can be calculated with the formula: (Weibel, 1967): 
т/*2-г2 (11) 
íbr megakaryocytes with diameters of 15, 20, 25 and 30 ym the theoretical num-
ber of sections is respectively 4,5,6 and 7. If only sections with a diameter 
of > 10 pm will be recognized the percentage of sections recognized: the 
Table 20 
Theoretical influence of the number of sections, the real and measured volumes 
and Holmes effect in serially sectioned (5 pm thickness) megakaryocytes of dif-
ferent size classes, assuming that sections of megakaryocytes with a diameter 
of less than 10 \lm are not recognized 
number of sections per megakaryocyte 
theoretical number 
% of theoretical number with 
a diameter >10 ym 
true volume of megakaryocytes 
whole megakaryocyte (um ) 
recognized part (section diameter 
>10 ym ) ,as % of true volume 
Holmes effect-volume 
of whole megakaryocyte, as % of 
whole, true volume 
of recognized part (section diameter 
>10 Ут),as % of recognized true volume 
Measured volume, as % of true 
volume (recognized part + Holmes 
effect of recognized part) 
True diameter of 
15 
4 
75% 
1767 
91% 
50% 
15,4% 
105% 
20 
5 
86% 
4189 
97% 
38% 
19,9% 
116% 
megakaryocytes (ym) 
25 
6 
92% 
8181 
99% 
30% 
19,4% 
119% 
30 
7 
94% 
14137 
100% 
25% 
18,0% 
]18% 
81 
theoretical number of sections of megakaryocytes, is respectively 75%, 86%, 92% 
and 94% (table 20). This is in good agreement with the percentage of recognized 
sections found in the serial study of 101 megakaryocytes (84%). 
The true volume of megakaryocytes of the mentioned 4 megakaryocyte size classes 
in table 20 was calculated with the formula: 
0.5236 (2R)3 (3) 
The volume of the recognized part of megakaryocytes (section radius >r) was 
calculated with the formula: 
2. f π χ2 ä(\[7TZ2 )= f π (2R2
 + г
2 )\/
К
2
 - г
2
 (12) 
г 
where г < χ < г i s . 
The calculation of the overestimation of the recognized part due to the Holmes 
effect is based on the following considerations: 
If spheres witn a radius R are sectioned, circular profiles with a radius χ are 
obtained at a distance of 
V t,2 2 R - χ 
from the centre. Such profiles occur with a probability of 
χ 
R y R 2 - x 2 (Weibel, 1967) 
2 
The volume of a cross-section with thickness Τ was estimated as ττ χ Τ, where χ 
is the maximum radius of the cross-section. 
All cross-sections containing the centre of the sphere have the maximum radius 
Τ 2 
R. Their probability of occurring is •=• . Their volume was estimated as π R T. 
The estimated mean volume of cross-sections with a maximum radius >r, can 
therefore be calculated as: 
R 
χ 2 Τ 2 
. π χ Τ α χ + τ τ . τ τ Η Τ = 2 r R 
r 
Y R 2 - x 2 
ί π I (2R2
 + Г
2 ) к 2 - г 2
 + ί π κ Τ
2 
To obtain the estimated volume of the sphere this mean cross-section volume was 
multiplied by the mean number of cross-sections from the recognized part of the 
sphere, being 
2 V ^ 
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resulting in the following formula for the estimated volume of the sphere: 
^. ( 2R2
 +
 r
2) (R2 - г2)
 +
 г R T\I^J 
3 R V 
Without the Holmes-effect the recognized volume of the sphere is (see 12): 
f π (2 к2
 +
 г
2)У7"І7 
The overestimation of the recognized part due to the Holmes effect can there­
fore be calculated with the formula: 
—j (2R +r 2) (R 2-r 2) + ir R T ^ R 2 - r 2 - | π (2 R 2 + т2Уп2-г2 (13) 
The result of the calculations show that in theory the determination of the 
total megakaryocyte volume with the employed morphometrical method, estimating 
the surface of transsections of megakaryocytes, results in an overestimation 
of the total megakaryocyte volume by a factor of between 5% and 19% for mega­
karyocytes with diameters between 15 and 30 \im (table 20). 
However the difference in diameters between megakaryocytes of ITP patients 
and control subjects will be much less than 15 pm because: 
a. The difference in true diameters between the smallest and the largest mega­
karyocytes proved to be only a little more than 15 pm in the serial section 
study of megakaryocytes from an ITP patient. 
b. The difference in true diameters between the smallest and the largest mega­
karyocytes in normal subjects will be no greater than in ITP since the diameters 
of sections of megakaryocytes were smaller in normal subjects than in ITP pa­
tients (fig.9). 
On the other hand the observed difference in total megakaryocyte volume between 
ITP patients and control subjects was 90%. Therefore the influence of the 
difference in diameters of megakaryocytes between ITP patients and control 
subjects on the errors of the determination of total megakaryocyte volume 
can be neglected and it can be concluded that the observed large difference 
in total megakaryocyte volume between ITP patients and control subjects is a 
real difference. 
С The significance of the observed difference in the number of sections of 
megakaryocytes between ITP patients and controls. 
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An increase in diameter of megakaryocytes/ results in an increase in the num­
ber of sections per megakaryocyte. In ITP patients the diameter of megakaryo­
cytes was more than in control sub]octs. Therefore one has to consider whether 
the increased number of sections of megakaryocytes is the result of an increase 
in the diameter of megakaryocytes alone or also of an increase in the number 
of megakaryocytes. 
In ITP patients the observed number of sections of megakaryocytes was 1.6 time 
more than in control subjects. So if one were to explain the difference in 
the number of sections between ITP and controls with a difference in true dia­
meters alone, the mean true diameter of megakaryocytes in ITP must be about 
2R 1.6 time more than in control subjects. (N= —- + 1; see 2.1.1.). Erom the 
Τ 
observed section diameters (fig.9) it is clear that the rather small dif­
ference in diameters of megakaryocytes between ITP and controls is not enough 
to explain the difference in the number of sections of megakaryocytes between 
ITP patients and control subjects. 
So the increased number of sections of megakaryocytes in ITP patients in com­
parison with control subjects is the result of both an increase m the number 
of megakaryocytes and an increase in the diameters of individual megakaryocytes. 
Conclusions 
The observed increased total megakaryocyte volume in marrow biopsies of 
ITP patients in comparison with control subjects is not the result of a dif­
ference in errois, of the morphometncal method for total megakaryocyte volume 
determination,caused by the difference m diameters of megakaryocytes between 
the two examined groups. The larger diameter of megakaryocytes in ITP patients 
in comparison with control subjects can only partly explain the increased num­
ber of sections of megakaryocytes found m ITP patients. So the increased 
total megakaryocyte volume in ITP patients is caused by an increase in the 
number of megakaryocytes as well as by an increase m the mean size of the 
megakaryocytes. 
The importance of the cellularïty of the bone marrow for the evaluation of the 
total megakaryocyte volume and number of sections of megakaryocytes 
The cellularïty of histological sections varied greatly both in control 
subjects and,in patients with chronic ITP, or a bone marrow hypoplasia or 
myeloproliferative diseases(fig. 4). Since the number of haemopoietic cells 
per kg body weight in man under normal conditions is rather constant, this 
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Fig. 19.Influences of cellularity of marrow biopsies on the estimation of the 
total megakaryocyte volume in normal contols and in patients with (a history 
of) thrombocytopenia or thrombocytosis. There is a direct relationship between 
the total megakaryocyte volume corrected for cellularity and that uncorrected 
for cellularity. The regression line is defined by у = 0.1928 χ 0.3988. The 
correlation coefficient is 0.936 
means that the total bone marrow volume of the body varies considerably. There­
fore a quantification of megakaryocytes, total megakaryocyte volume or mega­
karyocyte count, per unit marrow volume is unreliable unless a determination 
of the total bore marrow volume of the body is done. So it can be concluded 
that quantitation of megakaryocytes in marrow samples must be done in relation 
to a parameter for haemopoietic cellularity of the marrow sample. Otherwise 
the total megakaryocyte volume or the number of sections of megakaryocytes in 
histological sections can be over- or under estimated. In figs. 19 and 20 
it can be seen that this over- or under estimation can be relevant. 
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Fig.20.The influence of differences in cellularity of marrow biopsies on the 
megakaryocyte count in normal controls and in patients with (a history of) 
thrombocytopenia of thrombocytosis. In histological sections there is a direct 
relationship between the number of sections of megakaryocytes uncorrected 
for cellularity and corrected for cellularity. The cellularity is expressed 
as collective nuclear volume of non-megakaryocytic haemopoetic cells in 
proportion to the examined histological section volume. The quotient number 
of sections of megakaryocytes: number of test points on nuclei of non-mega-
karyocytic haemopoietic cells is plotted on the χ axis. The regression line 
is defined by y= 5.63 χ -0.20. The correlation coefficient is 0.8Θ9 
Clinical value of the total megakaryocyte volume in marrow biopsies 
With the results of the total megakaryocyte volume determinations, using the 
described morphometrical method, thrombocytopenia caused by an decreased pla­
telet production, as in hypo-plastic anaemia, could be differentiated from 
thrombocytopenia through an increased destruction of platelets as in chronic 
ITP (fig. 8). Thrombocytopenias can also be differentiated by determination 
of platelet survival. However, determination of platelet survival is often. 
not feasible in patients with a severe thrombocytopenia, at least not by 
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using autologous platelets. Platelet survival times determined using homologous 
platelets may be shortened by foregoing transfusions or pregnancies. If the 
determination of platelet survival is not feasible, or if the results are un-
reliable then determination of total megakaryocyte volume can be particularly 
useful for differentiating between hypoplastic thrombocytopenia and thrombo-
cytopenias caused through increased platelet destruction or ineffective thrombo-
cytopoiesis. 
A normal platelet count in patients with a history of ITP can be the result of 
an increased platelet destruction together with an increased platelet production; 
a compensated thrombocytolysis. The newborns of mothers with such a compen-
sated thrombocytolysis can have a severe thrombocytopenia probably due to the 
permeability of the placenta for antiplatelet antibodies from the mother. For 
obstetr ical reasons it is important to know if the child has a thrombocytopenic 
bleeding tendency. This can be expected if the life span of platelets from the 
pregnant woman is shortened. However, determination of platelet life span with 
radioactive markers during pregnancy should not be carried out. In these cases 
of pregnancy with a normal platelet count but a history of chronic ITP, deter-
mination of total megakaryocyte volume in marrow biopsies proved to be useful 
for detection of compensated thrombocytolysis. Our observations of 3 pregnant 
women with normal platelet count during pregnancy suggests a relationship 
between the increase of the total megakaryocyte volume of the mother and the 
severity and duration of the haemorrhagic diathesis of the child, 'jhis suggests 
that the chance of neonatal cerebral bleeding as the result of delivery can be 
predicted from the result of determination of total megakaryocyte volume from 
the mother. 
In patients with (a history of) ITP a stimulated thrombocytopoiesis was conside-
red to be present 21 times since there was a thrombocytopenia, a shortened pla-
telet life span or a child with a thrombocytopenia was born to the patient (chap-
ter 3 ). In these cases the total megakaryocyte volume was increased in 16 times 
and normal 5 times. However, it is questionable if the total megakaryocyte 
volume was normal in spite of a stimulated thrombocytopoiesis since 4 of these 
5 patients with a normal total megakaryocyte volume were splenectomized and 
normal values for total megakaryocyte volume m splenectomized subjects are 
unknown. It can not excluded that these values might be decreased in compari-
son with non-splenectomized subjects, since, as discussed in chapter 1, it 
is unknown if the regulatory mechanism for thrombocytopoiesis is directed 
toward constant platelet counts per kg body weight or per litre blood. If this 
feed-back mechanism is directed toward the platelet concentration of the blood, 
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this implies that after removal of the splenic platelet pool, the platelet pro­
duction will decrease about 30%. If this is true then the total megakaryocyte 
volume of normal sub3ects after splenectomy will also decrease 30% even though 
blood platelet counts remain normal So the upper border of the normal range 
for total megakaryocyte volume corrected for cellulanty will decrease from 7.8% 
before splenectomy to 5.5% after splerectomy. In the four splenectomized ITP 
patients with a stimulated thrombocytopoiesis the values for total megakaryocyte 
volume were between 5.5% and 7.8%, so they were perhaps somewhat increased. This 
would mean that in only one ITP patient (case no 7), m spite of a stimulated 
thrombocytopoiesis, the total megakaryocyte volume was not increased. 
Comparison of the estimated total megakaryocyte volume with the literature 
The principle of the method employed for determination of the total megakaryo­
cyte volume in marrow biopsies corresponds with the method used by Lundm et 
al. (1972). They determined the number and the mean area of sections of mega­
karyocytes from histological sections in photographs. The normal mean area of 
sections of megakaryocytes ι29ϋ vim ) was in acco "dance with our results. In 
normal subjects they found a total megakaryocyte volume of 20% less than in our 
study. Our values for total megakaryocyte volume in ITP patients agree in part 
with the findings of Harker (1970c). However in our study the increased total 
megakaryocyte volume was not found in all ITP patients and was less marked. 
The advantage of the method employed in this study for determination of the 
total megakaryocyte volume in marrow sections is that the product of the 
number of sections of megakaryocytes and their areas is estimated directly in­
stead of by separate determinations of the number of sections and their dia­
meters or areas. 
The standard deviation of the total megakaryocyte volume m our control group 
is 22% of the mean value. In this respect the method used is nearly compara­
ble with the isotope dilution method of Harker (1968) (SD 11%) and is preferable 
to the planimetrie method of Lundin et al (1972) (SD 53%). The observed range 
in total megakaryocyte volume in normal subjects can not be caused by the method 
of determination but arises from the biological range in total megakaryocyte 
volume. The biological variation in total megakaryocyte volume can be expected 
since platelet count and platelet life span show some variation between normal 
subjects. 
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The number of sections of megakaryocytes in marrow biopsies of ITP patients 
found in this study was in the same range as reported by others (table 21). 
Table 21 
The number of megakaryocytes in bone marrow sections in patients with chronic ITP 
Studies M egakaryocyte 
no. of sections 
(x normal) 
range 
No. of 
patients 
Platelet 
count 
(xl03/yl) 
Splenectomy 
Barta (1932) 1.0 
Lawrence and Kutti (1934) <1 <1-1 
1.1 0.5-1.9 Nickerson and Sunderland 
(1937) 
Harker (1970) 
This study 
3.0* 1.4-5.5 
1.5* 1.1-3.8 
1.9 1.1-3.4 
1.5 0.8-2.6 
1 
6 
4 
14 
7 
8 
14 
10 
27 (4- 94) before 
195 (9-313) after 
46 (7- 92) before 
125 (2-322) after 
* number of whole megakaryocytes not the number of sections 
**"markedly reduced" 
*** "widespread petechiae" 
Relationship between morphometrioal determinations and platelet counts 
In this study no relationship was found between total megakaryocyte volume and 
the peripheral platelet count in ITP patients (table 5). This confirmed the 
findings of Harker (1970c) and Kutti et al. (1973) in ITP patients. A relation-
ship between platel et count and total megakaryocyte volume can only be ex-
pected if a) shortening of platelet life span is equal in all ITP patients, 
b) if platelet distribution between the blood and spleen is constant and 
c) if the total megakaryocyte volume is a parameter for effective platelet 
production. However platelet survival varies considerably m ITP patients. 
So a relationship between peripheral platelet count and total megakaryocyte 
volume cannot be expected. Ibr the same reason, since there is a variable 
platelet destruction in ITP, one would not expect a relationship between the 
peripheral platelet count (which is the result of production and destruction) 
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and the mean megakaryocyte volume (which will be correlated with the produc­
tion alone) as was observed by Harker (1969, 1970 c). In our study, this 
relationship was much less clear. It seems unlikely that the difference between 
our results and Elarker ' s is caused by less acurate determinations of parameters 
of megakaryocyte size in this study, although the histological sections employed 
by us were thicker. 
Megakaryocyte plovdy 
In this study the percentage of megakaryocytes of 32 N and 64 N in control 
subjects was somewhat greater than in the literature (table 3). The ploidy 
values at which the frequency peaks of measured ploidy histograms were loca­
lized were a little greater than the 8N- IfoN- 32N and 64N values as calculated 
with the arbitrary fluorescence light units of 2N metamyelocytes (fig.15). The 
cause and significance of this phenomenon is not clear. This difference cannot 
be due to the 2N reference nuclei employed. Metamyelocytes were used as 2N 
reference because they are easily recognizable and do not proliferate. We found 
that the Fteulgen-DNA values of metamyelocytes were somewhat more than the values 
for polymorphonuclear leucocytes. This is in accordance with the observation 
of James (1973) who reported larger Fteulgen-DNA values in cells with a looser 
chromatin meshwork than in cells with the same karyotype but with condensed 
chromatin. The validity of the method emjioyed is supported by the results of 
ploidy values m 2 patients with chronic myeloid leukaemia and 1 patient with 
idiopathic thrombocytosis. In these patients respectively decreased and in­
creased DNA values have been measured (Penington 1971c, Lagerluf 1972; Harker 
et al.1969, Albrecht et al. 1974). 
Ifi this study an increase in ploidy values in patients with ( a history of) 
chronic ITP was found. This cannot be explained by a selective loss of small ΘΝ 
megakaryocytes in patients with ITP or a selective loss of large 64N, megaka­
ryocytes in control subjects during the marrow sampling or the subsequent pre­
parations, or by some selectivity during DNA measurements. Such selectivities 
cannot explain the observed shift of the peak frequency of the ploidy distri­
bution from 16N in control subjects to 32N m patients with chronic ITP. The 
ploidy findings in this study of ITP patients are quite the contrary of the 
results of Queisser et al. (1971) and Paulus et al. (1973) (table 3). In our 
study the subjects examined were all patients with chronic ITP in a steady 
clinical state. It is possible in patients with acute ITP that during the first 
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days of the disease the stimulation of thrombocytopoiesis has already led to 
an increase in cells which differentiate from precursor cells into megakaryo-
cytes, but that there has been insufficient time since the stimulation for the 
development of maximal ploidy values. In our patients with an acute thrombocyto-
penia due to cardiac surgery with extracorporal circulation there was also no 
increase in DNA values although there was a stimulated thrombocytopoiesis. The 
observed shift to higher ploidy values in patients with chronic ITP probably means 
that more megakaryocytes than normal reach a high ploidy level. Other explana-
tions could be the premature death of some ploidy classes or a selective altera-
tion 11 the maturation rate e.g. a prolonged maturation time of megakaryocytes 
of a high ploidy level or a shortened maturation time of megakaryocytes of a 
low ploidy level which would also result in an increase in the mean ploidy level. 
2.3. CONCLUSIONS 
The described morphometncal method for determination of the total megakaryocyte 
volume in bone marrow biopsies (the product of the number of megakaryocytes and 
their individual volumes) seems to be a good parameter for the potential pla-
telet production capacity of the marrow. Thrombocytopenia caused by hypoproli-
feration of the marrow could be differentiated from other forms of thrombo-
cytopenia. In patients with chronic ITP normal and increased values of the 
total megakaryocyte volume have been found. 
When there was a normal platelet count in pregnant subjects with a history of 
chronic ITP, the total megakaryocyte volume of marrow biopsies proved to be 
valuable for predicting the platelet count of the newborn. 
It was demonstrated that because of the differences in cellularity of the bone 
marrow sections between different subjects .quantitation of megakaryocytes per 
unit marrow volume is less valuable than qiantitation of megakaryocytes in re-
lation to a parameter for cellularity of the bone marrow. 
The estimation of the total megakaryocyte volume in histological marrow sections 
will be a parameter for platelet production when no abnormalities of platelet 
volume and megakaryocytopoiesis, such as extramedullary haematopoiesis, inef-
fective platelet production, changes in maturation- and platelet release velo-
city of megakaryocytes and very acute stimulation or suppression of platelet 
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production occur. Reports of other workers suggest that in practice the in-
fluence of these factors is often too small to lead to a discrepancy between 
the total megakaryocyte volume and platelet production. So the estimation of 
the total megácaryocyte volume in marrow biopsies can often be used instead of 
the estimation of platelet survival to gain an impression of platelet produc-
tion. 
In patients with chronic ITP the size and the polyploidy level of a part of 
the megakaryocytes was increased as well as the total megakaryocyte volume. 
An increase in megakaryocytic size and ploidy can be explained as an expression 
of a stimulated thrombocytopoiesis. 
The increase in total megakaryocyte volume of ITP patients cannot be explained 
only by the increase in the volume of the individual megakaryocytes; the total 
number of megakaryocytes proved to be also increased. 
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CHAPTER 3 
OBSERVATIONS ON SOME KINETIC ASPECTS OF MEGAKARYOCYTOPOIES IS AND 
THROMBOCYTOPOIESIS 
As described in the foregoing chapter an increased total megakaryocyte volume 
was found in marrow biopsies from patients with chronic ITP. To understand the 
significance of this increased megakaryocyte mass for platelet production one 
requires information regarding the rate of turnover of megakaryocytes and the 
effectivity of platelet production. Up until now direct measurements of these 
parameters have not been possible. In order t о gain an impression of the 
functional significance of the increased total megakaryocyte volume in ITP, a 
number of qualitative aspects of megakaryocytopoiesis have been studied; in par­
ticular DMA synthetic activity, maturation of megakaryocytes and the individual 
size of the platelets produced. 
Moreover in a number of ITP patients the effective platelet production was cal­
culated from the increase in blood platelet counts which occurred following sple­
nectomy. 
3.1. THYMIDINE, URIDINE AND METHIONINE UPTAKE BY MEGAKARYOCYTES MEA­
SURED USING AUTORADIOGRAPHY 
3.1.1. Introduction 
As described in chapter I recent concepts concerning megakaryocytopoiesis are 
derived mainly from autoradiographic studies of megakaryocytes and their pre­
cursors using Η-thymidine, combined with determinations of the DNA content of 
megakaryocytes and the estimation of their proportional distribution in the 
various maturation stages. 
In experimentally induced thrombocytopenia the following changes in megakaryo­
cytopoiesis are often observed: there is an increase in the number of megaka­
ryocytes, an increase in polyploidy and an increase in the percentage of mega-
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karyocytes labelled with H-thymidine (labelling index). In some studies changes 
in maturation of megakaryocytes and platelet release velocity have also been re­
ported (Femendegen et al. 1962; Ebbe et al. 1965, 1968a, b, 1970a; Odell et al. 
1962, 1969; Rolovic et al. 1970a,b, Mac Pherson 1974). An increase in the per­
centage of megakaryocytes labelled with thymidine can be interpreted as: 
1. an increased turnover of DNA synthesizing precursor cells in recognizable 
megakaryocytes 
2. an increased polyploidization in recognizable megakaryocytes 
3. a shortened megakaryocyte maturation time. 
Labelling studies of megakaryocytopoiesis in experimentally induced immune 
thrombocytopenia gave conflicting results. Rolovic et al. (1970a) concluded 
that in this condition the bone marrow fails to react properly to the stimulus 
of the low platelet count. They suggested an injurious effect of platelet anti­
bodies on megakaryocytes and therefore on platelet production. One of their ar­
guments was that the initial value of the thymidine labelling index after in­
duction of the thrombocytopenia in the immune thrombocytopenia group, was lower 
than the labelling index in the group with thrombocytopenia produced by throm-
bocytopheresis. However in similar experiments Odell et al.(1969) found evi­
dence of a normal stimulation of megakaryocytopoiesis, similar to the label­
ling pattern observed after massive bleeding (Odell et al. 1962). The different 
results obtained in experimentally induced thrombocytopenia may be explained 
by differences in experimental procedures such as injection-time of thymidine 
or the degree of the thrombocytopenia induced (Odell et al. 1971). Besides that, 
it can be questioned whether or not these experimental conditions are compara­
ble to pathological states in human beings. 
Observations concerning Η-thymidine labelling of human megakaryocytes are 
scarce. Cronkite et al. (1961), Muller (1967) and Clarkson et al. (1971)stu-
died human megakaryocytes after injection of H-thymidine in some patients. 
From these studies it can be concluded that only immature megakaryocytes are 
labelled and the mean time needed for DNA synthesis and maturation of megaka­
ryocytes together in man is probably about 5 days. This is longer than the 
period of 2-3 days observed in rats. Besides these in vivo studies there is one 
study of in vitro incubation of human megakaryocytes with Η-thymidine (Queisser 
et al. 1971). These authors observed no differences between the labelling indi­
ces obtained from three normal subjects and from three patients with ITP. The 
labelling index of megakaryocytes of type I (the most immature megakaryocytes) 
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varied from 32 to 54%. 
It can be concluded that studies of DNA synthetic activity of megakaryocytes 
in man are scarce. Moreover the significance of the results is difficult to 
appreciate because the in vivo labelling studies were performed in leukaemic 
and comatose patients. On the other hand, knowledge of DNA synthesis proved 
to be very important in the development of recent concepts of megakaryocytopoi-
esis in animals. For these reasons we decided to study the Η-thymidine incor­
poration activity of megakaryocytes in man, particularly in patients with throm­
bocytopenia and in control subjects. Moreover some studies concerning the uptake 
of labelled undine and methionine were performed to get an impression of ribo-
nucleic-acid-(RNA) and protein synthesis in normal subjects and m ITP patients. 
3.1.2. Materials and methods 
Preparation of autoradtographs 
H-thymidine 
Bone marrow obtained by needle aspiration from the sternum or iliac crest was 
sampled in plastic tubes with a citrate anticoagulant as described (2.2.l·). The 
marrow samples were incubated at 37 С for exactly one hour with tntiated thy­
midine (cinal concentration of 5 цС/т1) . Tntiated thymidine was obtained from 
the Radiobiochemical Centre Amersham with a specific activity of 5 С per mmol. 
Smears of the marrow were made on glass slides, air-dried, fixed in methanol 
(99.5%) for 30 minutes and thereafter stained according to the May Grünwald-
Giemsa technique (Merck). The stained smears were covered with Polyvinylchloride 
(PVC) to prevent chemography of the photographic film emulsion and to conserve 
the morphology of the stained cells during the autoradiographic procedure. The 
principle of this method has been described by Keyser and Wijffels (1967). The 
stained smears were covered with a PVC layer by dipping the smears in a 15% PVC 
solution in 1 part of butyl-acetate and 2 parts of tnchloroethylene with a semi-
automatic dipping apparatus as described by Vrensen (1970) with a withdrawl velo-
city of 12 mm/min. The smears were air-dried at room temperature for 1 day. Sub-
sequently the stained smears, covered with PVC, were coated with film emulsion 
by dipping the smears in liquid Ilford-L4 emulsion at a temperature of 32 С with 
the above mentioned dipping apparatus at a velocity of 84 mm/min. The autoradio­
graphic exposure time was 7 days. During this time the preparations were stored 
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ín the dark at 40C. The autoradiographs were developed in Kodak D 19 b developer. 
Η-uridine and H-methionine 
The same procedure as described above was used in incorporation studies of H-
3 
undine or Η-methionine, bothat final concentrations of 5 yC per ml bone marrow. 
Tritiated uridine and methionine were obtained from the Radiochemical Centre 
Amersham with specific activities of 30 С per mmol and 5 С per mmol respective-
iy· 
Morphological classification of megakaryocytes 
Megakaryocytes were classified approximately according to Feinendegen et al. 
(1962) : 
a. Type I: Earliest recognizable forms, with an intensely basophilic cytoplasm, 
without or with only sparee granulation, with a high nuclear-cytoplasmic ra­
tio and a nucleus showing granular chromatin. 
b. Type II: More differentiated forms, showing transition to an azurophilic cy­
toplasm, with more cytoplasmic granulation, a decreased nuclear-cytoplasmic 
ratio and with less granular chromatin in the nucleus. 
c. Type III: Further differentiated forms, with much cytoplasmic granulation, 
a low nuclear-cytoplasmic ratio, with coarse chromatin. This group also in­
cludes the most mature forms with pycnotic nuclei. 
d. Naked nuclei: There is no cytoplasm visible or only pale coloured cytoplasm 
without granulations. 
When the classification of the megakaryocytes was difficult, the amount of gra­
nulation and the colour of the cytoplasm was decisive for classification. 
Evaluation of autoradiographs 
The autoradiographs were evaluated by light microscopy, all by the same techni­
cal assistant. The number of labelled megakaryocytes was expressed as the per­
centage of the total number of megakaryocytes, or as the percentage of type I 
megakaryocytes which were labelled. This parameter will subsequently be termed 
'the labelling index of megakaryocyte^'. To prevent bias due to selection of mega­
karyocytes, all the megakaryocytes in a smear were examined. In parts of the 
marrow smears where chemography had occurred, it was difficult to see if mega­
karyocytes were labelled. These megakaryocytes were excluded not only for esti­
mation of the labelling index but also for the morphological differentiation. 
A minimun of 100 megakaryocytes were analysed from each subject, with a mean 
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value of 250 megakaryocytes. 
Examned subjeots 
H-Thymidine studies 
Normal controls (10) 
Twelve examinations were carried out in a group of 5 normal volunteers and 5 
patients without blood disorders or without diseases with known altered mega-
karyocyto-or thrombocytopoiesis. Patient no. 76 with febns e.c.i. and patient 
no. 77 with bronchogenic carcinoma were in a steady clinical state (table 23). 
Patients with chronic ITP (12) 
Fifteen examinations were carried out in a group of 12 patients. This group con­
tained patients before and after splenectomy. Seven of them were examined during 
treatment with corticosteroids. Four cases who were studied following splenec­
tomy showed, at the time of marrow aspiration, a normal blood platelet level. 
One of them (no. 14) was examined three days after splenectomy, in which period 
the blood platelet level had increased from 40 to 188 χ 10 /yl (table 24). 
Patients with postoperative thrombocytopenia (6). In four out of five patients 
who developed a thrombocytopenia after cardiac surgery for prostheses of valves, 
a marrow sample was taken on the second of third postoperative day. In one pa­
tient (no. 42) this was done on the seventh postoperative day. One patient 
(no. 43) who developed a thrombocytopenia after a massive blood loss during 
prosthetic hip surgery, was exaqined 2 days after the operation (table 25). 
Patients with various kinds of histories of thrombocytopenia (4). Four of five 
examinations in four patients with a history of severe thrombocytopenia were 
carried out during a period with normal platelet counts. One patient (no. 46) 
developed thrombocytopenic purpura during a fever period. The marrow sample from 
this patient was obtained while there was a rapid increase in the platelet count 
four days after the first haemorrhagic manifestation (table 26). 
3 3 
Η-Uridine and H-Methiomne-studies 
The studies with H-undme and Η-methionine were made in bone marrow samples 
from 3 control subjects and 6 patients with chronic ITP during a thrombocyto­
penic phase (table 27-30). 
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3.1.3. Results 
H-Thynridine autoradiography, as a parameter for DNA-synthesis 
Η-Thymidine autoradiography revealed almost exclusively the earliest recogni­
zable forms of megakaryocytes, type I. Rarely was a naked nucleic megakaryocyte 
labelled. Megakaryocytes of type II and III were not labelled. 
The reproducibility of the estimation of the labelling index 
A variation in the final concentration of Η-thymidine from 5 μο/πιΐ to 25 yC/ml 
marrow solution, did not influence the labelling index. Also dilution of the 
marrow cell concentration by a factor of 5, prolongation of the exposure time 
of the autoradiographs from 7 to 13 days and the absence or presence of 1 or 
2 Polyvinylchloride layers between the stained marrow smears and the photoemul-
sion layer, did not change the eventual labelling index. 
Table 22 
Reproducibility of the estimation of the frequency distribution of morphological 
3 
types and H-thymidme labelling indices in 5 subjects. Two marrow aspirates 
were taken at different times from each of 4 subjects 
Case no 
7 
8 
47 
62 
65 
Marrow 
aspirate 
10-04-·72 
04-05-,72 
05-07-,72 
14-01-,72 
іэ-об-^г 
12-04-·72 
04-05-,72 
10-03-'72 
12-04-'72 
10-03-·72 
10-05-·72 
Megakaryocyt 
I 
17 
20 
20 
20 
24 
21 
19 
25 
23 
24 
20 
type 
II 
12 
11 
11 
20 
15 
12 
7 
21 
17 
15 
8 
III 
57 
62 
64 
54 
55 
58 
60 
47 
51 
50 
61 
es (%) 
naked 
nuclei 
15 
7 
5 
6 
6 
9 
20 
8 
9 
11 
11 
L I of 
type I* 
34 
34 
28 
30 
24 
29 
26 
32 
32 
34 
31 
*Labelling index of type I megakaryocytes (% labelled) after in vitro incubation 
with tntiated thymidine 
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In five subjects the labelling indices were investigated two or three times on 
different occasions. The results of the estimations of the labelling index in 
repeated marrow aspirates m these 5 subjects are given in table 22. As can be 
seen, the reproducibility of the labelling index estimation is rather good. 
Table 23 
Percentages of megakaryocytes in various morphological maturation classes and 
Η-thymidine labelling indices in 10 control subjects 
Case Sex Age Marrow 
aspirate 
Diagnosis Megakaryocytes (%) 
type 
I II III 
naked 
nuclei 
L I of 
type I 
3H-TdR* 
62 
65 
69 
70 
72 
73 
74 
75 
76 
77 
36 
28 
10-03-'72 
12-04-'72 
ю-оз-'тг 
25 21 47 
23 17 51 
24 15 50 
10-05-'72 20 8 61 
36 16-05-'72 Gastritis? 21 14 59 
16 13-06-'72 Anorexia nervcsa 32 12 53 
34 10-03-'72 - 45 13 37 
58 24-04-'72 - 26 14 46 
60 24-04-'72 Lungfibrosis 24 16 55 
43 07-03-,72 - 25 15 52 
14 07-09-42 Febris e.c.i. 13 11 71 
65 29-05-'72 Bronchogenic 23 13 59 
carcinoma 
8 
9 
11 
11 
7 
3 
4 
14 
5 
8 
6 
4 
32 
32 
34 
31 
28 
28 
29 
33 
24 
21 
31 
31 
Mean (n=12) ± SD 25+8 14t3 53±9 8 ± 3 Э.5+4 
•Labelling index of type I megakaryocytes (% labelled) after in vitro in­
cubation with tntiated thymidine 
In twelve observations of ten control subjects the mean labelling index for 
megakaryocytes of type I was 29.5% ± 4 (1 SD) (table 23). 
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Table 24 
Percentages of megakaryocytes in various morphological maturation classes and 
Η-thymidine labelling indices in 12 patients with (a history of) chronic ITP 
Case no Sex Age Marrow 
aspirate 
Sple­
nec­
tomy 
Pred­
nison 
mg/day 
Platelet 
count 
(χ103/μ1) 
Megakaryocytes (%) 
type 
I II III 
naked 
mrlei 
L I of 
type I 
3H-TdR* 
10 
12 
13 
14 
19 
20 
21 
m 
f 
m 
f 
m 
f 
f 
f 
m 
m 
f 
f 
41 
55 
59 
65 
26 
23 
45 
65 
30 
13 
20 
60 
06-07-72 
28-07-72 
04-09-72 
10-04-72 
04-05-72 
05-07-72 
14-01-72 
19-06-72 
10-04-72 
17-04-72 
13-03-72 
03-03-73 
28-09-72 
05-06-72 
30-03-73 
-
-
-
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
+ 
-
-
60 
-
25 
10 
40 
20 
-
5 
5 
80 
-
15 
16 
38 
29 
16 
56 
184 
94 
2 
220 
16 
14 
188 
20 
80 
22 
23 
39 
17 
20 
20 
20 
24 
26 
34 
20 
13 
17 
26 
15 
15 
20 
12 
11 
11 
20 
15 
11 
11 
13 
12 
7 
14 
60 
54 
38 
57 
62 
64 
54 
55 
40 
44 
54 
74 
74 
53 
3 
8 
3 
15 
7 
5 
6 
6 
23 
11 
12 
1 
3 
7 
21 
31 
28 
34 
34 
28 
30 
24 
26 
31 
28 
16 
29 
37 
262 18 12 46 24 29 
Mean (n=15) ± SD 
Normal (n=12)± SD 
82±87 
208150 
23±7 13 ·3 55 ±11 
Z±8 14±3 53 ±9 
9+7 
8±3 
28±5 
29l5±4 
•Labelling index of type I megakaryocytes (% labelled) after in vitro incu­
bation with titriated thymidine 
Table 24 shows that the mean percentage of labelled megakaryocytes in twelve 
ITP patients was in the same range as in normal subjects: 28% ± 5 ( 1 SD). On­
ly one patient (no.14) examined 3 days after splenectomy, in which period the 
blood platelet count rose to normal, showed a rather low labelling index of 
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16%, while one other patient (no. 1) showed a boderlme value. In the chronic 
ITP patients there was no relation between the labelling index and the blood 
platelet level and no difference between the labelling indices before and 
after splenectomy. 
Table 25 
Percentages of megakaryocytes in various morphological maturation classes and 
Η-thymidine labelling indices in 6 patients with postoperative thrombocyto­
penia 
Case no Sex Age Marrow 
aspirate 
Diagnosis Platelet 
count 
(xloVpl) 
Megakaryocytes(%) 
type 
II III 
naked 
nuclei 
L I of 
type I 
3H-TdR* 
38 
39 
40 
41 
42 
43 
m 
m 
m 
f 
f 
f 
43 02-03-73 A.S.D. 83 
49 29-03-73 A.I. 80 
30 29-03-73 A.I.*** 64 
59 01-12-72 A.S.D.** 70 
50 28-11-72 M.I.**** 78 
65 06-12-72 Prosthe- 66 
tic hip 
42 
26 
32 
54 
38 
35 
12 
35 
22 
4 
10 
14 
45 
39 
46 
29 
46 
51 
1 
0 
0 
13 
б 
0 
57 
48 
34 
54 
53 
43 
Mean 
Normal 
(n= 6) ± SD 
(n=12) ± SD 
38±io leai 43±8 
25+8 14±3 53±9 
3±5 
8 + 3 
48±8 
29 5±4 
*Labelling index of type I megakaryocytes (% labelled) after in vitro incu­
bation with tritiated thymidine 
**A.S.D.ratrial septal defect, *** A.I.raortic insufficiency, ****M.I.rmitral 
insufficiency 
As is demonstrated in table 25 a high labelling index was observed in acute 
postoperative thrombocytopenia with a mean value of 48% ± 8 (1 SD) for type 
I megakaryocytes. The labelling indices of these acute forms of thrombocytope­
nia differed significantly from the labelling indices in normal subjects and 
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in patients with chronic ITP (Wilcoxon's two sample test; p=0.001) or patients 
with other kinds of thrombocytopenia (p=0.02) (fig. 21). 
JH thymidine labelling index 
of me^cikaryocytes of type I ("о) 
70 
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Fig. 21.Labelling index of megalaiyocytes (type I) incubated with H-thymidine, 
(10 control subjects, 12 patients with a history of chronic ITP, 6 patients 
with postoperative thrombocytopenia and 5 patients with various kinds of histo­
ries of thrombocytopenia). The labelling index in patients with acute postope­
rative thrombocytopenia is significantly increased in comparison with control 
subjects and patients with chronic ITP (p=0.001). 
Table 26 shows the labelling indices m five patients with various kinds of 
histories of thrombocytopenia. Two of these patients showed normal values, one 
patient showed a low value. One patient (no.46) who had just recovered from an 
acute thrombocytopenic period, showed a high labelling index of 47%, comparable 
with the high labelling in the postoperative thrombocytopenic group. 
H-Uridzne 
Labelling of megakaryocytes after in vitro incubation with H-undine was seen 
in all types of megakaryocytes with a predominance of the immature megakaryocytes. 
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Table 26 
Percentages of megakaryocytes in various morphological maturation classes and 
Η-thymidine labelling indices in 4 patients with various kinds of histories 
of thrombocytopenia 
Case no Sex Age Marrow 
aspirate 
Diagnosis Platelet 
count 
(ХІОЗДІІ) 
Megakaryocytes (%) 
type 
II III 
naked 
nuclei 
L I of 
t y p e I 
3H-TdR* 
44 
45 
46 
4 7 
m 23 23-02-72 auto-immune 124 22 9 57 11 
h e m o l y t i c anae -
m i a , splenonegafy 
f 32 14-04-72 lupus 80 20 8 46 26 
erythematosus 
m
 60 19-04-72 infectious 152 29 12 50 9 
thrombocytopenia 
m 17 12-04-72 thrombotic 100 21 12 58 9 
thrombocytopenic 
purpura? 
04-05-72 309 19 7 60 20 
15 
20 
47 
29 
26 
Normal (n=12) ± SD 25± 8 14±3 53І9 8±3 29.5+4 
*Labelling index of type I megakaryocytes (% labelled) after in vitro incuba­
tion with tritiated thymidine 
Moreover, as is demonstrated in table 27 and table 28, the results were si­
milar in control subjects and in ITP patients. Therefore, although the 
number of observations is rather small, no further investigations in this 
direction were performed. The significance of the high labelling index of 
megakaryocytes of the naked nuclei type observed in some ITP patients is very 
dubious because the absolute numbers of megakaryocytes of this type were 
very small. 
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Table 28 
Percentages of megakaryocytes in various morphological maturation classes and H-uridine labelling indices in 
6 patients with chronic ITP 
Case 
no 
1 
5 
6 
Sex 
m 
f 
m 
Age 
41 
55 
59 
Marrow 
aspirate 
06-07-72 
28-07-72 
04-09-72 
Splenec­
tomy 
-
-
_ 
Prednison 
mg/day 
-
-
60 
Platelet 
count 
(xl03/ul) 
16 
38 
29 
Megakaryocyte s 
type 
I II III 
22 17 55 
20 14 60 
35 13 48 
naked 
nuclei 
6 
6 
4 
Labelling index* 
type 
I II III 
naked 
nuclei 
50 16 5 21 
50 16 6 0 
49 8 5 10 
26 14-01-72 40 94 32 13 40 14 74 15 3 27 
19 
20 
13 28-09-72 
20 05-06-72 15 
20 
80 
27 12 57 
19 14 61 
43 0 2 0 
66 12 1 24 
* Labelling index of megakaryocytes (% labelled) after in vitro incubation with H-uridine 
Table 27 
Percentages of megakaryocytes in various morphological maturation classes and 
Зн-uridine labelling indices in 3 control subjects 
Case 
no 
Sex Age Marrow 
aspirate 
Diagnosis Megakaryocytes (%) 
type 
I II III 
naked 
nuclei 
Labelling index* 
type 
I II III 
naked 
nuclei 
62 m 37 04-07-73 - 16 14 70 0 50 б 2 0 
67 m 29 16-10-72 - 35 15 49 1 46 11 0 0 
78 m 25 22-09-72 - 22 14 59 5 47 19 3 0 
•Labelling index of megakaryocytes (% labelled) after in vitro incubation with 
tritiated uridine 
H -Methionine 
In a pilot study concerning autoradiography after Η-methionine incorporation, 
no differences were found between labelling indices in three control subjects 
and six patients with chronic ITP as is shown in table 29 and 30. 
Table 29 
Percentages of megakaryocytes in various morphological maturation classes and 
3 
Η-methionine labelling indices of megakaryocytes in 3 control subjects 
Case 
no 
Sex Age Marrow 
aspirate 
Diagnosis Megakaryocytes (%) 
type 
I II III 
naked 
nuclei 
Labelling index* 
type 
I II III 
naked 
nuclei 
70 f 16 13-06-72 anorexia 40 20 37 3 92 84 56 0 
nervosa 
77 m 65 29-05-72 bronchogenic 32 15 46 8 87 69 65 0 
carcinoma 
78 m 25 22-09-72 - 32 11 56 1 88 73 59 0 
•Labelling index of megakaryocytes (% labelled) after in vitro incubation with 
tritiated methionine 
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Table 30 
Percentages of megakaryocytes in various morphological maturation classes and Η-methionine labelling indices in 
6 patients with chronic ITP 
Case 
no 
Sex Age Marrow 
aspirate 
Splenec­
tomy 
Prednison 
mg/day 
Platelet 
count 
(χ103/μΐ) 
Megakaryocytes (%) 
type 
I TI III 
naked 
nuclei 
Labelling index* 
type 
I II 111 
naked 
nuclei 
1 
5 
6 
β 
19 
20 
41 06-07-72 
55 28-07-72 
59 04-09-72 
26 19-06-72 
13 28-09-72 
20 05-06-72 
16 
38 
27 10 62 
13 19 68 
60 
20 
_ 
29 
2 
20 
40 
29 
25 
16 
21 
12 
42 
47 
63 
15 80 29 15 52 
81 61 65 0 
50 29 29 0 
66 52 41 0 
83 64 59 0 
86 67 59 0 
93 65 70 3 
•Labelling index of megakaryocytes (%labelled) after in vitro incubation with H-methionine 
3.1.4. Discussion 
Thymidine labelling-maturation stage 
Labelling of megateryocytes was only seen in type I and in some naked nuclei. 
Labelling of "naked nuclei" must be explained by the loss of cytoplasm by me-
gakaryocytes of type I during the autoradiographic procedure. From animal stu-
dies Odell et al. (1968) also concluded that only the most immature megakaryo-
cytes are able to synthesize DNA. However, in other investigations, polyploidi-
zation of megakaryocytes was also seen in less immature types (Ebbe et al. 
1965; Müller 1967). This discrepancy may be caused by differences in criteria 
for maturation of megakaryocytes. 
Thymidine labelling indices of megakaryocytes were expressed as percentages of 
labelled megakaryocytes of type I and not as percentages of all megakaryocytes 
for the following reason: 
In areas with chemography which occurred mainly at the periphery of the marrow 
smear, it was difficult to see if megakaryocytes were labelled or not. There-
fore megakaryocytes in areas with chemography were excluded. However, large 
megakaryocytes of type III which are more frequently seen at the periphery of 
the marrow film will be more often excluded than smaller, immature, types of 
megakaryocytes. As mature types are unlabelled this selective exclusion will 
result in an overestimation of the labelling index of megakaryocytes of all 
types. The chance that labelled and unlabelled megakaryocytes of type I will 
lie in areas with chemography will be about equal. So for megakaryocytes of 
type I there is no selective exclusion of labelled or unlabelled cells and 
their labelling index is to be preferred above the use of a labelling index 
that includs all types of megakaryocytes together. 
Normal thymidine labelling in stimulated thrombocytopoiesis 
No difference was found between the labelling index of megakaryocytes incubated 
with Η-thymidine in control subjects and chronic ITP patients, suggesting a 
normal DNA synthetic activity of megakaryocytes in ITP patients. This result 
seems to conflict with the observations in experimentally induced thrombocyto­
penia in which an increased thymidine labelling index of the megakaryocytes 
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was observed (Odell et al. 1969). This contrast may be explained by a difference 
in duration of the stimulation of thrombopoiesis: acute stimulation will result 
in an increased influx of megakaryocytes from the unrecognizable precursor pool. 
Feinendegen et al. (1962) observed that these precursor cells have a high DNA 
synthetic activity. Thus an increased influx of precursor cells into the recog-
nizable megakaryocyte compartment will at first result in a high labelling in-
dex of the megakaryocytes. After some time the amount of megakaryocytes in 
the more mature megakaryocyte compartments will also increase and a new steady 
state with a normal labelling index will be obtained. This explanation of the 
normal thymidine labelling index of megakaryocytes in patients with chronic 
ITP, although one might expect a stimulated thrombopoiesis, is supported by 
the observations in this study in cases with an acute stimulation of thrombocy-
topoiesis. In 5 out of 6 patients with an acute severe thrombocytopenia follo-
wing an operation, the labelling index of megakaryocytes of type I was greater 
than in 31 out of 32 examinations in control subjects and various kinds of 
patients (fig. 21). Only the patient recovering from an acute infectious throm-
bocytopenia (no. 46), also showed a high labelling index. The increased influx 
of precursor cells with a high DMA synthetic activity into the recognizable 
megakaryocyte compartment can explain the high labelling index of megakaryocyte 
of type I m cases with an acute stimulation of thrombopoiesis. Otherwise an 
increase in endomitotic activity in type I or an increase in the maturation 
velocity from type I to type II will also result in an increased labelling in-
dex of megakaryocytes of type I. The normal labelling jndex of megakaryocytes 
of type I in cases of chronic ITP suggests that in megakaryocytes of type I 
the quotient between the time spend in DNA synthesis activity and the rest of 
the time spend m stage I is unchanged. If in megakaryocytes of type I this 
time, not spent in DNA synthesis, is not absolutely increased then this 
implies that there is no extra time available for polyploidization in stage I. 
On the other hand we observed an increased DNA content in megakaryocytes from 
chronic ITP patients. At first sight this suggests that in chronic ITP patients 
megakaryocytes which are coming from the precursor pool into the recognizable 
compartment have already obtained an increased DNA content in the precursor 
pool. However the increased mean DNA value in ITP patients seems to be the 
result of an extra-nuclear replication of about 10% of the megakaryocytes or 
their precursors (table 18). Even if this occurs in megakaryocytes of type I 
it is questionable if this rather small percentage can be detected with the 
methods used in this study. 
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The observed thymidine labelling index of megakaryocytes was in accordance with 
the results obtained by Queisser et al. (1971) in 3 normal cases and 3 chronic 
ITP patients and with the labelling index of megateiyocytes of all types to-
gether of about 12%, after in vitro incubation, observed by Clarkson et al. 
(1971) in two leukaemic patients. Comparison of the labelling indices of imma-
ture types observed by Clarkson et al. (1971) and Queisser et al. (1971) and 
the results of this study is not possible due to differences in morphological 
classification criteria. 
Uridine, methionine labelling 
Although undine and methionine used as markers for ribonucleic-acid-and pro-
tein synthesis are less specific than thymidine as a marker for DNA synthesis 
and the number of experiments carried out with these markers were small, the 
similar results obtained in patients with ITP and control subjects suggest 
that there are no important differences in ribonucleic-acid- and protein syn-
thesis. 
3.2. MATURATION OF MEGAKARYOCYTES STUDIED BY MORPHOLOGICAL DIFFE-
RENTIATION OF MEGAKARYOCYTES 
3.2.1. Introduction 
Megakaryocyte differential counts give some information about megakaryocyte 
kinetics, especially when studied together with autoradiography. For instance 
an increase m the percentage of immature megakaryocytes can be interpreted 
as: 
1. an absolute increase in megakaryocytes of type I 
2. a longer duration of megakaryocytes in the type I compartment; this may be 
the consequence of an increase in polyploidization 
3. a decrease in megakaryocytes of type II and III; this may be the result of 
premature cell death 
4. a shorter duration of megakaryocytes in type II and III compartments as a 
result of an accelerated maturation time. 
In most animal studies experimentally induced thrombocytopenia results in an 
increase in immature megakaryocytes after 24 hours (Craddock et al. 1955; 
Odell et al. 1962, 1969; Krizsa et al. 1968; Rolovic et al. 1970a). In some 
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studies these changes in the megakaryocyte differential count proved to be the 
result of an absolute increase in the number of megakaryocytes of type I while 
in other studies an accelerated maturation of more mature megakaryocyte was a 
contributory factor. Ebbe et al(1968a,b) observed a less obvious increase in 
the number of megakaryocytes of type I after acute stimulation and suggested 
that this was the result of a balance between an increased influx from precur-
sor cells into the visible megakaryocyte compartment with an accelerated matu-
ration time of the visible megakaryocytes. Megakaryocyte differential counts 
after prolonged depletion of platelets, comparable with chronic ITP, have scar-
cely been studied at all. Rolovic et al. (1970b) found a normal differential 
count in rats after a six week period of stimulated thrombocytopoiesis. This 
suggests a new steady state with an increased megakaryocyte turnover and even-
tually an increased maturation time. The duration of stimulation may be impor-
tant for the results of morphological differential counts and may explain the 
different results found by the various investigators. Probably this problem is 
analogous to the discrepancy in findings concerning the megakaryocytic size 
after different periods of stimulation. After acute depletion of platelets the 
increase in size of megakaryocytes reported by Marker (1968b) and Ebbe et al. 
(1968a) was less obvious than after prolonged depletion of platelets (Penning-
ton et al. (1970). 
Changes in proportional distribution of the various maturation stages and 
morphological abnormalities of megakaryocytes have been described in patients 
with ITP. A recent review is given by Rebuch et al. (1970). The reported ob-
servations are conflicting. This can be explained partly by differences in 
the classificiations of thrombocytopenic patients, especially in the older li-
terature. Sane megakaryocytic features reported in ITP are: a loss of platelet 
formation, a reduction in azurophilic granulation, vacuolization and coarsening 
of chromatin nuclear pattern. These qualitative alterations are almost undocu-
mented quantiiatmely and in fact in our experience their existence is very doubt-
ful. 
There are some well documented studies concerning the frequency distribution 
of megakaryocytic types in ITP patients. Diggs et al. (1948) showed a shift 
to immature megakaryocytes in 22 patients with ITP. However these observations 
were carried out in the acute stage of the disease. Presley et al. (1952), 
using well formulated criteria for maturity of megakaryocytes, studied acute 
and chronic ITP patients and also found an increased relative immaturity of 
megakaryocytes. In recent studies Queisser et al. (1971) reported a normal mega-
karyocyte differentiation in ITP while Harker (1970c) observed a decreased cyto-
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plasmic granulation, indicating a relative predominance of immature megakaryo­
cytes, only in chronic ITP patients with platelet counts of less than 20,000/ 
μΐ. In chronic ITP patients with platelet counts higher than 40,000/yl Harker 
found that the pattern of cytoplasmic granulation was not different from nor­
mal. Recent cytochemical studies by Kass (1973) showed that the ITP megakaryo­
cytes are enzymatically young when compared to normal megakaryocytes. Albrecht 
et al. (1974) described megakaryocytes in ITP, which were larger, more baso­
philic and which occasionally showed platelet formation in basophilic megaka­
ryocytes. 
3.2.2. Materials and methods 
Criteria for morphological classification of May Grunwald-Giemsa stained mega­
karyocytes are described under 3.1.2. Differential counts of megakaryocytes were 
carried out on autoradiographs of marrow smears from control subjects and the 
patients which were studied for thymidine incorporation of megakaryocytes. A 
minimum of one hundred megakaryocytes was differentiated. 
3. 2.3. Results 
The reproducibility of the determinations of the distribution of megakaryocytes 
in their various maturation classes in repeated marrow aspirates in 5 subjects 
is shown in table 22. 
The relationship between the labelling index of megakaryocytes incubated with 
Η-thymidine and the percentage of megakaryocytes of type I is given in 
figure 24. 
The proportional distribution of megakaryocytes in their various maturation 
stages in control subjects is given in fig. 22 and table 23. Most megakaryo­
cytes were classified as mature, type III, megakaryocytes. 
In 15 examinations of 12 patients with (a history of) chronic ITP the fre­
quency distribution of megakaryocytes did not deviate from normal (table 24). 
There was no relationship between the percentage immature, type I, megakaryo­
cytes and the platelet count in ITP patients. Megakaryocyte differential counts 
before and after splenectomy m ITP patients showed no essential differences. 
In the patients with acute thrombocytopenia following cardiac surgery and mas­
sive bleeding, a predominance of immature megakaryocytes was observed (table 25). 
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Fig.23.Morphological analysis of megakaryocytes classified approximately accor­
ding to Feinendegen et al. (1962) (10 control subjects, 12 patients with a histo­
ry of chronic ITP, б patients with acute postoperative thrombocytopenia and 5 pa­
tients with various kinds of histories of thrombocytopenia) 
The mean percentage of type I megataiyocytes m the post-operative thrombocyto-
penia group was 38%, in contrast to values of 25% and 23% in control subjects 
and patients with chronic ITP (fig. 23). These differences are significant, 
p=0.001, according to Wilcoxon's two sample test. 
In the patients with various other kinds of thrombocytopenia a normal differen-
tial count was observed (table 26).Patient no. 46, who was just recovering 
from an acute thrombocytopenia, also showed a normal percentage of type I mega-
karyocytes 
3.2.4. Discussion 
Although any classification of megakaryocytes into their various maturation 
classes is arbitrary and subjective, the results of this study m control sub-
jects agrees with other studies using megakaryocyte differential counts accor-
ding to the criteria of Feinendegen et al. (1962) (Queisser et al. 1971; Ebbe 
et al. 1965) -
As is many animal studies of experimentally induced acute thrombocytopenia we 
observed a predominance of immature megakaryocytes in patients with acute sti-
mulation of thrombocytopoiesis produced by thrombocytopenia following cardiac 
surgery or massive bleeding. This suggests an increased influx of megakaryocy-
tes into the visible megakaryocyte compartment or a relatively longer retention 
of megakaryocytes in the type I compartment. In chronic ITP patients no increase 
in type I megakaryocytes was observed in this study, suggesting a normal matu-
ration time of megakaryocytes or an equal increase in the maturation time of 
all maturation stages, compensated by an increased polyploidization time of 
megakaryocytes in the type I compartment. The percentage of megakaryocytes 
without cytoplasm (naked nuclei) varied from 1 to 26. This variation was more 
than the variation in the percentages of other types of megakaryocytes. More-
over, sometimes thymidine labelling of naked nuclei was observed while megaka-
ryocytes of type II and type III were never labelled in this study. Naked nuclei 
represent not only the final stage of degenerating megakaryocytes but also mega-
karyocytes which are damaged during the aspiration of the marrow sample, during 
the incubation period with the radioactive material or in the preparation of 
the marrow film. For this reason the relation between the percentages of mega-
karyocytes of types I, II and III are more important than the percentages of 
113 
naked nuclei. In some cases the number of megakaryocytes of type III will be 
decreased by selective accumulation of type III cells m the tail of the mar­
row film, which areas because of chemography are sometimes excluded from evalua­
tion. 
Some positive correlation between an increased Η-thymidine labelling index 
of megakaryocytes of type I and an increased percentage of megakaryocytes of 
type I was observed in patients with postoperative thrombocytopenia (fig. 24). 
This suggests an increased influx of megakaryocytes from the unrecognizable 
precursor compartment, an increased endoduplication of the nucleus of mega­
karyocytes of type I, or both. 
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Fig. ¿4. Relationship between percentage of megakaryocytes of type I and their 
labelling index after incubation with H-thymidine (10 control subjects, 12 
patients with a history of chronic ITP, 6 patients with acute postoperative 
thrombocytopenia and 5 patients with various kinds of histories of thrombocy-
topenia) . The regression line is defined by Y=0.65 χ + 15. The correlation 
coefficient is 0.608. 
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3.3. THROMBOCYTOPOIETIC ACTIVITY INDICATED BY PLATELETS SIZE DIS­
TRIBUTION 
3.3.1. Introduction 
Platelet size can be determined visually on blood smears by measurements of 
diameters of platelet areas and by electronic volume-plotting of platelet sus­
pensions. The results of the different techniques agree quite well (Garg et 
al. 1971, 1972; Murphy et al. 1972; Kraytman 1973; Paulus 1974). Normal plate­
let volumes vary from about 5 to 9 μ . Until recently it was accepted that the 
size of platelets diminishes during their ageing in the peripheral circulation. 
The log normal platelet volume distribution curve, observed with different tech­
niques, has been explained on the basis of age distribution (Mc Donald et al. 
1964; Bull et al. 1965; Goguel et al. 1973). However, recently Paulus (1974) 
provided data against an age-dependent platelet volume. He observed a log nor­
mal volume distribution in a platelet population with an age of some hours. 
Moreover Paulus (1974) found no decrease in the volume of these young platelets 
during their life span when they were transfused into patients lacking plate­
let production. He concluded that platelet volume distribution was not age-
dependent but was the result of the development of platelets in megakaryocytes. 
Paulus (1974) suggested that growth rate and fragmentation of the megakaryo-
cytic cytoplasm are decisive for the genesis of the volume distribution of 
platelets. 
An abnormal platelet size distribution, resulting in an increased percentage 
of large platelets (megathrombocytes) is observed in patients with a shortened 
platelet life span, such as patients recovering from consumptive thrombocyto­
penia, some hereditary platelet disorders and in some haematological diseases 
with increased and normal platelet turnover. (Kurstjens et al. 196Θ; Falcao 
et al. 1971; Saarni et al. 1971; Baadenhuysen 1971; Karpatkin et al. 1971; 
Garg et al. 1972; Godwin et al. 1972; Murphy et al. 1972; Paulus 1974). In ali 
cases (normal or abnormal thrombocytopoiesis) a log normal distribution of 
platelet volumes was observed. 
In ITP patients an increased percentage of large platelets was observed not 
only in thrombocytopenic patients but also in patients with a history of ITP 
with a normal platelet count but a decreased platelet survival (Garg et al. 
1971, 1972; Murphy et al. 1972,-Paulus 1974). This suggests the usefulness of 
the percentage of the large platelets as an index for a stimulated thrombocyto­
poiesis. Moreover the positive correlation between the percentage of large pla­
telets and the number of megakaryocytes found in various kinds of thrombocyto­
penia and non-thrombocytopenic disorders with shortened platelet survival, 
suggests the usefulness of the percentage of large platelets as an index for 
the degree of platelet production (Garg et al. 1971). However there was no po-
sitive correlation between the percentage of large platelets and the number 
of megakaryocytes in cases with thrombocytotic disorders and megaloblastic anae-
mias. 
So in ITP the significance of an increased percentage of large platelets can 
be: 
1. an indication of an increased platelet production 
2. an indication of an abnormal thrombocytopoiesis 
3. both 
Some arguments can be provided for the assumption that the abnormal platelet 
size distribution with an increase in large platelets in ITP indicated an in-
creased platelet production: 
a. Cases of ITP with a shortened platelet survival but a normal platelet count 
caused by compensated, increased platelet production, show an increased per-
centage of large platelets 
b. During successful treatment with corticosteroids or after splenectomy a 
rapid decrease in the percentage of large platelets occurrs in combination 
with a prolongation of platelet life span, although antiplatelet antibodies, 
which could possibly be deleterious for megakaryocytes, are still present. 
In this study platelet size distribution curves were investigated in ITP 
patients in order to look for signs of stimulated thrombocytopoiesis and 
correlations between platelet volumes and other measured characteristics of 
megakaryocytopoiesis. 
3.3.2. Materials and methods 
Measurement of platelet size 
Preparation of platelet suspensions 
Venous blood was collected in plastic tubes and anticoagulated with ethylene 
diamine tetra-acetate (Samama et al. 1973). Platelet rich plasma was obtained 
by centrifugation at room temperature (2.2.1.) . A sample of 10 yl platelet rich 
plasma was diluted in 10 ml Isoton (Coulter electronics, Bedfordshire, England). 
Platelet size measurements ware performed within 2 hours after blood sampling. 
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Size distribution was plotted with a Coulter model Ρ 64 plotter, full scale 
4096, attached to a Coulter counter, model ZF. A 50 μ aperture tube was used. 
The machine settings were as follows: Sensitivity 0.707 or 1.0: Controls (aper­
ture) 8 and Treshold 10. The calibration was performed with Coulter latex par­
ticles of 3.42 μ volume. Those particles showed a frequency peak in channel 
14 with a sensitivity setting of 0.707. Each Treshold division was equal to 
0.244 μ . So particle plots from channel 1 to 64 encomposed volumes of 0.25 
to 15.62 μ . 
Analysis of platelet size curves 
When the platelets were classified in log volume classes the frequency distri­
bution was symmetrical (fig. 25). Each frequency distribution was characterized 
by: 
a. the mode of the elog volume distribution (μ), indicating the peak frequency 
b. the standard deviation of the mode of the log volume (σ) indicating the 
variation in platelet size 
The mean platelet volume could be calculated from the formula 
mean platelet volume= exp. (μ + 0.5σ') (14) 
In some cases the largest platelets could not be visualized even at low am­
plification. In those cases the invisible part of the frequency distribution 
curve was calculated with an IBM computer from the available part of the 
curve assuming a log normal distribution. In some measurements a discordance 
between the measured frequency distribution and the expected log-normal curve 
distribution was found, caused by electrical background noise in the first 
channel. In those cases the measurement results of the first channels were dis­
carded. 
Examined subjects 
Control subjects (21) were volunteers, mostly healthy laboratory workers and 
some patients without blood disorders. Of 15 patients with (a history of) chro­
nic ITP 12 were studied after splenectomy. Most patients were in apparent re­
missen. In only 5 out of 17 examinations in 15 patients was the platelet count 
less than 100,000/μ1 at the time of examination. 
3.3.3. Results 
uatelet volume distribution proved to be log normal (fig. 25). 
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Fig. 25.Platelet volume distribution in a patient with chronic ITP. Platelets 
are classified in log volumes classes. The number on the abcis indicates the 
channel number of the coulter plotter. The number of platelets counted in each 
volume class is indicated by ® . The curve is the log normal distribution curve 
which, using an IBM computer, proved to correspond best with the measured da­
ta. 
In control subjects the mean platelet volume was 6.83 μ ± 0.85 (1 SD) (ta­
ble 31). Ten out of the seventeen examined patients with (a history of) chro­
nic ITP showed mean platelet volumes within the normal range (mean ± 2 SD). Seven 
ITP patients showed an increased mean platelet volume and an increased mode 
log volume (table 32, fig. 26). In two of these seven patients the variation 
in platelet size, expressed as the standard deviation of log volumes of plate­
lets, was increased. One patient (no.9), with a normal mean platelet volume, 
showed an increased variation in platelet size. The difference in the mean 
platelet volume between control subjects and ITP patients was significant 
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Table 31 
Platelet volume distribution in 21 control subjects 
Case 
no 
Sex Age Platelet 
volume de­
termination 
Diagnosis Platelet 
count 
(χ1(Γ/μ1) 
Platelet volume 
mean 
volume 
mode 
log vol. 
standard 
deviation 
log vol. 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
f 
f 
m 
f 
f 
f 
f 
f 
m 
f 
f 
m 
f 
m 
m 
f 
f 
f 
m 
m 
m 
65 
22 
31 
24 
33 
25 
26 
22 
25 
23 
64 
49 
21 
27 
23 
55 
49 
29 
42 
38 
27 
22-10-73 
19-10-73 
18-10-73 
23-10-73 
23-10-73 
19-10-73 
19-10-73 
19-10-73 
2-11-73 
31-10-73 
31-10-73 
31-10-73 
31-10-73 
30-10-73 
30-10-73 
29-10-73 
18-10-73 
17-10-73 
29-10-73 
26-10-73 
30-10-73 
-
-
-
-
-
-
-
-
-
-
Carcinoma of 
ovary 
Paraprotei­
nemia 
Anorexia 
nervosa 
-
-
Carcinoma of 
breast 
Hyperthyreoi-
dism (treated) 
-
Oesophagitis 
-
_ 
188 
284 
202 
2] 6 
144 
385 
218 
254 
156 
174 
316 
166 
218 
220 
274 
222 
297 
156 
272 
188 
220 
8.31 
6.90 
5.60 
6.39 
8.00 
5.32 
7.46 
5.34 
6.93 
6.98 
5.70 
6.88 
7.11 
6.65 
7.53 
7.22 
5.83 
7.37 
7.22 
7.58 
7.19 
1.99 
1.83 
1.60 
1.72 
1.95 
1.56 
1.91 
1.57 
1.79 
1.81 
1.63 
1.81 
1.83 
1.78 
1.90 
1.86 
1.63 
1.87 
1.86 
1.90 
1.86 
0.505 
0.451 
0.496 
0.519 
0.509 
0.472 
0.446 
0.459 
0.540 
0.516 
0.470 
0.487 
0.513 
0.479 
0.488 
0.483 
0.516 
0.505 
0.483 
0.501 
0.475 
Mean (n= 21)± SD 227І61 6.83 ±085 1 .79±αΐ3 0.491 + 0021 
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Table 32 
Platelet volume distribution in 15 patients with (a history of) chronic ITP 
Case 
no 
Sex Age Platelet 
volume de-
termination 
Splenec-
tomy 
Pred-
nison 
mg-'day 
Platelet 
count 
(xl03/y]) 
Platelet volume 
mean 
volume 
mode 
log vol. 
standard 
deviation 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
lu 
15 
18 
22 
m 
m 
f 
f 
f 
m 
f 
m 
f 
f 
f 
m 
f 
f 
f 
42 
20 
35 
28 
56 
60 
67 
27 
60 
25 
26 
30 
33 
22 
28 
24-10-73 
26-10-73 
24-10-73 
22-10-73 
29-10-73 
23-10-73 
29-10-73 
24-10-73 
29-10-73 
23-10-73 
26-10-73 
1-11-73 
18-10-73 
29-10-73 
18-10-73 
25-10-73 
29-10-73 
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
-
-
-
-
-
-
-
20 
-
-
-
-
-
-
40 
15 
-
329 
137 
307 
170 
87 
66 
240 
44 
42 
174 
165 
87 
414 
385 
209 
310 
111 
6.26 
8.48 
7.69 
7.25 
10.05 
8.81 
9.17 
9.00 
7.80 
10.35 
8.39 
9.84 
6.55 
7.83 
6.13 
5.55 
9.18 
1.71 
2.03 
1.94 
1.84 
2.14 
2.06 
2.10 
2.09 
1.88 
2.21 
2.02 
2.15 
1.77 
1.96 
1.72 
1.60 
2.06 
0.498 
0.442 
0.447 
0.531 
0.579 
0.481 
0.482 
0.463 
0.590 
0.504 
0.463 
0.522 
0.468 
0.443 
0.432 
0.477 
0.560 
Mean (n=17) ± SD 193:020 8.1411.44 1961018 0.493i0j048 
Normal (n=21) 1 SD 227+61 6.83ÌQ85 L79íQJ3 0.4911flJ331 
(p=0003). The difference in the Standard deviation of log volumes of platelets 
between ITP patients and control subjects was not significant. No correlation 
was found between platelet volume and blood platelet count or the age of the 
ITP patients. Only four patients with ITP were examined before splenectomy, 
and it was impossible to decide if the platelet volume of these patients dif-
fered from splenectomized patients. 
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Fig. 26.Parameters of platelet size distribution in control subjects and pa-
tients with (a history of) chronic ITP 
3.3.4. Discussion 
The calculated mean platelet volume of 6.8 μ in control subjects agrees with 
the findings of others (Bull et al. 1965; Karpatkin et al. 1969a,b; Garg et 
al. 1972; Paulus 1974). Only Paulus (1974) gives detailed information about 
platelet volume distribution by reporting the modes of the log volumes and stan­
dard deviations. In normal subjects he found a mode log volume of 1.3Θ to 1.86. 
In this study a range of 1.56 to 1.99 was found while the variation in platelet 
size in the individual subjects, as indicated by the standard deviation of log 
volumes of platelets, seemed to be smaller than that described by Paulus. In 
eight out of fifteen ITP patients the platelet size distribution was different 
from normal. The most important difference was the increased mean platelet vo­
lume. Only m 3 ITP patients was the variation in platelet size also increased. 
Our findings agree with other studies reporting an increased percentage of lar­
ge platelets in ITP patients. In agreement with Garg et al. (1972) we also ob-
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served patients with a history of ITP in apparent remission with an abnormal 
platelet volume distribution suggesting that there was still a stimulated throm-
bocytopoiesis caused by an increased platelet destruction compensated for by 
an adequate compensatory platelet production. In our study 5 patients were in 
a thrombocytopenic phase at the time of platelet volume distribution measure-
ments. All of them showed an abnormal platelet volume distribution. The corre-
lation between platelet volumes and the other observed parameters of thrombo-
cytopoiesis and megakaryocytopoiesis will be discussed in chapter 4. 
3.4. EFFECTIVE PLATELET PRODUCTION AFTER SPLENECTOMY 
3.4.1. Introduction 
While it is generally accepted that the spleen is an important site of platelet 
sequestration (Aster 1966, 1967; de Gabriele et al. 1967), the effect of the 
spleen on platelet production and the mechanism of postsplenectomy thrombocy-
tosis is still unclear. After splenectomy, performed for various reasons, a 
thrombocytosis is observed. In theory postsplenectomy thrombocytosis may be due 
to one or more factors. 
1. The removal of the splenic platelet pool (Ebbe 1968c; Knzsa et al. 1970). 
2. Prolongation of platelet life span. However in the studies of Leeksma et 
al. (1965) in man, and of de Gabriele et al. (1967c) and Aster (1967) in 
animals, platelet life span was unchanged after splenectomy. Abrahamsen 
(1972) even observed a mild transitory shortening of platelet survival in 
the first week after removal of the spleen. 
3. A shortened maturation time of megakaryocytes. Experimental work m animals 
gives no support for this explanation (Rolovic et al. 1970b). 
4. A non-specific stimulus of platelet production due to the surgical proce-
dure. This supposition must also be discarded because thrombocytosis after 
splenectomy is much more marked than after any other surgical procedure 
(Potts et al. 1941; Breslow et al. 1968). 
5. A specific influence of the spleen on the rate of platelet production or 
on the rate of platelet destruction. The existence of such a humoral fac-
tor is suggested by experimental studies in animals in which reimplantation 
of a small portion of the spleen prevented postsplenectomy thrombocytosis 
(Tarnuzi et al. 1967). Shulman et al. (1965) suggested that this humoral 
factor does not inhibit the platelet production rate but increases platelet 
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destruction through the reticuloendothelial system. In this study we calculated 
platelet production before splenectomy retrospectively from the rise in postope-
rative blood platelet counts . It is well known that there is a lag period be-
tween a stimulus for thrombocytopoiesis and the rise in platelet counts. This 
lag period is explained by the fact that the stimulus for thrombocytopoiesis 
acts on the megakaryocyte precursor compartment or on the most immature mega-
karyocytes. The transit time of the stimulated cells through the recognizable 
megakaryocyte compartment causes this lag period. In human beings there are in-
dications that this transit time is about 4 to 6 days (Cronkite et al. 1961; 
Muller 1967; Clarkson et al. 1971). If splenectomy were to influence the pla-
telet production rate^ a rise in platelet count should not occur during the 
first 4 to 6 days after removal of the spleen. For this reason the observed 
rise in blood platelet count during the first postoperative days must be ex-
plained on the basis of the presplenectomy platelet production level. 
This supposition is confirmed by the findings of Harker and Finch (1969) in 
some thrombocytopenic patients with myelofibrosis and Hodgkin's disease. They 
observed that the preoperative estimation of platelet turnover agreed with the 
rate at which the peripheral platelet count increased during the first 4 days 
after splenectomy. 
The postsplenectomy platelet production calculated from the peripheral plate-
let count will not reflect the platelet production before splenectomy if the 
platelet life span is altered. An increased platelet consumption postoperative-
ly is reported by Abrahamsen (1972). This factor leads to an underestimation 
of platelet production but will probably be of the same importance in different 
kinds of splenectomized patients. 
3.4.2. Materials and methods 
In patients who were splenectomized for various reasons, postoperative platelet 
count levels were evaluated retrospectively. Only patients in whom, during the 
first 10 postoperative days, at least 4 platelets counts were performed, were 
analysed. Splenectomies were done in the years 1957-1973 in the surgical depart-
ment (Head: Prof. Dr. W.J.H.Schmidt) . 
Examined subjects 
Chronic ITP (24) 
Twenty four patients with chronic ITP were examined. As earlier described under 
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the diagnostic criteria for chronic ITP the spleen weight in this group was nor-
mal. 
M.Hodgkin (31) 
A group of 31 patients with Hodgkin's disease contained patients in all stages 
of this disease. In none of them was the blood platelet count less than 100,000 
/μΐ before splenectomy. In most cases the spleen was removed during explorative 
staging procedures in untreated patients. The spleen weight was often increased, 
mean 291 grams + 123 (1 SD); with a maximum value of 530 grams. 
Splenic rupture (11) 
Eleven patients with traumatic injuries of the spleen were analysed. In some of 
them only a rupture of the spleen was diagnosed while in other patients there 
were also other traumatic injuries. In four cases the spleen was removed about 
one day after the accident. In the other cases there was a shorter interval be­
tween the accident and splenectomy. 
Some clinical data regarding the three groups of splenectomized patients are 
given in table 33. 
Table 33 
Clinical data on patients in which platelet counts following splenectomy were 
analysed 
chronic ITP 
Hodgkin 
Splenic rupture 
No. of patients 
male 
7 
19 
β 
female total 
17 24 
12 31 
3 11 
Age 
mean ± SD 
35 ± 17 
32 ± 10 
24 ± 12 
Platelet count 
(xl03/pl) 
before splenectomy 
22 ± 24 
275 ±112 
·> (normal :208±50) 
Caloulatbon of platelet production 
Platelet production was calculated from the blood platelet counts of the first 
four postoperative days with a very simpltSed model. The following symbols are 
used in this model: 
a= platelet count per yl before and at the time of splenectomy 
b= platelet count per yl on the first postoperative day. С to η platelet counts 
per yl on the second to η postoperative days. The following assumptions and 
simplifications were made for the first four postoperative days: 
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1. After splenectomy all platelets delivered by the bone marrow are distribu­
ted through the total blood volume and there are no other platelet pools 
comparable with the spleen. 
2. The increase in blood platelets postoperatively ((b-a), (c-a) etc.) is cau­
sed by postoperatively formed platelets. 
3. From the platelets formed after splenectomy on the first postoperative day: 
0.05(b-a) disappear, on the second postoperative day: 0.05(c-a) disappear 
etc. 
A disappearance rate of 0.05% was chosen for newly formed platelets in con­
trast with a disappearance rate of 0.10% for platelet population of a random 
age distribution. 
4. From the presplenectomy formed platelets, with a random age distribution, 
0.1 χ a per yl disappear per day. If there was a fall in platelet count on 
the operative day, as often occurred in Hodgkin patients, 0.1 χ b- was taken 
instead of -0.1 χ a. 
5. Platelet production per μΐ per day is the sum of the observed rise in blood 
platelet count and the calculated disappearance of the pre- and postsple-
nectomy formed platelets. This results on the first postoperative day in: 
(b-a) + 0.1 a + 0.05(b-a),on the second postoperative day in: (c-b)+ 0.1a 
+ 0.05(c-a) etc. 
In most of the ITP patients there was a very low platelet count before sple­
nectomy. Therefore the influence of the presplenectomy formed platelets popu­
lation (a) could be neglected. 
3.4.3. Results 
Mean values of platelet counts 
Mean values of platelet counts on the various postoperative days in the three 
groups of patients are given in figure 27. The data for the 1st 4 days are 
based on 87 estimations of platelet levels in 24 patients with chronic ITP, 
108 estimations in 31 patients with Hodgkin's disease and 33 estimations in 
11 patients with traumatic splenic ruptures. In the later postoperative period 
less platelet counts were performed (table 34). 
In patients with chronic ITP, platelet levels immediately after removal of the 
spleen show a continous marked rise, reaching a peak value of about 500x10 /μΐ. 
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Fig. 27. Mean daily platelet levels after removal of the spleen in 24 patients 
with chronic ITP, 31 patients with Hodgkin's disease and 11 patients with trau-
matic splenic ruptures 
The curves of platelet counts in splenectomized patients with Hodgkin's di-
sease or traumatic spleen injuries show a biphasic course: a slow rate of pla-
telet increase during 4 days is followed by a more striking rise. Another dif-
ference between the platelet levels after splenectomy in the three groups of 
patients is the postoperative dip seen in Hodgkin's patients and traumatic 
patients but not in the ITP patients. The mean daily platelet values in pa-
tients with splenic ruptures show an irregular course. In this group the num-
ber of examined patients and the number of platelet counts per patient were 
less than in the other groups. After the 5th day the course of the platelet 
counts in the three groups of patients was about the same. 
Individual values of -platelet counts 
Generally the platelet count rise after splenectomy in chronic ITP patients 
was regular, while in patients with Hodgkin's disease or splenic ruptures a 
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Table 34 
Pre- and postoperative platelet counts in 24 patients with chronic ITP, 31 pa­
tients with Hodgkin's disease and 11 patients with traumatic splenic ruptures 
Ρ r e-
chronic ITP 
n:24 
M.Hodgkin 
n:31 
Splenic 
ruptures 
n:ll 
mean* 22 
SD 24 
η 24 
mean 275 
SD 112 
η 30 
maan(208*) 
SD (50** 
η 
0 
64 
33 
7 
1 
105 
80 
21 
191 
81 
25 
139 
62 
7 
2 
154 
111 
22 
199 
80 
29 
128 
38 
9 
P o s 
3 
199 
128 
23 
218 
104 
28 
205 
75 
9 
t -
4 
247 
144 
21 
229 
90 
26 
225 
59 
8 
o p e 
5 
274 
198 
17 
292 
126 
30 
225 
82 
4 
г а 
6 
357 
247 
18 
327 
144 
25 
356 
119 
8 
t i ν 
7 
419 
316 
20 
343 
115 
23 
453 
169 
8 
e d 
8 
494 
285 
14 
463 
201 
23 
506 
219 
7 
a y 
9 
503 
304 
13 
444 
171 
21 
571 
233 
7 
10 
468 
241 
13 
521 
211 
18 
558 
215 
10 
11 
424 
238 
11 
509 
206 
15 
556 
262 
5 
* mean platelet count (xlO /μΐ) 
** normal platelet count 
period of slow increase durine' 4 to 7 days was followed by a striking increase. 
This node in the platelet count course never occurred before rhe -Ith postope­
rative day. In 22 out of 24 patients with chronic ITP a significant rise in 
blood platelets was observed, reaching a peaketo 13 days (mean 9 days) after 
splenectomy. In patients with Hodgkin' s disease the postoperative peak was 
reached 7 to 17 days (mean 13 days)after splenectomy. 
The oalaulated platelet produotion 
The platelet piodjution calculated in each patient from the blood platelet 
counts of the first four postoperative days resulted in a mean platelet pro­
duction of 62 χ 10 /μΐ/day (SD 45 xlO ) in patients with chronic ITP and 
37 χ 103/Ul/day (SD 33 χ 10 ) in patients with Hodgkin's disease (fig. 28). 
This difference was significant (p=0.03; Wilcoxon's two sample test). In ITP 
patients and Hodgkin's patients there was no difference in calculated pla-
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telet production between each of the first 4 postoperative days. However in 
Hodgkin's patients the platelet production on the fifth postoperative day was 
significantly higher than on the fourth day. In ITP patients platelet produc­
tion on 4th and 5th day was equal. There was no correlation between the cal­
culated platelet production and the blood platelet count before splenectomy or 
the age of the patients in either chronic ITP patients or in Hodgkin's patients. 
In patients with traumatic injuries of the spleen the number of platelet counts 
during the first 4 postsplenectomy days was insufficient for reliable calcula­
tion of platelet production. 
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Fig.28. Platelet production calculated from the blood platelet counts during 
the first 4 days after splenectomy in 24 patients with chronic ITP and 27 pa-
tients with Hodgkin's disease 
3.4.4. Discussion 
The calculation of platelet production, with use of the simplified model for 
different disappearance rates of old and young platelets, is not free from 
criticism. The use of more sophisticated mathematical models in this study 
was not considered to be useful for the following reasons: 
1. The influence of the surgical procedure on the consumption of platelets is 
in the first postoperative days much more important than the natural dis-
appearance rate (Abrahamsen 1972). 
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2. The assumption of a normal platelet life span after splenectomy m ITP pa­
tients is, at least for some patients not valid. 
3. The accuracy of routine platelet counts used in this retrospective study is 
rather low. 
In patients with chronic ITP the calculated platelet production during the 
first four days after splenectomy was higher than in patients with Hodgkin's 
disease. In Hodgkin's disease platelet production will be normal or increased 
(Abrahamsen 1970, 1972). Therefore the difference in calculated platelet pro­
duction between the ITP group with a mean value OL 62 χ 10 /μΐ/day, and the 
Hodgkin group with a mean value of 37 χ 10 /μΐ/day suggests that the mean 
platelet production in ITP immediately after splenectomy is about twice the 
normal production. The individual calculations m ITP patients showed a ma­
ximum increase in platelet production of about 4 times the mean value in 
Hodgkin's disease. The difference in platelet production between patients with 
Hodgkin's disease and ITP will be underestimated because in our model a nor­
mal platelet life span was assumed in ITP patients after splenectomy. However, 
shortened platelet survival will occur m some ITP cases after splenectomy. 
One of our basic assumptions is that platelet production during the 1st 4 
days after removal of the spleen will be the same as the platelet production 
before splenectomy. This was assumed because m man there is a lag period of 
about 5 days between the stimulus for a change in platelet production and the 
change in platelet delivery of the bone marrow into the blood (Cronkite et 
al. 1961; Muller 1967; Breslow et al. 1968; Clarkson et al. 1971). This was 
supported by the observed equal calculated platelet production in Hodgkin's 
disease before and during the fist days after splenectomy: immediately post­
operative the calculated production was 36 χ 10 /μΐ/day; the presplenectomy 
blood platelet level of 275 χ 10 /yl also requires a daily platelet production 
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of about 36 xlO /μΐ/day assuming that the spleen pools 30% of all platelets 
and a platelet life span of 10 days. It therefore seems reasonable to assume 
that also in ITP patients the calculated platelet production immediately post­
operative reflects the platelet production before splenectomy. As, moreover, 
we observed an increased platelet production in ITP immediately after splenec­
tomy, this implies an increased platelet production in most chronic ITP patients 
before splenectomy. 
Finally a general remark about postsplenectomy thrombocytosis: 
A significant rise in calculated platelet production in Hodgkin patients from 
the fourth to fifth postoperative day was found,while in the same period m 
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patients with traumatic injuries a node in the course of the platelet counts 
was observed. It was calculated that this could not be explained by the removal 
of the splenic platelet pool and an unchanged platelet production, but suggests 
that splenectomy is a stimulus for an increased platelet production. This sple-
nectomy-stimulus is more important than tne stimulation of thrombocytopoiesis 
through other surgical procedures. So the old problem of the inhibitory func-
tion of the spleen on thrombocytopoiesis is still unsolved. 
3.5. CONCLUSIONS 
The observed normal thymidine incorporation by megakaryocytes in chronic ITP 
patients points to a normal DNA synthetic activity of the recognizable megaka-
ryocytes. This observation, together with the normal frequency distribution 
of megakaryocytes in the various morphological maturation classes, suggest 
that maturation time of megakaryocytes in chronic ITP patients is normal. Pilot 
studies concerning the incorporation of undine and methionine in vitro by 
megakaryocytes also gave indications for a normal activity of ITP megakaryo-
cytes. So the morphological frequency distribution and the incorporation of 
thymidine, undine and methionine argues against qualitative changes in mega-
karyocytopoiesis in chronic ITP patients. Platelet production calculated from 
the rise in blood platelet counts during the first days after splenectomy proved 
to be about twice the normal platelet production in chronic ITP patients. There 
are good arguments that this platelet production during the first days after 
splenectomy is identical to platelet production before splenectomy. The cal-
culated increased platelet production in ITP suggest that the observed increase 
in platelet volumes in ITP is an indication of an increased platelet production 
and is not an indication of an abnormal thrombocytopoiesis. The observed change 
in platelet count and in calculated platelet production after splenectomy in 
non-ITP patients suggests that the maturation time of megakaryocytes is about 
5 days. 
Moreover the postsplenectomy thrombocytosis in these non-ITP patients can not 
be explained by the removal of the splenic platelet pool alone, but also sug-
gests an inhibitory function of the spleen on thrombocytopoiesis. 
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CHAPTER 4 
GENERAL DISCUSSION 
Äs discussed in chapter 1 it is generally accepted that platelet survival is 
decreased in ITP. From the literature the influence of platelet production on 
the development of the thrombocytopenia m ITP is not clear. This seems to be 
due to the inaccuracy of calculating platelet production by methods using iso-
topically labelled platelets. In this study we tried to g a m some insight into 
platelet production m ITP employing other methods: on the one hand by investi-
gations on megakaryocytopoiesis and thrombocytopoiesis and on the other by cal-
culating platelet production, using platelet counts immediately after splenecto-
my in ITP patients in comparison with other splenectomized sub]ects. The aspects 
of megakaryocytopoiesis and thrombocytopoiesis were studied m which, according 
to tne literature concerning stimulated thrombocytopoiesis m human or animal 
experiments, differences might be expected. As described in chapters 1 and 2, 
the most relevant changes which may be expected in a stimulated thrombocytopoi-
esis are an increase in: 
a. the total megakaryocyte volume 
b. the mean individual megakaryocyte volume 
с the number of megakaryocytes 
d. the ploidy level of megakaryocytes 
e. the percentage of young (immature) megakaryocytes 
f. the percentage of megakaryocytes with DNA synthetic activity 
g. the platelet volume 
In this study (3.1,3. and 3.2.3.) an increase in the percentage of young (imma­
ture) megakaryocytes and an increase in the percentage of megakaryocytes with 
DNA synthetic activity occurred only immediately following an acute stimula­
tion of thrombocytopoiesis and not in chronic stimulation. Although this obser­
vation on first sight is in disagreement with the literature, the normal percen­
tage of immature megakaryocytes was easily explained by the duration of the sti­
mulation of thrombocytopoiesis in chronic ITP patients. The normal DNA synthetic 
activity of megakaryocytes in patients with chronic ITP can also be explained by 
the duration of the stimulation and by the fact that the observed ploidy level 
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of megakaryocytes in chronic ITP was only moderately increased (3.1.4.).The 
group of patients with chronic ITP studied, showed an increased (p=0.03) plate-
let production (3.4.3.) and the other changes expected in a stimulated thrombo-
cytopoiesis (excluding the 2 above mentioned parameters): 
a. the total megakaryocyte volume in marrow biopsies was on the average 1.9 times 
greater (pOOOOJ) than normal (2.2.2.). 
b. the individual megakaryocyte volume was greater than normal as demonstrated 
by the diameter of sections of metpkaiyocytes which was on the average 1.2 
times increased (p= uOOl) and by the mean area of sections of megakaryocytes 
which was on the average 1.1. times increased (p= 0.04). 
c. the number of megakaryocytes was increased (2.2.3.^. 
d. the mean ploidy level of megakaryocytes was 1.1 times greater than normal 
(p=0.06) (2.2.2.). 
g. the mean platelet volume was 1.2 times greater (p= 0.003) than normal (3.3.3). 
So an increased platelet production and changes in megakaryocytopoiesis and 
thrombocytopoiesis, as expected in a stimulated thrombocytopoiesis, were found 
in the groups of ITP patients. This does not mean that the increase in plate-
let production is as much as might be expected from the increased potential 
platelet production capacity. The observation in the groups of patients with 
ITP shows that there is a quantitative agreement between the increase in pro-
duced total platelet volume and the increase in total megakaryocyte volume, 
since the total megakaryocyte volume increase was 1.9 times, the increase in 
the number of produced platelets was 1.7 times and the increase in the mean 
platelet volume was 1.2 times. Despite this quantitative conformity of static 
parameters, thrombocytopoiesis might be ineffective if the turnover rate of 
megakaryocytes is greater than normal. However in this study evidence was 
found that indicated that the maturation time of negakaryocytes is not shortened 
when thrombocytopoiesis is stimulated: 
a. In non-ITP patients an increase m platelet production was found after sple-
nectomy (3.4.2.). Despite this stimulation of thrombocytopoiesis a normal 
megakaryocyte maturation time of about 5 days was found. 
b. The normal percentage of megakaryocytes of type I combined with the normal 
thymidine labelling of megakaryocytes in patients with chronic ITP also 
suggest a normal maturation time (3.2.4.). 
Another argument for a normal megakaryocyte maturation time despite a stimula-
tion of thrombocytopoiesis can be deduced from the observations of Harker et 
al. (1969) and Kutti et al. (1973 ). They found a direct, linear relationship 
between the total megakaryocyte volume and platelet production. If the maturation 
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time of the megakaryocytes is increased in stimulated thrombocytopoiesis one 
would expect that the increase in the total megakaryocyte volume would be less 
than the increase in platelet production. As well was these quantitative agree-
ments between platelet production capacity (total megakaryocyte volume) and 
platelet production there is still another argument against an ineffective throm-
bopoiesis in ITP in patients with inpffective thrombocytopoiesis the mean (indi-
vidual) megakaryocyte volume is normal or decreased (Harker et al. 1969). But 
in patients with chronic ITP an increased megakaryocyte size has been found by 
Harker et al. (1969) and again in this study. 
The lack of indications for an ineffective thrombocytopoiesis does not exclude 
abnormalities in megakaryocyto- and thrombocytopoieis. That is to say, it 
cannot be excluded that megakaryocytes may be destroyed before they can release 
platelets particularly since antibodies have been demonstrated on megakaryocytes 
from some ITP patients (Pisciotta et al. 1953, Mac Kenna (1962). If these anti-
bodies led to a destruction of megakaryocytes one would expect that specifically 
the mature megakaryocytes, which have may antigens m common with platelets, 
would be destroyed. However in this study a normal percentage of mature, type 
III, megakaryocytes have been found and Harker et al. (1969) found a normal 
cytoplasm-nucleus ratio in megakaryocytes from ITP patients. 
To summarise; the results of our investigations in groups of patients with 
(a history of) ITP support the idea of an increased platelet production in 
ITP which is quantitatively in conformity with the observed increase in plate-
let production. The results from the groups of ITP patients gave no indications 
of an ineffective thrombocytopoiesis or disturbance of megakaryocyto- or throm-
bocytopoiesis. The results of the described investigations make a partial 
destruction of megakaryocytes appear unlikely, although this cannot be ex-
cluded with certainty. 
After this discussion of the results from the groups of patients with ITP, the 
results in the individual patients will be discussed. The results of the va-
rious parameters of megakaryocytopoiesis and thrombocytopoiesis in the indivi-
dual patients are given in the appendix .Patients with ITP showed a clear 
overlap of normal and increased values (2.2.2., 3.1.3., 3.2.3., 3.3.3. and 
3.4.3.) as is summarized in table 35. Of these parameters megakaryocyte volume, 
the mean section diameter and the mean platelet volume were the three parameters 
which were most frequently abnormal in ITP. An attempt was made to classify 
133 
ITP patients by use of these three parameters. In table 36 the values of these 
parameters in patients with ITP are arranged according the severity of the 
thrombocytopenia and the determined degree of stimulation of thrombocytopoiesis 
at the date of the bone marrow examination. The degree of stimulation of thrombo­
cytopoiesis was indicated and evaluated as: 
+++ : platelet count less than 40,000/yl, 
++ : platelet count 40,000 - 80,000 /Ml, 
+ : platelet count 80,000 -110,000 /μΐ, a normal platelet count unless there 
was a shortened platelet life span or a normal platelet count and an offspring 
with neonatal thrombocytopenia, 
- : normal platelet count and normal platelet life span (determined by isotopie 
labelling of platelets) 
^ : normal platelet count but no determination of platelet life span available. 
Table 35 
Number of increased aid normal values for parameters of megakaryocytopoiesis and 
thrombocytopoiesis in patients with ITP 
total megakaryocyte volume 
mean megakaryocyte volume 
(section diameter) 
mean megakaryocyte ploidy 
mean platelet volume 
calculated platelet production 
Total number 
of 
investigations 
24 
24 
14 
17 
24 
Number of 
above the 
normal 
range 
18 
15 
3 
7 
6 
values 
below the 
normal 
range 
0 
0 
0 
0 
0 
21 marrow biopsies were taken during stimulation of thrombocytopoiesis. In 
these the total megakaryocyte and the mean section diameter were increased 
16 and 13 times respectively (table 36). In one splenectomized patient with 
a history of ITP a stimulation of thrombocytopoiesis seems unlikely because 
the platelet count and platelet life span were normal. In this patient the 
total megakaryocyte volume, the mean section diameter and the mean platelet 
volume were normal· indicating a complete remission after splenectomy. In two 
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Table 36 
Comparison of the degree of stimulation of thrombocytopoiesis and the results 
of determinations of total megakaryocyte volume, mean section diameter of mega­
karyocytes and mean platelet volume in patients with (a history of) ITP 
Case 
no. 
8 
17 
13 
16 
14 
15 
la 
12 
18 
9 
6a 
6b 
7a 
6c 
Sa 
4 
2 
11 
3 
10a 
10b 
5b 
7b 
lb 
22 
Platelet 
count 
(xl03/nl) 
at the 
Stimu-
lation 
time of mar-
row examinations 
2 
7 
8 
10 
10 
10 
16 
23 
35 
48 
55 
58 
56 
66 
92 
92 
110 
166 
170 
200 
205 
156 
322 
268 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
++ 
++ 
++ 
++ 
++ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
τ» 
-ρ 
-
Megakaryocyte 
total 
volume 
_ 
t 
+ 
+ 
+ 
+ 
+ 
t 
t 
+ 
+ 
= 
+ 
+ 
+ 
= 
+ 
+ 
= 
= 
t 
+ 
= 
mean sec­
tion dia­
meter 
_ 
t 
+ 
t 
+ 
= 
= 
+ 
t 
= 
_ 
t 
•t-
= 
+ 
+ 
+ 
= 
+ 
+ 
+ 
+ 
= 
Platelet 
count 
Stimu­
lation 
at the time of 
platelet volume 
examination 
44 
87 
ƒ 385 
\414 
329 
ƒ 209 
\ 310 
42 
"V 66 
240 
66 
87 
170 
137 
165 
307 
\ 174 
; 
87 
240 
329 
111 
++ 
+ 
-
·> 
++ 
++ 
7 
+ + 
+ 
•> 
·> 
•> 
•з 
+ 
+ 
7 
-
•э 
Mean plate­
let volume 
t 
+ 
=-
= 
=1 
= 
+ 
+ 
+ 
+ 
= 
= 
= 
= 
+ 
+ 
+ 
= 
+ 
splenectomized patients in which stimulation of thrombocytopoiesis had not been 
studied the increased total megakaryocyte volume and mean section diameter sug­
gested that after splenectomy an increased platelet destruction was compensated 
by an increased platelet production. A determination of platelet volume was per­
formed 6 times in patients in whom thrombocytopoiesis was thought to be stimulated 
(table 37). In only one of them was no increase in the mean platelet volume ob­
served (no.9). However in this splenectomized patient the variation in platelet 
size was much greater than normally. Moreover this was a peculiar patient because 
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Table 37 
Comparison of the degree of stimulation of thrombocytopoiesis and the mean pla­
telet volume in patients with a history of ITP 
At the time of platelet volume estimation 
Case 
no. 
9 
8 
6 ab 
5 b 
14 
22 
2 
11 
4 
10 ab 
7 a 
3 
1 a 
15 
15 
Platelet 
count (xlOJ/Ul 
42 
44 
66 
87 
87 
111 
137 
165 
170 
174 
240 
307 
329 
385 
414 
Stimulation 
++ 
++ 
++ 
+ 
+ 
7 
7 
? 
7 
+ 
7 
7 
-
7 
7 
Mean platelet 
volume 
= 
+ 
+ 
+ 
+ 
t 
= 
= 
= 
t 
+ 
= 
= 
= 
= 
the platelet life span was normal in spite of a thrombocytopenia. In patients 
with a history of ITP with dubious stimulation of thrombocytopoiesis the pla­
telet volume varied between 2 and 8 times normal. Of the 2 patientswith an 
increased platelet volume one patient also showed an increased total megakaryo­
cyte volume suggesting a compensated thrombocytolysis while in the other patient, 
whose total megakaryocyte volume was not determined, the low borderline value 
for blood platelet counts (111,000/μ1) also suggested a stimulated thrombocyto­
poiesis. In six patients with a stimulated thrombocytopoiesis, values of all 
three parameters (total megakaryocyte volume, the mean section diameter and 
platelet volume), were together available nine times. On two occasions all 
three parameters were increased, five times two were increased, and twice 
only one of the parameters was increased. So in cases with a stimulated throm­
bocytopoiesis the total megakaryocyte volume, the mean section diameter and 
the mean platelet volume are generally increased but sometimes normal. There­
fore several explanations are possible: 
1. changes in all three parameters occur dependent on the degree of stimulation 
of thrombocytopoiesis. It is conceivable, for instance, that moderate stimula­
tion only causes an increase in the number of megakaryocytes. This will result 
in an increase in the total volume of megakaryocytes but not in an increase in 
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the mean section diameter of megakaryocytes as has been observed in some cases in 
this study. So it is also conceivable that the only result of a moderately stimu-
lated thrombocytopoiesis is an alteration in platelet volume or megakaryocyte 
volume. However in this study no correlation was found between the degree of 
the thrombocytopenia and the frequency of increase m total megakaryocyte volume, 
section diameter or platelet volume. There was also no correlation between the 
degree of the thrombocytopenia and the degree of increase of the various mention-
ed parameters. 
2. It is possible that after splenectomy the normal value for total megakaryo-
cyte volume is 30% less than before splenectomy (2.2.3.). If this is true then 
the value for the total megakaryocyte volume ir patients with stimulated throm-
bocytopoiesis is increased in all but one patients and there is no longer a 
discrepancy between the increased mean section diameter and the normal total 
megakaryocyte volume in the three splenectomized ITP patients. 
3. With the techniques employed, moderate alterations in the parameters used to 
recognize stimulated thrombocytopoiesis are undetectable. 
4. The parameters of stimulated thrombocytopoiesis are influenced by other 
factors. E.g. it is conceivable that antiplatelet antibodies led to alterations 
in the individual megakaryocyte volume and/or to destruction of megakaryocytes. 
Arguments against this hypothesis have been mentioned above. 
5. \&rious pathogenic factors exist. In this case ITP should be considered as 
a clinical syndrome with various pathogenetic factors which lead to various 
alterations in me^caryocytopoiesis and thrombocytopoiesis. However, there 
are too many combinations of normal and increased values of total megakaryocyte 
volume, individual megakaryocyte volume and platelet volume to classify ITP 
patients into a series of logical subgroups. 
A classification of ITP patients into various types is not facilitated by conside-
ration of the mentioned parameters together with other characteristics such as age, 
sex, course of the thrombocytopenia (neither spontaneous nor following treatment 
with corticosteroids or splenectomy). A classification of patients with ITP into 
patients with ineffective and patients with effective thrombocytopoiesis is also 
not possible because only in some patients, for whom the total megakaryocyte 
volume was known, could the platelet production also be calculated (immediate-
ly after splenectomy). Moreover the values for the calculated platelet produc-
tion, although useful for comparing groups of patients, are too inaccurate 
for individual patients because complications such as postoperative infec-
tions and haemorrhages influence the calculated production. So the analysis of 
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the various cnaractenstics of patients with ITP does not lead to a logical 
classification into sub-groups. 
Our observations suggest that the effect of splenectomy is less favourable in 
patients with ITP in whom the total megakaryocyte volume is not clearly increased. 
The number of observations is still small. Therefore at this moment we can not 
advise against splenectomy in patients with ITP when the total megakaryocyte 
volume is not increased. However, the finding of a normal total megakaryocyte 
volume in ITP patients should lead to more conservative management: treatment 
with corticosteroids and immunosuppressive agents should be carried out more 
extensively and relative contra-indications for splenectomy should be accorded 
more weight. 
If the total megakaryocyte volume is decreased in patients with the diagnosis 
ITP, then this diagnosis should be reconsidered because in this study it has 
never been observed in undisputed ITP patients. 
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SUMMARY 
Etom the literature the role of platelet production in the pathogenesis of a 
thrombocytopenia m patients with chronic idiopathic thrombocytopenic purpura 
(ITP) is not clear. This study concerns the level of platelet production in 
ITP which has been examined by investigating some aspects of megakaryocytopoie-
sis and thrombocytopoiesis. 
In chapter 1 the literature on megakaryocytopoiesis, thrombocytopoiesis and 
platelet kinetics under normal and pathological conditions is briefly reviewed. 
Special attention has been paid to phenomena suggesting a stimulating thrombo-
cytopoiesis because such parameters have been thought to be valuable indica-
tions for an increased platelet production in ITP. 
Chapter 2 deals with the method for examination of the productivity of mega-
karyocytes by a study of their number and their individual volumes; the total 
megakaryocyte volume in marrow biopsies as an indication of platelet produc-
tion capacity. From the literature and our own observations, it is clear that 
determinations of the number of megakaryocytes in bone marrow aspirates, espe-
cially in marrow smears, are unreliable. Attention has been directed towards 
the importance of the individual volume of megakaryocytes for their platelet 
production capacity. Using the described histometric method, the product of 
the number of megakaryocytes and their volumes in marrow biopsies has been deter-
mined. The results of these histometric determinations in 18 patients with 
chronic ITP were significantly increased in comparison with 14 control sub]ects, 
while in patients with a thrombocytopenia caused by bone marrow hypoplasia 
lower figures were obtained. In some patients with a history of ITP but normal 
platelet counts, an increase in total megakaryocyte volume was found sugges-
ting that platelet destruction was still increased but was compensated by an 
increased platelet production. Diagnosis of such compensated thrombocytolysis 
proved to be of practical importance in three pregnant women with a history of 
ITP but with normal platelet counts. This information makes it possible to 
predict that the offspring of su<h patients may show a thrombocytopenia 
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which could be important for the management of the delivery. The increase in 
total megakaryocyte volume in ITP is caused by an increase m the number, as 
well as in the individual volumes, of megakaryocytes. Attention is directed 
towards the importance of cellulanty of the bone marrow biopsy in judging the 
sig η ificance of the total megakaryocyte volume of a marrow biopsy for the 
total megakaryocyte volume of the body. 
Moreover in chapter 2 the observed increase in ploidy levels determined by 
microfluorometric measurements of Peulgen stained nuclei in patients with 
chronic ITP is discussed. This increase is in accordance with the increase m 
the individual megakaryocyte volume in ITP and will result in an increase in the 
platelet production capacity of the individual megakaryocytes. 
While chapter 2 deals with some static aspects of megakaryocyto- and thrombo-
cyto-poiesis, chapter 3 deals with some dynamic aspects . namely metabolic 
and functional aspects of megakaryocyto- and thrombocytopoiesis. After in 
vitro incubation of megakaryocytes with radioactive thymidine, the thymidine 
uptake, as studied by autoradiography, proved to be normal in 12 patients with 
chronic ITP. On the other hand, in 5 out of 6 patients with an acute stimula­
tion of thrombocytopoiesis, the labelling index of megakaryocytes was increased. 
3 3 
Pilot autoradiographic studies concerning H-undme and Η-methionine uptake 
suggest that there are no important alterations in RNA- and protein synthesis-
activity in ITP patients. Autoradiographs were prepared using a special tech­
nique in order to conserve the morphology of May Grunwald Giemsa stained cells-
By this means it was possible to classify megakaryocytes in autoradiographs 
into various maturation classes. This classification was normal in those 
patients studied, who had chronic ITP while in 2 patients with an acute post­
operative thrombocytopenia an increase in the number of immature, type I, me­
gakaryocytes was observed. The reasons for considering the combination of 
normal distribution of megakaryocytes in their various maturation cldsses and 
a normal thymidine labelling index of megakaryocytes in chronic ITP patients, 
as an indication of a normal megakaryocyte maturation time are discussed. 
The platelet volume proved to be increasaiin patients with chronic ITP. The 
significance of this finding for stimulated or abnormal thrombocytopoiesis 
is discussed. 
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Finally, in chapter 3 it is demonstrated that the mean platelet production in 
24 patients with ITP is about twice that of 42 patients with Hodgkin's disease 
or traumatic splenic ruptures. This comparison has been made by calculating 
platelet production from blood platelet counts immediately after splenectomy. 
From these observations it can, moreover, be concluded that postsplenectomy 
thrombocytosis in non- ITP patients is not only due to removal of the spleen, 
as is often asserted, but is also partly caused by an increased platelet produc-
tion which becomes evident about five days after splenectomy. Those five days 
are seen as the time needed for maturation of the megäaryocytes and so this 
supports our conclusion that the maturation time of human megakaryocytes is not, 
or is only slightly, increased if thrombocytopoiesis is stimulated. 
In chapter 4 the results described in the foregoing chapters are brought to-
gether and analysed. The mean increase in the total megakaryocyte volume in 
marrow biopsies in the group of ITP patients studied, is quantitatively m ac-
cordance with the mean increase in calculated platelet production observed m 
a retrospective study of a group of patients with ITP, which also includes 
another group of ITP patients. Since in this study no indications have been 
found for a shortened megakaryocyte maturation time when thrombocytopoiesis 
is stimulated, the quantitative agreement between the increase in total mega-
karyocyte volume and the increase in platelet production suggests that throm-
bocytopoiesis is effective in ITP. 
Using the parameters of megakaryocytopoiesis and thrombocytopoiesis which are 
most frequently abnormal (increased) in patients with ITP together with the 
patients clinical characteristics, an attempt is made to classify patients 
with ITP into different types. In most patients the findings suggest an in-
creased platelet production. In some patients no adequate reaction of the bone 
marrow to the thrombocytopenic stimulus seems to occur. This is accompanied 
by unsuccesful splenectomy. However such patients were rare and there were 
many transitional stages between them and ITP patients with signs of an 
increased thrombopoietic activity in whom splenectomy was succesful. Therefore 
a logical classification of ITP patients based on the parameters employed 
in this study was not possible. 
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Appendix 
Survey of investigations m all examined patients. The results of the determinations 
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of the various megakaryocytes and platelet parameters are expressed as functions of 
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19Ь7 Poor 12 ITP 
1940 Poor 13 ITP 1)66, removal of 
1966 Poor accessory spleen 
1.7 = 
1.4 + 
28-02-73 Moderate 14 ITP 
1.0 = 
1.1 = 
1955 Good 15 ITP;intermittert thrombocytopenia 
28-11-72 Poor 17 ITP 
0.9 = 
0.8 = 
18 ITP 
19 ITP 
+ + 
1.3 t 
1972 
1 4 - 1 0 - 7 1 
Good 
Good 
2 0 ITP 
21 ITP 
22 ITP 
23 Hypoplastic thrombocytopenia 
25 Hypoplastic thrombocytopenia 
26 Hypoplastic thrombocytopenia 
< 0.1 •}· 06-04-72 Poor 27 Lupus erythematosus 
28 Drug induced' 
Thrombocytopenia (gold) 
0.8 = 29 Thrombocytopathy 
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30 fam. thrombocytopenia 
31 fam. thrombocytopenia 
32 primary thrombocytosis 
1.0 
0.6 4· 
33 urticaria pigmentosa,thrombocytosis 
34 rheumatoid arthritis(thrombocytosis 
35 myelofibrosis 
36 chronic myeloid leukaemia 
37 chronic myeloid leukaemia 
0.6 Ψ 
38 atrial septal defect^ 
r 
40 insufficiency 
41 atrial septal defect 
42 mitral insufficiency 
post 
operative 
> 
thrombo­
cytopenia 
43 prosthetic hip surgery 
44 auto-irranune haemolytic 
anaemia ,splenomegaly 
)5-71 Moderate 45 lupus erythematosus 
46 infectious thrombocytopenia 
47 thrombotic thrombocytopenic 
purpura? 
)unt= .50,000-100,000/μ1; poor if platelet count: < 50,000/μ1 
re indicated by =. Values falling outside of the normal range are indicated by +or4·. 
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